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Definitions 
 
1-General  practitioner: (GP) 
A physician whose practice consists of providing ongoing care covering a variety of 
medical problems in patients of all ages, often including referral to appropriate specialists, 
also called family doctor (UNRWA, 2004).  
 
2-Senior Medical Officer: (SMO)  
A physician whose practice responsible for operation and administration of  the  health 
centre to which he/she assigned including organization of  services, personnel supervision, 
supply management and reporting (UNRWA,2004). 
 
3-Essential medicines:  
Essential medicines are those that satisfy the priority health care needs of the population. 
They are selected with due regard to public health relevance, evidence on efficacy and 
safety, and comparative cost-effectiveness which is called EDL, (WHO, 1992). 
 
4-local opinion leaders:   
Defined as health professionals nominated by their colleagues as being educationally 
influential, (Management Science for Health, 1997). 
 
5- Prescribing encounters (PE): 
It is the patient encounter who is prescribed medicines, if  antibiotics its called Antibiotics 
prescribing encounters (APE), (WHO,1993). 
 
                                                
                                                                                           III 
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6-Academic detailing:                                                                                                             
                       
 In educational outreach or "academic detailing", which is usually used to improve 
prescribing practices after completion of training, brief, targeted, face-to-face educational 
visits to clinicians, principles of communications theory and behavioural science are           
                                                                                                                           combined 
with conventional education technique, (Soumerai, and Avorn 1990).             
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Abstract 
Antibiotics therapy is considered to be a major component of patient management in 
primary health care, despite this recognition, unnecessary antibiotic prescribing remains 
common. To evaluate the general practitioners prescribing patterns in UNRWA health  
centers in Gaza strip, 1080 prescriptions were collected retrospectively from all the 15 
health centers, 72 from each clinic and studied using WHO indicators, in addition to 
structured questionnaire to evaluate knowledge, attitude, and practices of the general 
practitioners. The study revealed over consumption of antibiotics as the percentage of 
encounters receiving antibiotics was  55.4%, percentage of encounters receiving  
antibiotics injection 2.2%, percentage of antibiotics prescribed by generic names 4.5%, 
percentage of antibiotics from UNRWA Formulary 99.7%, and average number of drugs 
per encounter was 2. Also 14.6% of prescription were with no diagnosis mainly in the 
family files , the commonest diagnosis reported was URTI (37.1%) and (82.8%) of them 
were provided antibiotics. The study showed the importance of training and experience as 
a sources of information. Also physicians interest in clinical guidelines has never been 
great, only 9.5% of UNRWA Formularies available in front of general practitioners. 
General practitioners attitude toward antibiotics prescription was generally good, but their 
interest was high to prescribe antibiotics in case of fever 65.1%, time pressure 72.6%, 
treatment uncertainty 28.6%. 96.4% of respondents agree that antibiotics are over 
prescribed, the most important factors for overuse was over-crowding 65%, clients 
pressure 55.7%, antibiotics prescribed without examination and diagnosis 36% and lack of 
knowledge 31%. And the most important general practitioners initiatives for promotion of 
prudent use of antibiotics were health educations of consumers 48.7%, training 47.4%, 
reducing overcrowding 33% and improving knowledge 29.4%. The study concluded that 
rational use of antibiotics needs to be emphasized through multi-faceted interventions as 
informational, educational, measures. The key elements should include updating 
knowledge for the providers, clinic based patient education and community outreach 
activities, in addition to  regulatory and managerial policies as establishment of ―UNRWA 
Therapeutic Committee‖, active dissemination of UNRWA Drug Formulary,  training and 
supervision. 
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 ٍيخض اىذساعح
 
  فً ػٍاداخ اىىماىح   اىؼاٍٍىُ أَّاؽ وطف اىَؼاداخ اىحٍىٌح ٍِ قثو الأؽثاء
  6002غضج 
٠ؼزجش اٌؼلاط ثبٌّؼبداد اٌؾ١ٛ٠خ ِٓ اٌّىٛٔبد الأعبع١خ فٟ ثشٔبِظ اٌشػب٠خ  الأٌٚ١خ ٚػٍٝ اٌشغُ ِٓ رٌه فاْ اٌٛطف 
  ٌٚزم١١ُ أّٔبؽ ٚطف اٌّؼبداد اٌؾ١ٛ٠خ ِٓ لجً الأؽجبء اٌؼبِ١ْٛ  فٟ ػ١بداد اٌٛوبٌخ فٟ, اٌغ١ش ػشٚسٞ ٠ؼزجش شبئؼب
اٌغزخ اٌغبثمخ ِٓ شٙش ٠ٌٛ١ٛ  ٚطفخ ؽج١خ رّذ فٟ الأشٙش 0801لطبع غضح   لبَ اٌجبؽش ثأخز ػ١ٕخ ػشٛائ١خ ِىٛٔخ ِٓ 
 ٚطفخ ِٓ وً ِشوض ثبعزخذاَ ِإششاد ِٕظّخ اٌظؾخ اٌؼبٌّ١خ ثبلإػبفخ 27,  ِٓ وً اٌّشاوض 6002ؽزٝ د٠غّجش 
ٌمذ أٚػؾذ اٌذساعخ . رٛعُٙٙ ٚوزٌه ِّبسعزُٙ ف١ّب ٠خض اٌّؼبداد اٌؾ١ٛ٠خ ,ئٌٝ اعزج١بْ لذَ ٌلأؽجبء ٌزم١١ُ ِؼشفزُٙ 
ٚٔغجخ اٌؾمٓ ٌٍّؼبداد % 4.55أْ ٕ٘بن ص٠بدح فٟ اعزٙلان اٌّؼبداد اٌؾ١ٛ٠خ ؽ١ش أْ ِإشش اٌظشف ٌٍّشػٝ وبْ 
ٚٔغجخ اٌّؼبداد اٌّٛطٛفخ ِٓ اٌمبئّخ الأعبع١خ لأدٚ٠خ % 5.4ٚاٌظشف ثبعزخذاَ الاعُ اٌؼٍّٟ % 2.2اٌؾ١ٛ٠خ 
ِٓ اٌٛطفبد ثذْٚ % 6.41ثبلإػبفخ ئٌٝ . 2ِٚزٛعؾ ػذد الأدٚ٠خ اٌّٛطٛفخ فٟ اٌٛطفخ اٌٛاؽذح ٘ٛ % 7.99اٌٛوبٌخ 
%) 1.73(ٚوبْ اٌزشخ١ض الأوضش ش١ٛػب ٘ٛ اٌزٙبة اٌغٙبص اٌزٕفغٟ اٌؼٍٛٞ  رشخ١ض خظٛطب فٟ ٍِفبد اٌؼبئٍخ
 أّ٘١خ اٌزذس٠ت ٚاٌخجشح    وّب أٚػؾذ اٌذساعخ.  ٌٙب ح ؽ١ٛٞاد ٚطف ِؼبد   ِٓ ٘زٖ اٌؾبلاد لذ رُ% 8.28ٚٔغجخ 
% 5.9ٌىٓ ا٘زّبَ الأؽجبء ثبٌذٌ١ً اٌذٚائٟ ٌ١ظ وج١شا ؽ١ش أْ ٔغجخ اٌّٛعٛد ِٕٙب أِبَ الأؽجبء ٘ٛ  , وّظذس ٌٍّؼٍِٛبد
أِب اٌزٛعٗ ٌلأؽجبء ثخظٛص طشف اٌّؼبداد اٌؾ١ٛ٠خ فمذ وبْ ع١ذا ٌىُٕٙ ٠ؾجزْٚ اٌٛطف فٟ ؽبٌخ  ٚعٛد اٌؾّٝ , 
رإوذ  ػٍٝ %  4.69غبٌج١خ الأؽجبء %. 6.82ٚفٟ ؽبٌخ اٌزشخ١ض اٌغ١ش ٚاػؼ % 6.27ٚػغؾ اٌٛلذ % 1.56
ٚعٛد ص٠بدح فٟ طشف اٌّؼبداد ٚأُ٘ اٌؼٛاًِ اٌزٟ رإدٞ ئٌٝ الإفشاؽ فٟ طشف اٌّؼبداد ٟ٘ اصدؽبَ اٌؼ١بدح 
وّب أْ أُ٘ % . 13ٚٔمض اٌّؼشفخ % 63ٚٚطف اٌّؼبداد ثذْٚ رشخ١ض % 7.55ٚػغؾ اٌّش٠غ % 56
% 4.74رذس٠ت اٌؼبٍِ١ٓ , %7.84الالزشاؽبد ٌزؾغ١ٓ ٚطف اٌّؼبداد اٌؾ١ٛ٠خ ٟ٘ ص٠بدح اٌٛػٟ اٌظؾٟ ٌٍّشاعؼ١ٓ 
خٍظذ اٌذساعخ ػٍٝ ػشٚسح رأو١ذ رشش١ذ اعزخذاَ % . 4.92ٚرؾغ١ٓ اٌّؼشفخ ٌلأؽجبء % 33رمٍ١ً الاصدؽبَ ,
ؽ١ش وبٔذ اٌؼٕبطش اٌشئ١غ١خ  ٟ٘ رؾذ٠ش اٌّؼٍِٛبد ٌّضٚدٞ ,  اٌّؼبداد اٌؾ١ٛ٠خ ِٓ خلاي ئعشاءاد ِزؼذدح اٌغٛأت
اٌخذِخ ٚرٛػ١خ اٌّشاعؼ١ٓ فٟ اٌّشاوض اٌظؾ١خ ٚوزٌه ػًّ أٔشطخ ِغزّؼ١خ ثبلإػبفخ ٌزٕف١ز ع١بعبد رٕظ١ّ١خ ٚئداس٠خ 
 .اٌزذس٠ت ٚاٌشلبثخ,اٌزٛص٠غ إٌشؾ ٌذٌ١ً اٌٛوبٌخ اٌذٚائٟ ,  رأع١ظ ٌغٕخ دٚائ١خ  ِضً
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Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1: Introduction 
 
1.1 Background 
Drug therapy is considered to be a major component of patient management in health care 
settings, including primary health care. Although the benefits gained by patients from 
pharmacological interventions are valuable, the risks of drugs per se and the consequences 
of inappropriate use cannot be overlooked. Additionally, the cost of medicine is a matter of 
great concern in both developing and industrialized countries. Of the various classes of 
drugs, antibiotics receive special attention as more money is spent on them than many 
 23 
other drugs (Guglielmo, and Brooks, 1989). Some antibiotics also have specific side-
effects and extensive antibiotic use can lead to the development of resistant 
microorganisms (Farrar, 1985).  Hans Hogerzeil, Director ad interim of Essential Drugs 
and Medicines Policy at WHO (2004a) says that "Most people see a lack of access to 
medicines as the main problem," "Unfortunately, the irrational use of available medicines 
is also a major threat to health and leads to considerable waste." (Hogerzeil, 
2004)."Irrational use of medicines includes: over-treatment of a mild illness; inadequate 
treatment of a serious illness; misuse of anti-infective drugs; over-use of injections; self-
medication of prescription drugs; premature interruption of treatment. Several country 
figures show that such practices are frequent, and not exclusively in developing countries" 
(WHO,2004b). Overuse of most medicines contributes to drug resistance. For example, 
overuse of chloroquine, the traditional remedy for malaria, has led to resistance which has 
been recorded in over 80 countries. Resistance to penicillin, used to treat gonorrhea, is 
present in as many as 98% of patients in certain regions (WHO, 2004b). According to 
figures gathered by surveys presented to WHO, in 2000, about 60% of antibiotics in 
Nigeria were prescribed unnecessarily. In Nepal, over 50% of antibiotics prescribed in 
1996 were not needed and 40% of medicines expenditure in the same year was wasted due 
to inappropriate prescriptions (WHO, 2001). Globally, the figure for unwarranted 
antibiotics prescriptions stands at roughly 50%. "Misuse of antibiotics, overuse of 
injections, and under-use of life-extending drugs for illnesses such as HIV/AIDS, heart 
disease, and other chronic illnesses together constitute a global epidemic of irrational use 
of medicines," explains Jonathan Quick, incoming president and CEO of Management 
Sciences for Health. "This epidemic results in untold needless suffering and costs millions 
of lives each year." (WHO, 2004b). The judicious use of antibiotics: The dictionary 
meaning of judicious is "having or showing reason and good judgment in making 
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decisions". With reference to antibiotics, judicious use implies using an antibiotic only 
when indicated, choosing a cost-effective agent which provides appropriate antimicrobial 
coverage for the diagnosis that is suspected and prescribing the optimal dose and duration 
of the antimicrobial. The WHO Global Strategy for Containment of Antimicrobial 
Resistance (2001) defines the appropriate use of antimicrobials as the cost-effective use 
which maximizes clinical therapeutic effect while minimizing both drug-related toxicity 
and the development of antimicrobial resistance. Injudicious use of antibiotics for both 
humans and animals  (Shea, 2003) has long been recognized as a global problem. While 
over the counter access to antibiotics is mentioned as an important contributor towards 
injudicious antibiotic use in developing nations, as shown in a number of studies there are 
many provider, practice and patient characteristics which drive antibiotic overuse in 
developed nations such as the. United States numerous approaches have been proposed as 
a solution to this complex, multi-factorial problem. While some countries have shown a 
striking improvement in antibiotic use, in some cases associated with a drop in the problem 
of antimicrobial resistance, (Seppala, et al, 1997) there is abundant opportunity for 
improvement in most of the world. UNRWA assessment on 2003/2004 of health 
expenditure on medical supplies   revealed that about of 15% of the total drugs supplies 
was allocated for antimicrobial drugs.  The rate of irrational use of antibiotic identified by 
the study on prescription practice of antimicrobial drugs conducted in 2003/2004 at 
UNRWA Gaza Field was 58.2% which has signal effect on health status of the population 
as well as on the cost of the health care. More over study on antimicrobial resistance in 
2003 to commonly isolated microorganisms at UNRWA laboratories Gaza Field showed 
alarming rates of resistance of microorganisms to commonly used antibiotics, so there is a 
great need to replace these medicine by new generation which will increase the load on the 
budget. Therefore it is necessary to improve the rational antibiotic use, exploring the 
 25 
factors of irrational antibiotic use and to put a plan for regulating antibiotics auditing 
practice. 
1.2 The aim of the study 
To evaluate the current prescribing pattern by the physicians and to identify the potential 
factors of irrational use of antibiotics in UNRWA health centers Gaza Strip. 
1.3 Objectives 
General  
To evaluate current prescribing pattern of antibiotics by UNRWA general practitioners 
primary health care Gaza,  2006. 
Specific  
1-To identify the prescribing pattern of antibiotics in relation to percentage of encounters 
with an antibiotics prescribed. 
2-To determine the percentage of antibiotics prescription with generic name. 
3-To outline the availability and use  of information in UNRWA Health centers as clinical 
guideline about the use of antibiotics in management of infectious diseases and UNRWA 
drugs Formulary. 
4-To highlight the potential factors of irrational use of antibiotics. 
5-To evaluate knowledge attitude and practice of general practitioners about antibiotics 
prescribing pattern at UNRWA Health Facilities. 
 
1.4 Research questions 
1-Is there a relationship between irrational prescription and lack of UNRWA drugs 
Formulary (EDL)?  
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2-What is the percentage of encounter with an antibiotics prescribed (PEA)? 
3-What are the potential factors that lead to poor prescribing patterns? 
4-What are the sources of  antibiotics prescribing information ? 
5-Are the UNRWA drugs Formulary (EDL) available and used at the health facility? 
6-What is the percentage of antibiotics prescribed by generic name? 
7-Are the antibiotics prescribed from UNRWA drugs Formulary (EDL)? 
8-What is the most common antibiotic prescribed? 
9-Are the general practitioners having good knowledge and information about antibiotics? 
10-Are the general practitioners receiving in service training related to antibiotics? 
 
1.5 Demographic characteristics 
Background 
Geographically, the Strip forms the westernmost portion of the Palestinian territories in 
Southwest Asia, having land borders with Egypt on the south-west and (occupied land 
1948) on the north and east. On the west, it is bounded by the Mediterranean Sea. The 
Gaza Strip is a narrow coastal strip of land along the Mediterranean, in the Middle East. It 
takes its name from Gaza, its main city, and has about 1,428757 (July 2006 est.) residents, 
mostly Palestinians, in an area of just 360 km², population density ( the number of persons 
per unit of area) is 3,823/km² (July 2005 est.). The Strip itself and its population is under 
the jurisdiction of the Palestinian Authority, which also operates the Strip's Rafah border 
crossing into Egypt under European Union supervision (The World Fact book for Gaza 
Strip, 2007). 
 
Demographics of the Gaza Strip 
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The majority of the Palestinians are direct descendants of refugees who fled or were 
expelled from their land in Palestine during the 1948 Arab-Israeli War. By 1967, the 
population had grown about six-fold, and the Strip's population has continued to increase 
since that time. Poverty, unemployment, and poor living conditions are widespread, and 
their causes have been attributed to the extremely high birth rate, disruptions to the 
economy due to Israeli closure policies since the first intifada. 2006 estimation by 
International Market Research, World Fact Book for Gaza Strip,2007 revealed that: The 
total population of Gaza Strip were : 1,428,757, and the age structure is as follow : 0-14 
years: 48.1% (male 351,642; female 335,060) , 15-64 years: 49.4% (male 360,147; female 
345,318) and 65 years and over: 2.6% (male 15,231; female 21,359)  (World Fact Book 
for Gaza Strip,2007 ).  
Also birth rate is 39.45 births/1,000 population, death rate is 3.8 deaths/1,000 population 
and net migration rate is 1.48 migrant(s)/1,000 population , so the population growth rate is 
3.71% and is characterized by  Demographic gap as a Gaza’s  population is constantly 
growing extremely rapidly due to high birth rates and low death rates., quality of health 
has improved enough that death rates fall into the "accepted" range, which is usually well 
below 10 per 1000 people. However, birth rates remain high, and the country becomes 
"trapped" in a self-perpetuating cycle.  The sex ratio: At birth: 1.05 male(s)/female, under 
15 years: 1.05 male(s)/female, 15-64 years: 1.04 male(s)/female, 65 years and over: 0.71 
male(s)/female and total population: 1.04 male(s)/female. Infant mortality rate: total 
population: 22.4/1,000 live births, male: 23.48/1,000 live births, and female: 21.27/1,000 
live births. Life expectancy at birth: total population: 71.97 years, male: 70.67 years and 
female: 73.34 years. Total fertility rate: 5.78 children born/woman. Literacy is defined  as 
age 15 and over can read and write ,percent  of the total population: are 91.9%, male: 
96.3% and female: 87.4% (World Fact Book for Gaza Strip,2007 ). 
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1.6 Geography 
Gaza Strip is located in the Middle East (at 31°25′N 34°20′E). It has a 51km border with 
the (occupied land 1948), and an 11km border with Egypt, near the city of Rafah. Khan 
Yunis is located 7km northeast of Rafah, and several towns are located along the coast 
between it and Gaza City. Beit Lahia and Beit Hanoun are located to the north and 
northeast of Gaza City, respectively. The Gaza Strip has a temperate climate, with mild 
winters, and dry, hot summers subject to drought. The terrain is flat or rolling, with dunes 
near the coast. The highest point is Abu 'Awdah (Joz Abu 'Auda), at 105 meters above sea 
level. Natural resources include arable land (about a third of the strip is irrigated), and 
recently discovered natural gas. Environmental issues include desertification; salination of 
fresh water; sewage treatment; water-borne disease; soil degradation; and depletion and 
contamination of underground water resources. (World Fact Book for Gaza Strip, 2007 ). 
 
 
1.7 Economy 
Economic output in the Gaza Strip declined by about one-third between 1992 and 1996. 
This downturn has been variously attributed to Israeli closure policies the imposition of 
generalized border closures which disrupted previously established labor and commodity 
market relationships between occupied land 1948(Israel) and the Strip. The most serious 
negative social effect of this downturn was the emergence of high unemployment. The 
unemployment rate is 20.3% (includes West Bank) (2005). 63.1% of the Gaza strip 
population is under the poverty line (2005). The World Bank has compared the 2001-2002 
recession brought about by the Second Intifada and the blockade of access points by Israel 
to the 1929 economic crisis. The UN institution in 2006 underlines that unemployment, 
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which was estimated to 23% in 2005, would increase to 39% in 2006, while poverty, 
estimated at 44%, would increase to 67% in 2006. (World Fact Book for Gaza Strip,2007 ). 
1.8 Health care providers 
There are four different types of health providers in the West Bank and Gaza Strip. The 
most important is the Ministry of Health. The other three are UNRWA, national and 
international NGOs and the private sector. MOH primary health care centres provide free 
services to individuals who subscribe to the government health insurance scheme. Services 
for pregnant women, children below three years of age and individuals with certain 
infectious diseases or suffering from mental illness are also provided free of charge at 
government facilities. UNRWA clinics provide free primary health care to registered 
refugees, while NGO clinics provide care at subsidized rates or cost . Hundreds of private 
settings (profit) are operated by private individual medical specialists,  physicians, dentists, 
pharmacists, lab technicians and X-ray technicians, it provides services for fees paid either 
by private insurance or by the patient MOH hospitals assist members of insured 
households, provided that appropriate referral has been obtained. The non-insured pay for 
services at rates fixed by the MOH, which at the time of writing were about US$ 100 for 
each day spent in hospital. Services for individuals involved in automobile accidents and 
admitted to government hospitals are covered by insurance companies. NGO hospitals 
charge fees for their services. Admissions to them are subsidized by UNRWA or the MOH 
if the referral has been duly authorized. Private maternity hospitals provide obstetric 
services and are paid for by private insurance or by the patient. Treatment abroad, that is 
treatment in health institutions not belonging to the Government whether in or outside the 
West Bank and Gaza Strip, is available to insured household members, provided that the 
appropriate referral has been obtained. Co-payments are required for such treatments; 
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exemption is granted to social security cases and for expensive treatments. The non-insured 
must pay for their treatment themselves (Obeidallah, et al,2000). 
 
1.9 Primary health care Facilities by level in Gaza 
1. UNRWA primary health care services run by 18 centers three of them are sub centers.  
2. MOH owns and operates 56 PHC centers out of which 29 level (II), 19 level (III) and 7 
of level (IV). In addition to, one specialized mental health clinic in Khan Younis. In 
general, there are 10 centers working 3 shifts (24 hours, emergency services), 9 centers 
working 2 shifts and the rest of centers working only one shift, one of which has a delivery 
unite in Gaza city .  The PHC centers provide special health care services in different 
aspects, 44 centers provide antenatal care and family planning services, in addition to 100 
specialized clinics and 25 dental and oral clinics. About 34 centers have laboratories and 12 
centers have x-Ray units (MOH,2004). 
3. Non-governmental Organizations, (NGOs) Clinics (Non profit), in 2004, the health 
sector in NGOs owns and operates 51 PHC centers in Gaza. Some centers include medical 
laboratories to perform simple investigations, and many pharmacies that provide the 
attendants with low cost medications (MOH, 2004). 
 (1) MIHR report to CIPIH, April 2005 WHO ref. CIPIH study 10d ( (2) Journal of Antimicrobial 
Chemotherapy 2004 54(2):529-533; 
1.10 UNRWA Health Services 
UNRWA owns and operates 18 centers in Gaza three of them are sub-centers. 
The number of registered refugees  was 1016964 in Gaza; therefore, the ratio of refugees 
per center was 56,498 . The UNRWA offered comprehensive primary health services free 
of charge for all refugees and plays a noticeable role in the vaccination program in 
cooperation with the MOH, in addition to curative services, as provision of outpatient 
medical care including issue of medicines, laboratory, radiological, oral health services, 
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physiotherapy,  antenatal and postnatal care and other specialized services. Furthermore, all 
refugees have the right of accessibility to the governmental health care services. In 
UNRWA Gaza Field there were 3,069462 subtotal visits seen by physicians with ratio of 
repeat visit to first visit 4.3. The workload in Gaza was decreased  from 137 in 2005 to 95 
by the end of 2006 after recruitment of additional medical officer through job creation 
program. (UNRWA, 2006). 
 
1.11 UNRWA Expenditure on Medical Supplies  
According to UNRWA report in 2005 the spend on medical supplies and equipment  
represented the  second highest  line of expenditure in health after staff costs . Total 
expenditure on medical supplies and equipment from all funds (regular cash budget in  
kind contributions and emergency appeals ) in 2005 was approximately USD 14.62 million 
with an increase by 29 per cent from the rate of expenditure in 2004 . That increase was 
due to the introduction of new groups of antibacterial  medicines and the increased demand 
on the medicines that  are used for the treatment of non-communicable  diseases, however 
the spend on medical supplies and equipment represented approximately 21 per cent of 
total expenditure on  medical care services during 2005 and the same percent in 2006. 
Medical supplies and equipment distributed as follow 82% for drugs  and 18% for 
equipments, antibiotics represented 14% of drugs expenditure(UNRWA,2006). Also the 
annual study of the trends of utilization of medical supplies was carried out during 2005, 
analysis of data on expenditure on medical supplies revealed the following: Average 
expenditure on medical supplies per outpatient medical consultation was USD 1.8 , 
Agency- wide , the highest rate of USD 3.2 per medical consultation was from Lebanon 
field followed by Syria and Gaza ( USD 1.7 ), the lowest rates were observed in Jordan & 
West Bank (USD 1.5) . The high rate of expenditure in Lebanon is due to the in kind 
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donation received from Ameri cares in the from medications and disposable medical  
supplies . Average expenditure on medical supplies per registered refugee was USD 3.4, 
Agency wide. The highest rate of USD 7.2 per registered refugee was from Lebanon due to 
the in kind donation received , followed by USD 4.9 in Gaza , USD 3.7 in Syria and USD 
3.0 in west bank . The lowest rate was USD 1.8 in  Jordan . Expenditure on antibacterial 
medicines represented 15 per cent of total expenditure on drugs (UNRWA,2005) with a 
slight reduction from that of 2004 due to improved prescribing practices of antibacterial 
medicines, in spite of the introduction of the new expensive antibacterial medicines. 
Follow up measures have been introduced in order to improve rational antibacterial 
prescribing practices Agency wide during 2005. The measures included a follow up study 
on prescribing rates of antibacterial medicines ,preparation of clinical guidelines and the 
updated UNRWA model Formulary. The follow up study revealed reduction in the rates of 
prescribing of antibacterial medicines Agency wide from 53 per cent in 2004 to 28 per cent 
in 2005, increased to 31% in 2006.  In 2005 the lowest rate was 15 per cent in Lebanon and 
the highest rate was 36 per cent in Gaza , 24 per cent in Jordan , 33 per cent and 34 per 
cent in Syria and West Bank respectively  (UNRWA, 2005), while in 2006 the lowest rate 
was 20% in Lebanon and the highest was in Gaza Field  39%.  
 
 1.12 UNRWA model formulary “of essential medicines” 
The first edition of UNRWA model formulary of essential medicines was prepared in 1991 
in order to provide a ready guidance on use of essential medicines programmed by the 
Agency.  Since then, the formulary went through several revisions in order to reflect the 
numerous additions, deletions and changes in specifications of essential medicines used in 
the program consistent with WHO recommended list of essential medicines and recent 
advances in pharmacology. The fifth edition 2005 of the formulary comprises a section 
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providing guidance on prescribing medicine, as well as fourteen chapters on medicines 
acting on the various systems and three annexes on drug interactions and use of medicines 
during pregnancy and breast feeding. It was updated and distributed to all fields of 
UNRWA. Adequate copies were made available to every medical officer and specialist 
aiming at providing a ready reference to assist UNRWA medical personnel in selection of 
appropriate medicines for treatment of patients. The Formulary was presented in a user 
friendly format for easy handling aiming at promoting rational prescribing practices 
consistent with WHO recommendations and recent advances in pharmacology (UNRWA, 
2005). 
 
1.13 Justification of the study 
Antibiotics save lives! We must save antibiotics! 
 
Inappropriate  use of antibiotics has often been identified as a problem in effective health 
care delivery and results in wastage of scarce resources and widespread health hazard 
(WHO,2006). High level of antibiotic use, often clinically unnecessary, have led to steady 
increase in drug resistance ( Radyowijai and Haak, 2003).  Previous studies of UNRWA 
revealed irrational use of antibiotics in Gaza Field characterized by high prescribing rate 
about 53%  (UNRWA ,1999) . Also another study on 2004 /UNRWA Health Centers 
revealed that the rate of prescribing antibiotics was 58.2%  .The above results are 
considered high compared with the ideal values of WHO 20.0 % - 26. 8% ,(WHO,1993). 
Total expenditure on medical supplies in 2005 was approximately USD 14.62 million with 
an increase 29% from  the rate of  expenditure in 2004 . Indiscriminate and unconcerned 
use of antibiotics has led to development of  antimicrobial resistance making the misused 
drugs inefficacious . Consequently, newer groups of antibacterial  medicine was introduced 
(UNRWA, 2005). Also expenditure on antibacterial medicates represented 15% of the 
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drugs expenditure which represent the second biggest budget line in the health system, 
after salaries. ( UNRWA ,2005). The indiscriminate use of antibiotics can have significant 
adverse effects on the health status of the population as well as on the cost of health care. It 
influence the outcome of treatment and increase the risk of developing adverse reactions of 
antibiotics including rapid emergence of resistance strains (UNRWA,1999). Follow up 
measures have been introduced in order to improve rational antibiotic prescribing practices 
during 2005, these measures include preparation of clinical guidlines and updated 
UNRWA model formulary ―of Essential medicine‖. So since the introduction of  the 
UNRWA Formulary there is a need to evaluate antibiotics prescribing patterns , the 
attitude and practice of general practitioner toward antibiotic prescription  and illustration 
of many aspects related to the possible factors of irrational use of antibiotics specifically 
the compliance of general practitioners  with the UNRWA model formulary  . 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
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Chapter 2: Literature Review 
Almost half of all medicines globally are used irrationally. This say medicines experts at 
the World Health Organization (WHO,2004b), and can have severe consequences : adverse 
drug reactions, drug resistance, protracted illness and even death. In addition, the financial 
cost incurred by individuals and governments due to irrational use is unnecessary and often 
extremely high, particularly in developing countries where patients often pay for medicines 
out of pocket (WHO,2004a). "Most people see a lack of access to medicines as the main 
problem," says Hans Hogerzeil, Director ad interim of Essential Drugs and Medicines 
Policy at WHO. "Unfortunately, the irrational use of available medicines is also a major 
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threat to health and leads to considerable waste" (WHO,2004a). Irrational use of medicines 
includes: over-treatment of a mild illness; inadequate treatment of a serious illness; misuse 
of anti-infective drugs; over-use of injections; self-medication of prescription drugs; 
premature interruption of treatment. Several country figures show that such practices are 
frequent, and not exclusively in developing countries (WHO,2004a). The inappropriate use 
of antibiotics has often been identified as a problem in effective health care delivery and 
results in wastage of scarce resources and widespread health hazards (WHO,2006). Also 
high levels of consumption of antibiotics, often clinically unnecessary, have led to steady 
increase in drug resistance, the effectiveness of many antibiotics is lost almost as quickly 
as scientists discover them (Radyowijati and Haak ,2002). Low-income countries , whom 
the majority of the world’s population belong, believed to have an important role in this 
phenomena, where on averages, 35% of total health budget  is spent on antibiotics in these 
countries  ( Isturis and Carbon ,2000). According to National Ambulatory Medical Care 
Survey , developed countries, also play a role in the abuse of antibiotics as 110 million 
prescription of oral antibiotics were written in 1992  in USA many of them have been 
given unnecessarily (Mc Caig and Hugles ,1995). 
2.1 UNRWA'S Antibiotics situation 
 
UNRWA Assessment of health expenditure on medical supplies during the past several 
years showed that about 15% out of total expenditure of medical supplies was allocated for 
antibacterial drugs (UNRWA, 2005). LeGrand, et al, in 1999 reported that many studies 
have been done to document antibiotics use patterns and indicate that over prescribing, 
multi-drug prescribing, misuse of drugs and the use of unnecessary expensive drugs are the 
most common problems of irrational antibiotics use by prescribers as well as consumers. 
The International Network for the Rational use of drugs (INRUD) in collaboration with the 
WHO action program in 1993 on essential drugs  undertook  a project to develop field tests 
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on basic drug use indicators it was tested in the twelve developing countries: Yemen, 
Sudan , Malawi, Bangladesh, Indonesia, Nigeria, Uganda, Zimbabwe, Nepal, Guatemala, 
Tansania, and Ecuador, the results from the previous developing countries, showed that 
prescription of one  or more antibiotics were high in Uganda & Sudan (56% & 63% 
respectively). (Hogerzeil, et al, 1993). Also study conducted in 100 primary health care 
centers in 5 provinces of the Islamic Republic of Iran using WHO indicators revealed that 
prescription pattern was 58% (Cheraghali , et al, 2004). As in many health sectors 
UNRWA has a mission to provide appropriate antibiotics therapy including efficiency, 
effectiveness, safety, of sufficient quantity and high quality for the whole refugee’s 
population and free of charge. UNRWA’S 5th edition of Essential drugs list formulary 
(EDL) and Standard Treatment Guidelines (STG) for antibiotics prescription including  
Sexual Transmitted Disease (STD) and management of common infectious diseases were 
introduced in 2005 and for most of the medical officers to be acquainted with the updated 
information. UNRWA Studies about prescribing antibacterial drugs in the field of Gaza in  
2004 and 1999 was 58.2% and 53% respectively which mean that is increasing and has 
signal effect on health status of the population as well as on the cost of the health care. The 
inappropriate use of antibiotics contributes to: adverse clinical outcomes, spread of 
antimicrobial resistance, unnecessary expenditures by consumers, and heavy economic 
burden to health-care system. Antibiotics represented 14% of drugs expenditure (UNRWA, 
2006).  
Although the irrational use of antibiotics has been widely described there is a paucity of 
researches  about the factors that influence it. There for assessment of irrational use of 
antibiotics will enable UNRWA to evaluate the prescribing pattern after the introduction of 
EDL and STG and explore the factors that influence it (UNRWA, 2005). Moreover study 
on antimicrobial resistance to commonly isolated microorganisms at UNRWA laboratories 
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was conducted in 2003 in the five fields .The findings revealed alarming rates of resistance 
of microorganisms against most of the commonly used antibiotics. Should this trend 
continue in future years, most of the commonly used antibiotics, will loose their efficacy in 
treatment of infective diseases. This is a major concern in term of growing risks to human 
life ,ethical considerations relevant to use of medicine of low or doubtful efficacy and 
unjustified expenditure when there is evidence of high resistance. Due to increased 
resistance of microorganisms to the conventional antimicrobial medicine, the agency 
responded to the results of the anti-microbial resistance study by deleting the antimicrobial 
drugs that showed high resistance and introducing new generations of antibacterial drugs 
of higher efficacy but at a considerable higher cost. Unless appropriately prescribed, the 
new generations will themselves become less effective because of resistance (UNRWA, 
2004). 
 
 
 
 
2.2 Definitions of an antibiotic  
Antimicrobial agents are not always classified in an identical way. Sometimes drugs such 
as antiprotozoals, antihelminthics or antituberclosis agents are placed in a separate 
category from other antibiotics, while other systems may classify all these products in a 
single category of anti-infective or antimicrobials .The indicators of antibiotic use are quite 
sensitive to whether or not certain groups of drugs are included as antibiotics, especially in 
environments where problems such as parasitic infestation or tuberclosis are common. 
Another issue in the definition of antibiotics for drug use indicators is whether topical 
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antibiotics preparations, such as skin cream and ophthalmic ointments, should be counted 
as antibiotics. 
Table below provides a classification scheme for the common classes of anti-infective 
drugs derived from the WHO model list of essential drugs. The classes which are 
recommended to be counted as antibiotics are marked in this table. Metronidazol  used as ( 
antiprotozoal) should in this context not counted as antibiotic . However, sulfa drugs are 
counted as antibiotics. Also antibiotics eye ointment and skin cream such as Neomycine 
sulphate and Bacitracin ointment  for skin infection and Silver Sulphadiazine 1% cream for 
burn  are counted as antibiotics under this system. The literal definition of Antibiotic is 
against (anti-) life (-biotic); Often detrimental to host, however the old definition of 
antibiotic is a chemical substance produced by various species of microorganisms that is 
capable, in low concentrations, of inhibiting the growth of or killing other microorganisms 
(Rollins and Joseph 2000). The antibiotic have no effect against viruses, fungi, or 
parasites. Antibiotics are one class of antimicrobials, a larger group which also includes 
anti-viral, anti-fungal, and anti-parasitic drugs. They are relatively harmless to the host, 
and therefore can be used to treat infections (selective toxicity). The term, coined by 
Selman Waksman, originally described only those formulations derived from living 
organisms, in contrast to "chemotherapeutic agents", which are purely synthetic. 
  
  Table (2.1) Antimicrobial classification for prescribing indicators 
  
 
            
 
Count as 
Antibiotic 
Code in WHO 
Model list 
Class 
 6.1.3 Antifilarials  
 6.1.4 Antischistosomals  
Yes 6.2.1 Penicillins  
Yes 6.2.2 Other antibacterials  
 6.2.3 Antileprosy drugs  
 6.2.4 Antituberculosis drugs  
 6.3 Antifungal  
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 6.4.1 Antiamoebic and antigiardiasis drugs  
 6.4.2 Antileishmaniasis drugs  
 6.4.3 Antimalarial drugs  
 6.4.4 Antitrypanosomal drugs  
Yes 13.2 Anti-infective dermatological drugs  
Yes 21.1 Anti-infective ophthalmological agents  
  
    From WHO Model list of Essential Drugs (WHO,1993) 
 
 
Nowadays the term "antibiotic" is also applied to synthetic antimicrobials, such as the sulfa 
drugs. Antibiotics are generally small molecules with a molecular weight less than 2000. 
They are not enzymes, some antibiotics have been derived from mould, for example the 
penicillin class (Todar, 2002). 
" So the new definition of  Antibiotic is  a substance produced by a microorganism such as 
bacteria and fungi or a similar product produced wholly (synthetic) or partially (semi-
synthetic) by chemical synthesis and in low concentrations inhibits the growth of 
(bacteriostatic) or kills (bactericidal) microorganisms "(Rollins and Joseph, 2000). 
 
 
2.3 History of the Development of Antibiotics 
The great modern advances in chemotherapy have come from the chance discovery that 
many micro-organisms synthesize and excrete compounds that are selectively toxic to 
other micro-organisms. These compounds are called antibiotics and have revolutionized 
medicine. The period since World War II has seen the establishment and extremely rapid 
growth of a major industry, using micro-organisms for the synthesis of, amongst other 
compounds, chemotherapeutic agents. The first chemotherapeutically effective antibiotic 
was discovered in 1929 by Alexander Fleming (1881-1955), a British bacteriologist, who 
had long been interested in the treatment of wound infections. He noticed among a pile of 
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Petri dishes on his bench one that had been streaked with a culture of Staphyloccocus 
aureus which was also contaminated by a single colony of mold.  Fleming isolated the 
mold, which proved to be a species of Penicillium, and established that culture filtrates 
contained an antibacterial substance, which he called penicillin. Penicillin proved to be 
chemically unstable and Fleming was unable to purify it. Working with impure 
preparations, he demonstrated its remarkable effectiveness in inhibiting the growth of 
many Gram-positive bacteria, and he even used it with success for the local treatment of 
human eye infections. In the meantime, the chemotherapeutic effectiveness of other, non-
antibiotic compounds such as sulphonamide had been discovered, and Fleming, 
discouraged by the difficulties in purifying penicillin, abandoned further work on the 
problem. Ten years later a group of British scientists headed by H. W. Florey (1898-1968) 
and E. Chain (1906-1979) resumed the study of penicillin. Clinical trials with partly 
purified material were dramatically successful. By this time, however, Britain was at war; 
and the industrial development of penicillin was undertaken in the United States, where an 
intensive program of research and development was begun in many laboratories. Within 
three years, penicillin was produced on an industrial scale. Today it remains one of the 
most effective chemotherapeutic agents for the treatment of many bacterial infections. The 
various penicillin vary with respect to the chemical composition of their side chain. The 
penicillin that was first isolated in Peoria, Illinois, designated penicillin G, carried a benzyl 
side chain. The penicillin isolated soon after in England, designated penicillin F, carried an 
isopentanyl side chain. Penicillin G proved the most successful and later it became possible 
to remove the side chain and replace it by a variety of chemical substituents, thereby 
producing semisynthetic penicillins. For example, penicillin V is resistant to acid and 
therefore can be administered orally because it is not inactivated in the stomach; 
ampicillin is also acid resistant and also effective against enteric bacteria; oxacillin is 
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resistant to the action of lactamase, the enzyme produced by certain "penicillin-resistant" 
strains of bacteria. The remarkable chemotherapeutic efficacy of penicillin for certain 
bacterial infections, primarily those caused by Gram-positive bacteria, prompted intensive 
research into new antibiotics. In the 1940s, a second clinically important antibiotic, 
streptomycin, effective against both Gram-negative bacteria and Mycobacterium 
tuberculosis, was discovered by A. Schatz and S. Waksman. This was the first example of 
a broad-spectrum antibiotic. Other antibiotics with even broader spectra of activity, such as 
the tetracycline, were subsequently discovered. The search for new antibiotics remains an 
empirical enterprise. So far, they have proved very effective as antibacterial agents, 
although some bacteria do acquire resistance to antibiotics, so there is a continuous search 
for new and effective antibacterial agents. Antibiotics have proved less effective in the 
treatment of fungal infections. Antifungal antibiotics, such as nystatin and amphoterecin B 
are considerably less successful therapeutically than their bacterial counterparts, at least in 
part because their toxicity is far less selective. There are no known antiviral antibiotics. 
Since 1945, thousands of different antibiotics produced by fungi, actinomycetes or 
unicellular bacteria have been isolated and characterized. A small fraction of these are of 
therapeutic value. Their nomenclature is complicated as one antibiotic may be sold under 
several different names. For example in the United States the compound, which in Europe 
has the generic name rifampicin, is called rifampin. Its proper chemical class name is 
rifamycin and it is also sold under the trade names Rifactin and Rifadin, among others 
(Gale, 2006). Resistance to penicillin in some strains of staphylococci was recognized 
almost immediately after introduction of the drug. (Resistance to penicillin today occurs in 
as many as 80% of all strains of Staphylococcus aureus). Surprisingly, Streptococcus 
pyogenes (Group A strep) have never fully developed resistance to penicillin and it 
remains a reasonable choice antibiotic for many types of streptococcal infections. 
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Interestingly, penicillin has never been effective against most Gram-negative pathogens 
(e.g. Salmonella, Shigella, Bordetella pertussis, Yersinia pestis, Pseudomonas) with the 
notable exception of Neisseria gonorrhoeae. Gram-negative bacteria are inherently 
resistant to penicillin because their vulnerable cell wall is protected by an outer membrane 
that prevents permeation of the penicillin molecule (Todar, 2002). 
 
2.4 Micro-organisms that produce antibiotics 
 Penicillium and Cephalosporium produce Beta-lactam antibiotics, penicillin, 
cephalosporin, and their relatives.  Actinomycetes, mainly Streptomyces species  produce 
tetracyclines, aminoglycosides (streptomycin and its relatives), macrolides (erythromycin 
and its relatives), chloramphenicol,  rifamycins, and most other clinically-useful antibiotics 
that are not beta-lactams. Bacillus species, such as B. polymyxa and Bacillus subtilis  
produce polypeptide antibiotics (e.g. polymyxin and bacitracin), and B. cereus produces 
zwittermicin. These organisms all have in common that they live in a soil habitat and they 
form some sort of a spore or resting structure. It is not known why these microorganisms 
produce antibiotics but it may rest in the obvious: affording them some nutritional 
advantage in their habitat by antagonizing the competition; or the subtle: acting as some 
sort of hormone or signal molecule associated with sporulation or dormancy or 
germination. Antibiotics are secondary metabolites of microorganisms and they are 
produced at the same time that the cells begin sporulation processes. Most of the 
microorganisms that produce antibiotics are resistant to the action of their own antibiotic, 
although the organisms are affected by other antibiotics (Todar, 2002). 
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2.5 Indications for antibacterial therapy 
Kakkilaya in 2002 stated that antibiotics are the most important weapons in our hands. 
Each one of them have been invented after spending considerable amount of time, energy 
and money. Therefore, we cannot afford to lose them. He also emphasized the importance 
of exertion considerable restraint in prescribing antibacterial and restrict the use of 
antibacterial to only certain definite indications as follow: 
1-Definitive therapy: This is for proven bacterial infections, antibiotics (read antibacterial) 
are drugs to tackle bacteria and hence should be restricted for the treatment of bacterial 
infections only. This may sound silly, but most doctors seem to forget this simple fact. 
Attempts should be made to confirm the bacterial infection by means of staining of 
secretions/fluids /exudates, culture and sensitivity, serological tests and other tests. Based 
on the reports, a narrow spectrum, least toxic, easy to administer and cheap drug should be 
prescribed.  
2-Empirical therapy: Empirical antibacterial therapy should be restricted to critical cases, 
when time is inadequate for identification and isolation of the bacteria and reasonably 
strong doubt of bacterial infection exists: Septicemic shock/ sepsis syndrome, immune-
compromised patients with severe systemic infection, hectic temperature, neutrophilic 
leukocytosis, raised ESR etc. In such situations, drugs that cover the most probable 
infective agent/s should be used.  
3-Prophylactic therapy: Antimicrobial prophylaxis is administered to susceptible patients 
to prevent specific infections that can cause definite detrimental effect. These include anti-
tubercular prophylaxis, anti-rheumatic prophylaxis, anti-endocarditis prophylaxis and 
prophylactic use of antimicrobials in invasive medical procedures etc. In all these 
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situations, only narrow spectrum and specific drugs are used. It should be remembered that 
there is no single prophylaxis to 'prevent' all possible bacterial infections.  There are more 
than 100 antibacterial available today, and each one has its own spectrum of activity, 
adverse effect profile and cost. The doctor should consider many factors before prescribing 
an antibacterial agent so as to make the treatment most effective with least adverse effects 
and cost. Also Kakkilaya in 2002 highlighted the  factors that should be considered while 
prescribing an antibacterial agent which are as follow: Site of infection, type of infection, 
severity of infection, isolate and its sensitivity, source of infection,  host factors  and drug 
related factors (Kakkilaya, 2002). 
 
2.6 Medicines prescription by generic name 
According to Huss in 2003 there are at least four important issues behind the concept of 
generic drugs : 
1-Communication: The use of international nonproprietary names facilitates 
communication among health professionals and citizens as we all use the same 
terminology for certain drugs. 
2-Avoidance of manipulation:  The ultimate success of marketing is to brand the drug 
name of a certain company into every body mind. When one ask about a good analgesic 
drug, every body mention aspirin, but nobody proposes acetysalicylic acid. The same 
phenomenon can be observed in other area of marketing the brand name.  
3-Economic production of drugs:  The aim of any economy should be the avoidance of  
waste, not the establishment of monopolies. This can be best achieved through multiple 
providers that compete for the most economic way of production. 
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4-Unrestricted research and knowledge generation:  Human creativity and ingenuity 
should not be restricted by commercial interest (Huss, 2003). 
 
2.7 Appropriate or ( Rational ) Prescribing of  an antibiotics  
Definition of rational use of antibiotics : means based on logic, it reflects the mindset of 
the person prescribing antibiotics. Therefore rational antibiotic therapy would mean 
antibiotic therapy given by physician with a rational mindset. WHO, in 2002 stated that  
“Rational drug use involves: the correct drug, administered by the best route, in the right 
amount, at optimum intervals, for the appropriate period, and after an accurate 
diagnosis”. 
The terms "appropriate" and "rational" use of drugs are used interchangeably. The 
Conference of Experts on the Rational Use of Drugs, convened by the World Health 
Organization in Nairobi in 1985 defined that:  "Rational use of drugs requires that patients 
receive medications appropriate to their clinical needs, in doses that meet their own 
individual requirements for an adequate period of time, and the lowest cost to them and 
their community."  The definition implies that rational use of drugs, especially rational 
prescribing should meet certain criteria as follows: 
 Appropriate indication: The decision to prescribe drug(s) is entirely based on 
medical rationale and that drug therapy is an effective and safe treatment. 
 Appropriate drug:  The selection of drugs is based on efficacy, safety, suitability 
and cost considerations. 
 Appropriate patient: No contra-indications exist and the likelihood of adverse 
reactions is minimal, and the drug is acceptable to the patient. 
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 Appropriate information: Patients should be provided with relevant, accurate, 
important and clear information regarding his or her condition and the 
medication(s) that are  prescribed. 
 Appropriate monitoring: The anticipated and unexpected effects of medications 
should be appropriately monitored (Laing , and Ross-Degnan,1992). 
Since the introduction of antimicrobial agents, there has been an association between 
antibiotic use and the development of antimicrobial resistance. Antibiotic therapy 
eradicates not only pathogenic organisms but also the protective normal flora. This so 
called "selective pressure" results in colonization with bacteria that are resistant to the 
original therapy. The result has been an increase over the past two decades in antibiotic 
resistance among common bacterial causes of outpatient infections. The appropriate use of 
antibiotics is vital for two main reasons. Firstly, to ensure the best possible clinical 
outcome in treating a patient; and secondly, to reduce the development of further antibiotic 
resistance. Several studies have demonstrated that a substantial portion of the antibiotics 
prescribed in the outpatient setting are given for viral illnesses or bacterial diseases where 
the benefit of antibacterial therapy is marginal. The reasons for prescribing antibiotics in 
these situations are related to medical and social factors. Physicians should be familiar with 
the clinical situations in which they should provide antibiotics and those in which they may 
safely be withheld. Physicians should understand the motivations of patients who are 
seeking antibiotics and provide education, empathy and alternative treatments ( Colgan, 
and Powers ,2001). 
Study in West-Bank and Gaza by Obeidallah, et al, 2000  revealed that  there is a general 
tendency to over-prescribe drugs. This is particularly true and of great concern in relation 
to antibiotics and injections. However, there are indicators that the problem is significant 
and costly. There is also widespread prescription of fixed-dose combination drugs. With a 
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few notable exceptions, prescription of such drugs is not recommended. Doctors tend also 
to prescribe more expensive brand name drugs; current legislation does not allow generic 
name drug substitution. Public service doctors are not aware of the costs of the drugs they 
prescribe and there is no mechanism to monitor on a regular basis drug prescriptions and 
consumption patterns. Lack of budget ceilings on drug consumption in health institutions 
also contributes to over-prescribing. Therapeutic protocols do not form part of the 
guidelines used by the Public Health Department or in hospitals. The United Nations Relief 
and Works Agency for Palestine Refugees in the Near East (UNRWA) and some 
nongovernmental organizations (NGOs) have developed their own guidelines based on 
internationally accepted standards, but adjusted to the local situation. The preparation and 
adoption of therapeutic protocols together with an Essential Drugs List and in-service 
training could improve the situation and the quality of care. This would also alleviate the 
psychological pressure exerted on doctors by patients requesting drugs and would provide 
the basis for patient’s education about this issue (Obeidallah, etal,2000). 
The bottom line for increasing rational use of medicines is the improvement of health  
systems, which can only be achieved through multilateral partnerships concretely  
promoting development, WHO and other agencies have worked to promote rational  use of 
medicines through advocacy and education  programmes for health providers, prescribers 
and consumers. Further steps to be promoted in the future are: advice to policy makers on 
market and price controls and limiting the medicines options for a  country to those that are 
strictly necessary for the public health priority concerns ( WHO, 2004a). 
In 2006 WHO  advocates 12 key interventions to promote more rational use: 
1. Establishment of a multidisciplinary national body to coordinate policies on medicine 
use. 
2. Use of clinical guidelines.  
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3. Development and use of national essential medicines list.  
4. Establishment of drug and therapeutics committees in districts and hospitals.  
5. Inclusion of problem-based pharmacotherapy training in undergraduate curricula.  
6. Continuing in-service medical education as a licensure requirement.  
7. Supervision, audit and feedback. 
8. Use of independent information on medicines.  
9. Public education about medicines.  
10. Avoidance of perverse financial incentives. 
11. Use of appropriate and enforced regulation.  
12. Sufficient government expenditure to ensure availability of medicines and staff. 
 (WHO,2006). 
 
2.8 Inappropriate or (Irrational) prescribing of an antibiotics 
Unfortunately, in the real world, prescribing patterns do not always conform to the above 
criteria and can be classified as inappropriate or irrational prescribing. Irrational 
prescribing may be regarded as "pathological" prescribing, where the above-mentioned 
criteria are not fulfilled. In  2002, WHO define inappropriate prescribing  when 
antimicrobials are: not equitably available, used by too many people, to treat the wrong 
disease,  in the wrong dosage,  for the wrong period of time, and/or  not in the correct 
formulation or strength. Similarly WHO in 2004 described the common patterns of 
irrational prescribing, which may be manifested in the following forms:   
The use of drugs when no drug therapy is indicated, e.g., antibiotics for viral upper 
respiratory infections, the use of the wrong drug for a specific condition requiring drug 
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therapy, e.g., tetracycline in childhood diarrhea requiring ORS, the use of drugs with 
doubtful/unproven efficacy, e.g., the use of antimotility agents in acute diarrhea, the use of 
drugs of uncertain safety status, e.g., use of dipyrone (Baralgan, etc.), failure to provide 
available, safe, and effective drugs, e.g., failure to vaccinate against measles or tetanus, 
failure to prescribe ORS for acute diarrhea, the use of correct drugs with incorrect 
administration, dosages, and duration, e.g., the use of IV metronidazole when suppositories 
or oral formulations would be appropriate, the use of unnecessarily expensive drugs, e.g. 
the use of a third generation, broad spectrum antimicrobial when a first-line, narrow 
spectrum, agent is indicated. Some examples of commonly encountered inappropriate 
prescribing practices in many health care settings include: Overuse of antibiotics and 
antidiarrheals for non specific childhood diarrhea, indiscriminate use of injections, e.g., in 
malaria treatment, multiple drug prescriptions, excessive use of antibiotics for treating 
minor ARI., minerals and tonics for malnutrition (Laing , and Ross-Degnan,1992).  
There is a wide variation in the prescribing of antibiotics. In primary health care 30%–60%  of 
patients receive antibiotics, perhaps twice the number of patients with real clinical need. 
Misuse is common and may take the form of incorrect dosage or inappropriate prescription. 
For instance, studies from various parts of the world report that over 80% of patients with 
viral respiratory tract infections receive antibiotics, as is the case for childhood diarrhoea 
when the appropriate treatment would be oral rehydration salts (ORS). Irrational, or 
inappropriate, use of antimicrobials is a global problem affecting all countries and health 
systems and ultimately all consumers and patients (WHO, 2002).   
A multitude of factors affect the use of antimicrobial medicines. Some of the more 
pertinent include the following:  Education on prudent use of, and resistance to 
antimicrobials is lacking among dispensers and prescribers. It is thus not surprising that 
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drugs are frequently used in inappropriate doses and combinations. Empiric treatment 
predominates because of the widespread lack of diagnostic services. Drug sales may 
constitute a significant portion of prescribers’ income. Antimicrobials are available over-
the-counter (OTC) in many countries and may be purchased   without prescription. 
Inefficient regulatory mechanisms or poor enforcement thereof, with lack of quality 
assurance and with marketing of substandard drugs, are important contributory factors. 
Marketing of antimicrobials by the pharmaceutical industry influences prescribing 
behaviour and use patterns. And for veterinary drugs: antimicrobial growth promoters are 
often not considered drugs and are licensed, if at all, as feed additives (WHO, 2002).  
 
 
 
 
Ozkurt, et al, in 2005 grouped the irrational use of antibiotics in to eight categories: 
1- No indication. 
2- Improper dosage or dosage interval.  
3- Unnecessary or improper combination.  
4- Reserve or broad spectrum antibiotic. 
5- Improper beginning time for prophylactic use or improper duration of treatment.  
6- Incorrect choice of antibiotic (antibiotic is not appropriate for diagnosis or disease). 
7- More expensive and toxic drugs.  
8- Any combinations of the above (Ozkurt, et al, 2005). 
 
2.9 Factors Underlying Irrational Use of Drugs  
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There are many different factors which affect the irrational use of drugs. In addition, 
different cultures view drugs in different ways, and this can affect the way drugs are used. 
The major forces can be categorized as those deriving from patients, prescribers, the 
workplace, the supply system including industry influences, regulation, drug information 
and misinformation, and combinations of these factors as below Table (2.2). All of these 
factors are affected by changes in national and global practices. For example, the frequent 
use of injections is declining in many African countries because of the fear of AIDS. In 
some countries, however, the use of injectibles remains high due to false assumption of 
prescribers that injections will improve patient satisfaction and that they are always 
expected by the patients. (Laing , and Ross-Degnan,1992). 
 
 
Table (2.2). Driving forces which affect the irrational use of drugs.  
 
Driving forces which affect the irrational use of drugs 
-Patients , drug misinformation. -Misleading beliefs  
-Patient demands/expectations 
-Prescribers , lack of education and training -Inappropriate role models  
-Lack of objective drug information 
-Generalization of limited experience 
-Misleading beliefs about drugs efficacy 
-Workplace , heavy patient load - Pressure to prescribe  
- Lack of adequate lab. capacity 
- Insufficient staffing 
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-Drug Supply System , unreliable suppliers -Drug shortages  
-Expired drugs supplied 
-Drug Regulation, non-essential drugs available -Non-formal prescribers  
-Lack of regulation enforcement 
-Industry , promotional activities 
-Misleading claims 
(Laing , and Ross-Degnan,1992). 
A local study was conducted on 2000 by  Obeidallah , et al  clarified a need to establish 
and implement a drug policy aimed at ensuring not only that effective and safe drugs of 
good quality are available at affordable prices, but also that drugs are rationally prescribed 
and used. He summarized the Causes of irrational use of drugs in PNA health institutions  
as follows: 
No national formulary has been published and made available to medical practitioners, 
there is no control over medical schools; prescribers have graduated from different 
countries with different training in the rational prescribing of drugs, there are no 
therapeutic protocols, there is no formal in-service training programme for practitioners, 
prescribers have few opportunities to access non-biased drug information, and there is no 
manual on prescribing essential drugs. Also he stated that there are no drug review bodies 
at various levels of health care to:  
Monitor the supply and use of drugs  ensure the economic use of drugs, and  adequate 
supplies of critical essential drugs in institutions. Currently, the public sector in the West 
Bank and Gaza Strip does not have policies to deal with irrational use of drugs. The issue 
is scarcely addressed. The need to establish and implement a national policy dealing with it 
is therefore urgent. Several measures could and should be taken in the short run in order to 
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improve the rational use of drugs while a coherent drug policy is developed 
(Obeidallah,etal,2000).  
 
2.10 Magnitude of the problem 
1-Locally in Palestine 
 In 2002 by El Khoudary clarified that there was an over use and misuse of antibiotics in 
treating pediatric acute respiratory infection 77.8% of study children were prescribed 
antibiotics, and 77.7% of these antibiotics were unnecessary. Amoxicilline trihydrate was 
the antibiotics of choice for treating acute upper and lower respiratory infection. 
Antibiotics were prescribed more to older children, high income families, town's children, 
children with fever, those who had diffuse redness of tonsils and children with wheezes. 
Both acute lower respiratory infections and tonsillitis cases received more antibiotics than 
other cases.( El Khoudary ,2002). In the same year another study have been carried out by 
WHO to determine the magnitude of the problem of irrational drug use and when  ,113 
isolates of Streptococcus pneumoniae from children with acute lower respiratory tract 
infections were tested for drug resistance. Resistance rates were: penicillin 88%, 
cefuroxime 85%, erythromycin 63%, tetracycline 45%, chloramphenicol 27% and 
ofloxacin 2%. Resistances to erythromycin and cefuroxime were significantly associated 
with penicillin resistance as were hospitalization and previous use of beta-lactam 
antibiotics. (WHO,2002 ).  Also drug situation analysis study for the West Bank and Gaza 
Strip was conducted in 2000 by Ministry of Health in collaboration with  WHO Health 
Coordinator in Jerusalem, Coordinator of the Drug Action Program and Essential Drugs 
Medicines & Policy/WHO which revealed the magnitude of problems relating to irrational 
prescribing of drugs, specifically:  
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-A liberal, sometimes arguable, use of antibiotics (40-50% of patients were prescribed  
antibiotics), analgesics, non-steroid anti-inflammatory drugs (NSAIDs) and steroids. 
- Doctor’ propensity to prescribe drugs by brand name rather than generic name. 
- Questionable combination of different drugs in a single prescription. 
 -The large number of drugs prescribed to every patient. 
The study also highlighted other issues, the most significant of which relates to the doctor-
patient relationship. The average consultation time spent by doctors with each individual 
patient seemed to be insufficient, ranging from less than one minute to three minutes. This 
could be due to the large number of patients that an individual prescriber may have to see: 
up to 120 patients during his/her 6.5 hours’ duty. Examination of patients in such a context 
should be considered insufficient since it often results in incorrect diagnosis and 
inappropriate treatment. Previously, Ross-Degnan et al in 1993 stated that the  average 
patient contact time at health facilities in developing countries, was often only one to three 
minutes. This is too short for effective communication, and prescribers will not consult 
guidelines or other information if they are forced to see one patient a minute ( Holloway, 
2005 ).  Moreover, it is clear that in such circumstances prescriber-patient communication 
hardly exists and presumably hinders patient’s understanding of their disease and of 
prescriptions, and ultimately their compliance. Addressing the causes of the overcrowding 
of clinics will require the development of policies and interventions. But it is clear that the 
quality of care cannot be high when prescriber’s workloads are so heavy (Obeidallah, et 
al,2000). There is no supervision or monitoring of drug use in health facilities. Prescribers 
are not trained in the application of therapeutic protocols. In-service training on rational 
prescribing, commonly considered an essential policy measure in efforts to ensure rational 
use of drugs in health institutions, is never carried out (Obeidallah, et al,2000).  
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2- Regional:  
While the reports from different countries, were not sufficiently comprehensive to 
determine in detail the scale of antimicrobial drug resistance at regional level, it indicates 
that drug resistance as a consequence to irrational prescription of antibiotics is both widely 
present and increasing. Factors contributing to increasing resistance include wide 
availability of antimicrobial drugs in private pharmacies, often without the need for 
prescriptions, and unnecessary and widespread use of new generations of antibiotics for 
uncomplicated conditions. The following sample of studies from the region reflects the 
great similarity between countries in terms of scope and magnitude of the problem of 
antimicrobial resistance. Several of the studies listed clearly identify the link between 
various elements of irrational drug use and resulting drug resistance (WHO,2002 ). 
In Jordan: The percentage of encounters with antibiotics prescribed was 60.9% overall, 
ranging at different centers from 46.7% to 83.3% (Otoom, et al 2002). The overuse of 
antibiotics is still a problem in Jordan, despite the negative effects of indiscriminate 
prescribing and consumption (Otoom, et al 2002). Dr. Asem A. Shehabi presented local 
data on antibiotic resistance in workshop about Rational Use of Drugs Strategy 
Development, Jordan, 2004. He noted there had been a dramatic increase in penicillin 
resistance to Streptococcus pneumoniae (an important community pathogen causing 
meningitis, pneumonia, otitis media, etc) over recent years. High levels of antimicrobial 
resistance in urinary and faecal pathogens were also reported with similar rates of 
resistance occurring to antibiotics commonly used in both out-patients and in-patients (a 
reflection of high community use of antibiotics). There were also severe problems of 
antibiotic-resistant nosocomial infection in tertiary hospital neonatal and adult intensive 
care units. Dr. Shehabi noted that increasing antibiotic resistance required the use of newer, 
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more expensive and sometimes more toxic antibiotics; it also raised the real danger that 
physicians will run out of effective antibiotics to treat certain infections. The data 
highlighted the need for antibiotic control policies. 
In Egypt (Assiut): In a major reference hospital 25 Mycobacterium tuberculosis isolates 
from patients who had been treated for at least 1 year for tuberculosis were evaluated. 
Multi-drug resistance was found among 11 (44%) of the isolates (WHO,2002). 
In Iraq (Mosul): Of a total of 600 isolates of E. coli collected, of which over 90% were 
E. coli type 1 and 8.3% serotyped as enteropathogenic E coli, resistance to 11 
antimicrobial agents was assessed. Over 40% were antibiotic-resistant and of these 77.1% 
were resistant to more than one antibiotic (WHO,2002). 
In Kuwait: 1253 urinary tract isolates were analysed for sensitivity to 13 antimicrobial 
agents commonly used for the treatment of urinary tract infections. High resistance of 
E. coli was noticed to ampicillin, sulfonamides and trimethoprim/sulfamethoxazole. The 
authors concluded that the ―generous policy for the prescription of especially ampicillin 
and other broad spectrum antibiotics in uncomplicated infections has generated this serious 
consequence‖ (WHO,2002). 
In Lebanon: 153 clinical enterococcal isolates were tested against 11 antimicrobial agents. 
The majority of isolates were Enterococcus faecalis (72.5%) followed by Enterococcus 
faecium (22.9%). Resistance was found against ampicillin (0.9% and 14%), erythromycin 
(59% and 40%), tetracycline (72% and 34%), chloramphenicol (32% and 11%), rifampicin 
(36% and 57%), ciprofloxacin (23% and 34%) and norfloxacin (22% and 8%). The authors 
concluded that ―These variable antimicrobial rates of resistance suggest a surveillance 
programme for antimicrobial resistance in this country would be helpful to help control 
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infection, guide empirical antibiotic therapy and implement a policy of antibiotic usage‖ 
(WHO,2002). 
In Saudi Arabia: A review study concludes that the problem of antimicrobial resistance is 
widespread, that the causative factors are uncontrolled and that national strategies to 
address the problem are lacking. The multiplicity of factors driving antimicrobial 
resistance requires that solutions are built around collaboration of governmental agencies, 
pharmaceutical companies, health care providers and consumers. Leadership should be 
provided by a national steering committee on antimicrobial resistance (WHO,2002). 
In Sudan (Khartoum): A study of the prevalence of resistance to six commonly used 
antimicrobial agents in faecal coliforms from children showed high resistance patterns 
ranging from 96% to ampicillin to 70% to chloramphenicol; 39% of children had isolates 
resistant to all six antibiotics studied and 80% against at least four.  (WHO,2002).  
 
3- Globally: 
According to figures gathered by surveys presented to WHO, in 2000, about 60% of 
antibiotics in Nigeria were prescribed unnecessarily. In Nepal, over 50% of antibiotics 
prescribed in 1996 were not needed and 40% of medicines expenditure in the same year 
was wasted due to inappropriate prescriptions (WHO,2004b).  In Pakistan (Multan): 2840 
urine samples were tested to determine the frequency and antibiotic susceptibility pattern 
of uro-pathogens. For E. coli ampicillin, ceftazidime, nitrofurantoin and gentamicin 
sensitivity was 26%, 20%, 80% and 65% respectively. Enterococcus isolates showed 40% 
sensitivity to ampicillin. The authors conclude that the resistance pattern of uro-pathogens 
causing urinary tract infections to common antimicrobial agents is changing and must be 
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taken into account when selecting treatment strategies. Therefore, antibiotic policy should 
be set according to local survey data. (WHO,2002). Globally, the figure for unwarranted 
antibiotics prescriptions stands at roughly 50%. Irrational use of drugs due to inappropriate 
prescription can also lead to adverse drug events which cause illness or death. In the 
United Sates, adverse drug events represent one of the six leading causes of death 
(WHO,2004a). 
"Misuse of antibiotics, overuse of injections, and under-use of life-extending drugs for 
illnesses such as HIV/AIDS, heart disease, and other chronic illnesses together constitute a 
global epidemic of irrational use of medicines," explains Jonathan Quick, incoming 
president and CEO of Management Sciences for Health. "This epidemic results in untold 
needless suffering and costs millions of lives each year. "Currently, about 20000 medicines 
are sold on the global market. WHO's List of Essential Medicines, which includes 
examples of medicines addressing all the major diseases of public health importance, 
contains 316 products. The wide range of very similar medicines that exist for the same 
condition can lead to irrational use and all the negative consequences this brings with it 
(WHO,2004b).    
WHO’s 2002-2003 data show the following antimicrobial resistance global prevalence 
rates:  malaria (chloroquine resistance in 81 out of 92 countries);  tuberculosis (0-17% 
primary multi-drug resistance);  HIV/AIDS (0-25% primary resistance to at least one 
antiretroviral drug);  gonorrhoea (5-98% penicillin resistance); pneumonia and bacterial 
meningitis (0-70% penincillin resistance in streptococcus pneumonia); diarrhoea: 
shigellosis (10-90% ampicillin resistance, 5-95% cotrimoxazole resistance);  hospital 
infections (0-70% resistance of staphy-lococcus aureus to all penicillins and 
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cephalosporins). ―The rapid and alarming spread of antimicrobial resistance around the 
world has not been matched by a concerted and powerful public health response.‖     
2.11 The concept of essential medicines  
Since the 1970s many developing countries have started national programmes for essential 
drugs to promote the availability, accessibility, affordability, quality, and rational use of 
medicines. The cornerstones of such programmes are the careful selection of essential 
medicines for public supply and reimbursement, based on a systematic review of 
comparative efficacy, safety, and value for money; evidence based national clinical 
guidelines as the basis for training and rational prescribing; and a national medicines 
policy to balance conflicting policy objectives and to express government commitment to a 
common goal ( Hogerzeil, 2004). The concept of essential medicines was launched in 1977 
with the publication of the first World Health Organization's Model List of Essential 
Medicines. Since then the list has been revised every two years. By the turn of the century, 
156 mostly developing countries have a national list of essential medicines, two thirds of 
which have been updated in the past five years. Lists of essential medicines are also used 
by UNICEF , the United Nations high commissioner for refugees, and many non-
governmental organizations. Follow up measures have been introduced by UNRWA 
during 2005 in order to improve rational antibiotic prescribing practices, these measures 
include preparation of clinical guidlines and updated the 5
th
 edition of UNRWA model 
formulary ― of Essential medicine ―  National lists of essential medicines are used to guide 
the procurement and supply of medicines in the public sector, reimbursement schemes, 
medicine donations, and local production of medicine; they also help define the training of 
health workers. In short, lists of essential medicines provide the scientific and public health 
basis for focus and expenditure in the pharmaceutical sector.  
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2.12 The value of clinical guidelines and lists:  
Good evidence shows that clinical guidelines and lists of essential medicines, when 
properly developed, introduced, and supported, improve prescribing quality and lead to 
better health outcomes. But there is also an economic argument. Firstly, in developing 
countries pharmaceuticals are the second biggest budget line in the health system, after 
salaries. Secondly, new essential medicines are expensive. The advantages of limited lists 
are therefore both medical and economical. From a medical point of view they lead to 
better quality of care and better health outcomes and help focus quality control, drug 
information, prescriber training, and medical audit. Economically they lead to better value 
for money, to lower costs through economies of scale, and to simplified systems of 
procurement, supply, distribution, and reimbursement ( Hogerzeil, 2004). Also The use of 
clinical practice guidelines can be an effective means of changing behavior, (Grimshaw, 
and, Russell, 1993) such as promoting the appropriate use of antibiotics. (Cabana, Rand, 
and Powe,1999).  
 
Table (2.3). Barriers to Clinician Adherence to Clinical Practice Guidelines  
 
Barrier  
 
Explanation 
Lack of awareness Clinician unaware that the guidelines exist 
 
Lack of familiarity Clinician aware of guidelines but unfamiliar with specifics 
 
Lack of agreement Clinician does not agree with a specific recommendation made 
in guidelines or is 
averse to the concept of guidelines in general 
 
Lack of self-efficacy Clinician doubts whether he or she can perform the behavior 
 
Lack of outcome 
expectancy 
Clinician believes that the recommendations will be 
unsuccessful 
Lack of motivation Clinician is unable/unmotivated to change previous practices 
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*Adapted from (Cabana, Rand, and Powe,1999) 
Effective clinical guidelines should improve patient care while enhancing cost savings. 
However, cost savings should not be the primary motivating factor.  The guidelines should 
also reflect data on resistance, recognizing that local patterns of resistance often differ 
across geographic regions. Hence, effective guidelines should be readily adaptable for 
implementation locally. A meta-analysis of relevant studies has shown that there are 
numerous barriers to adherence to practice guidelines as in (Table 2.3). 
 
 
 
 
2.13 Impact of Inappropriate Use of Drugs 
The impact of this irrational use of drugs can be seen in many ways:  reduction in the 
quality of drug therapy leading to increased morbidity and mortality, waste of resources 
leading to reduced availability of other vital drugs and increased costs, increased risk of 
unwanted affects such as adverse drug reactions and the emergence of drug resistance, e.g., 
malaria or multiple drug resistant tuberculosis, psychosocial impacts, such as when 
patients come to believe that there is "a pill for every ill". This may cause an apparent 
increased demand for drugs (Laing , and Ross-Degnan , 1992).  
 
Guideline-related 
barriers 
Guidelines are not easy or convenient to use 
 
Patient-related barriers Clinician may be unable to reconcile guidelines with patient 
preferences 
 
Environmental-related 
barriers 
Clinician may not have control over some changes (eg, time, 
resources, organizational constraints) 
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Medicines becoming useless due to overuse:  
On June 2005 World Health Assembly highlighted a major global health problem:  that 
many medicines are becoming ineffective because their overuse or wrong use have enabled 
life-threatening microbes to become resistant to antibiotics and other drugs.  Action to curb 
irrational drug use is now urgent, yet not much has been done until now. Both the irrational 
use of drugs, and the anti-microbial resistance have reached alarming proportions. The 
World Health Organization says that antimicrobial resistance is one of the world’s most 
serious public health problems. A major cause is the wrong use of medicines, worldwide, 
more than 50% of all medicines are prescribed, dispensed or sold inappropriately, and 50% 
of patients fail to take them correctly. These startling facts were presented by WHO 
officials at a briefing for World Health Assembly (WHA, 2005) participants on “Irrational 
use of medicines damages health and wastes resources.”  
 Holloway, K. in 2005 reported that:  ―Only two thirds of the world’s population have 
regular access to medicines, and of the people who do receive medicines, more than half of 
those people are prescribed medicines incorrectly,‖ ―And of the people that are prescribed 
medicines, more than half of those people fail to take them correctly.‖ Arithmetically, that 
would mean that less than a quarter of medicines prescribed are used appropriately. 
Holloway  also gave some data on adverse consequences of irrational drug use: 
 2.3 to 4.7 million new cases of hepatitis B and C and 160,000 new cases of HIV per 
year, resulting from 15 billion injections per year, half of which are non-sterile.  
 4 to 10 percent of hospital inpatients suffer an adverse drug reaction in developed 
countries.  This is the fourth to sixth leading cause of death in the US and costs 
$130 billion in the US and 466 million pounds sterling in the UK yearly.  
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 There is increasing antimicrobial resistance, with resistance of up to 70-90 percent 
to original  first-line antibiotics for dysentery (shigella), pneumonia 
(pneumococcal), gonorrhoea, and hospital infections (staph. Aureus).  
―Irrational drug use is a very serious global public health problem and much more action is 
needed at national level,‖ she concluded (WHA, 2005). 
2.14 Factors contributing to antibiotics  overuse: 
In addition to the prescription of antibiotics for viral infections, a variety of factors 
contribute to the inappropriate use of these agents, such as patient expectations, time 
constraints imposed on the clinician, and the practice of defensive medicine ( Schwartz, 
Bell , and Hughes 1997). Many patients who consult clinicians expect an antibiotic to be 
prescribed; as a result, clinicians may feel pressured to write antibiotic drug prescriptions 
to satisfy patients and to maintain good physician- patient relationships. Receiving an 
antibiotic reinforces the patient’s perception that antibiotics are warranted in similar 
situations. Thus, patients may continue to consult clinicians each time similar symptoms 
occur, expecting that antibiotics are again needed. Clinicians also may prescribe antibiotics 
as a rapid means of treating patients’ symptoms rather than taking the time to educate 
patients that antibiotics are not always necessary, especially if a viral infection is 
suspected. Moreover, clinicians may prescribe antibiotics as part of a defensive approach 
to avoid the potential sequelae of not prescribing for patients with bacterial infection. 
However, clinicians should recognize that patient satisfaction is not compromised by the 
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absence of an antibiotic prescription  provided that patients understand the reasons ( 
Hamm, Hicks, and Bemben,1996). Hamm, Hicks, and Bemben  have demonstrated that 
patient satisfaction was affected by patient perceptions that the clinician spent enough time 
discussing the illness and by patient knowledge about the treatment choice. Decreasing 
excess antibiotic use is an important strategy for combating the increase in community-
acquired antibiotic-resistant infections ( Guillemot, Courvalin, and the Working 
Party,2001). A WHO, 2005  policy paper on ―Containing antimicrobial resistance‖ says 
that many of the microbes that cause infectious disease no longer respond to common 
antimicrobial drugs such as antibiotics, antiviral and antiprotozoal drugs. ―The problem is 
so serious that unless concerted action is taken worldwide, we run the risk of returning to 
the pre-antibiotic era when many more children than now died of infectious diseases and 
major surgery was impossible due to the risk of infection.‖ ―Countries should consider 
regulating and monitoring the quality of drug advertising and of the pharmaceutical 
industry’s promotional practices, and enforcing sanctions for violations ‖(WHO , 2005). 
 
2.15 Global Strategy for Containment of Antimicrobial Resistance  
Antimicrobial resistance is a natural biological phenomenon of response of microbes to the 
selective pressure of an antimicrobial drug. Resistance may be inherent, which explains the 
phenomenon of opportunistic infection or acquired.The introduction of every antimicrobial 
agent into clinical practice has been followed by the detection in the laboratory of strains 
of micro-organisms that are resistant. Such resistance may either be a characteristic 
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associated with the entire species or emerge in strains of a normally susceptible species 
through mutation or gene transfer. With the widespread use of antimicrobials, the 
prevalence of resistance to each new drug has increased. The prevalence of resistance 
varies between geographical regions and over time, but sooner or later resistance emerges 
to every antimicrobial. While much evidence supports the view that the total consumption 
of antimicrobials is the critical factor in selecting resistance, the relationship between use 
and resistance is not a simple correlation. In particular, the relative contribution of mode of 
use (dose, duration of therapy, route of administration, dosage interval) as opposed to total 
consumption is poorly understood. Paradoxically, under use through lack of access, 
inadequate dosing, poor adherence and sub-standard antimicrobials may play as important 
a role as overuse. There is consensus, however, that the inappropriate use of antimicrobial 
agents does not achieve the desired therapeutic outcomes and is associated with the 
emergence of resistance. For this reason, improving use is a priority if the emergence and 
spread of resistance is to be controlled (WHO,2001). 
 
The development of antibiotic-resistant  
The development of antibiotic-resistant bacteria seems to be an inevitable consequence of 
using antimicrobial drugs. Antimicrobial resistance has increased since the introduction of 
antibiotics. Penicillin was first used in the early 1940s and by 1950, most Staphylococcus 
aureus organisms were resistant to the drug by virtue of elaboration of a penicillinase 
enzyme. Concern about the resistance increased in the late 1990's since then, many 
governmental and agency reports have been published regarding the agricultural use of 
antibacterials, advising less use of antibacterials, appropriate choice of antibacterials and 
regimens, prevention of cross-infection and development of new antibacterials. 
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Antimicrobial drug resistance (AMR) jeopardizes the effectiveness of the treatment of 
bacterial, viral, fungal and parasitic infections worldwide (Cosgrove, and Carmeli ,2003). 
Also in 2003 Radyowijati and Haak stated that high levels of antibiotics use, often 
clinically unnecessary, have led to steady increase in drug resistance. Low-income 
countries, whom the majority of the world’s population belong, believed to have an 
important role in this phenomena, where on averages, 35% of total health budget  is spent 
on antibiotics in these countries ( Isturis and Carbon ,2000). The emergence of a resistant 
population of bacteria in a patient as a result of antibiotic use generally occurs through a 
process termed "selective pressure." Studies using special culture techniques show that 
healthy persons normally harbor small numbers of bacteria that are intrinsically resistant to 
antibiotics (Olson , et al, 1984).  
A survey gathered by Doern , et al, 1996 from 30 U.S. medical centers in 1994 and 1995, 
of clinically significant outpatient isolates of Streptococcus pneumoniae, the most common 
bacterial cause of most respiratory tract infections, revealed that 23.6 percent of strains 
were not susceptible to penicillin. Intermediate resistance was detected in about 14.1 
percent of isolates, while about 9.6 percent of strains demonstrated high-level resistance. 
(Doern ,et al,1996). Appropriate prescribing of antibiotics may slow the rate at which 
resistance becomes widespread throughout the community. A study in Finland 
demonstrated that erythromycin resistance among group A streptococci decreased from 
16.5 to 8.6 percent over a four-year period during a nationwide program relying on 
national guidelines to limit the use of erythromycin (Seppala, et al ,1997). According to the 
Centers for Disease Control and Prevention, in approximately 50 percent of the antibiotic 
prescriptions written by office-based physicians are unnecessary (CDC,2001). Also 
developed countries play a role in the abuse of antibiotics as 110 million prescription of 
oral antibiotics were written in 1992 in USA many of them have been given unnecessarily 
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(Mc Caig and Hugles ,1995). A good portion of antibiotic use appears to be for viral or 
spontaneously resolving bacterial infections. The Centers for Disease Control and 
Prevention (CDC) estimates that about 100 million courses of antibiotics are prescribed by 
office-based physicians each year, and that approximately one half of those prescriptions 
are unnecessary.(Principles of judicious use of antimicrobial agents for pediatric upper 
respiratory tract infections. Pediatrics 1998). Studies evaluating physicians' prescribing 
patterns have found that almost 50 percent of office visits for colds and upper respiratory 
tract infections (URTI), and 80 percent of visits for acute bronchitis are treated with 
antibacterial agents.
 
(McCaig, and Hughes,1995).  This prescribing pattern persists despite 
the fact that antibacterial agents have no effect against a viral disease such as the common 
cold. Data from numerous studies show that antibacterial agents do not significantly 
shorten the duration of illness in acute bronchitis ( Fahey, Stocks, and Thomas,1998).  
Physicians continue to prescribe antibiotics despite acknowledging the association of 
antimicrobial use and bacterial resistance. In one study 97 percent of surveyed physicians 
agreed that overuse of antibiotics is a major factor contributing to antimicrobial resistance.
 
(Watson, et al,1999).  However, an evaluation of the practice patterns of these same 
physicians revealed continued prescribing of antimicrobials for viral illnesses. Other 
potential harms of indiscriminate antibiotic prescribing include allergic reactions, adverse 
reactions and drug-drug interactions  (Gonzalez, et al , 2001 ). 
The WHO Global Strategy for Containment of Antimicrobial Resistance, addresses this 
challenge. It provides a framework of interventions to slow the emergence and reduce the 
spread of antimicrobial-resistant micro-organisms through: 
— Reducing the disease burden and the spread of infection. 
— Improving access to appropriate antimicrobials. 
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— Improving use of antimicrobials. 
— Strengthening health systems and their surveillance capabilities. 
— Enforcing regulations and legislation. 
— Encouraging the development of appropriate new drugs and vaccines. 
 
 
2.16 Drug use indicators for primary health care facilities 
 
In 1993, WHO and INRUD developed and published a standard methodology for selected 
drug use indicators in health facilities. (WHO, 1993; Quick, et al,1997) Since then, several 
intervention studies have been conducted using these indicators, and review of the 
published studies with adequate study design was presented at the 1st International 
Conference for Improving the Use of Medicines (ICIUM) in Thailand in 1997. These 
indicators can be used to identify problems in general prescribing and quality of care at the 
health facilities. Results from the use of these indicators can help identify the motives for 
irrational use and other problems in the use of medicines. The data collected can then be 
used to design appropriate interventions and to measure the impact of those interventions 
(ICIUM,1997). 
Table (2.4): Derived standard values for the WHO prescribing indicators 
 
 
 
1.6 - 1.8 
(ICIUM,1997) 
1. Average number of drugs per encounter 
 
20.0 - 26.8 % 
 
2.Percentage of encounters with an antibiotic prescribed 
 
 
13.4 - 24.1 % 
 
3.Percentage of encounters with an injection prescribed 
 
 
100 % 
 
4.Percentage of drugs prescribed by generic name 
 
 
100 % 
 
5.Percentage of drugs prescribed from the essential drug list or 
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formulary 
 
 
(ICIUM,1997) 
2.17 Strategies for promoting judicious use of antibiotics  
The clinically and economically inappropriate use of antibiotics is a major international 
problem which receives comparatively little attention. There is both overuse and under-
use.  The consequences include preventable mortality and morbidity from treatment failure 
and unnecessary adverse effects of drugs, increased selection pressure on antibiotic 
resistant micro-organisms and waste of scarce health care resources. While these problems 
affect all countries, they are most acute in developing countries that can least afford them 
(WPCCID,1996). Also it is estimated that half or more of all medicines are used 
inappropriately worldwide, both by providers and consumers ( Holloway, 2005 ). A review 
by WHO in 2004 of 630 medicine use surveys done during 1990-2004  in developing and 
transitional countries shows that more than half of all patients are not treated in compliance 
with clinical guidelines (WHO, 2004). The overall WHO Medicine Strategy for 2004-
2007. was 4 policy, access, quality & safety and rational use.  A major step towards 
rational use of medicines was launched in 1977 with the publication of the first World 
Health Organization's Model List of Essential Medicines., designed to help countries 
formulate their own national lists. In 1989, the International Network for the Rational Use 
of Drugs (INRUD) was formed to conduct multidisciplinary intervention research to 
promote the rational use of medicines with a particular emphasis on resource poor  
countries. (WHO, 2002). The desired goal is clinically appropriate, cost-effective and 
equitable use of antibiotics  in order to slow the development of antibiotic resistance and 
improve health outcome, to attain this, the recommended strategies are: 
 
1. Informational and educational factors and policies  
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―To write prescriptions is easy, but to come to an understanding with people is hard‖ 
(Kafka, 1952). Most doctors are aware that antibiotic resistance is an emerging problem 
created largely by the overuse of antibiotics (Schwartz , Bell , and Hughes, 1997). This 
widespread awareness of doctors suggests that providing information or education alone 
will be insufficient to change their prescribing behavior. Overcoming barriers to more 
judicious prescribing will require development of materials to support change, 
implementation of effective techniques to catalyze that change, and development of 
supportive structures in healthcare organizations. Key elements include evidence based 
recommendations for diagnosis and treatment backed by professional societies; materials 
for patient education; and information to facilitate provider-patient communication ( 
Edward, and Benjamin, 1998). Educational approach attempt to inform or persuade 
prescribers, dispensers, or patients to use antibiotics in the proper, rational and efficient 
way. There are many types of this approach such as continuing medical education (CME) 
activities (meetings, conferences, online access) (Christakis, et al 2001), in-service 
training, face-to-face education, small group discussions, seminars, workshops and printed 
education materials (Ross-Degnan, et al,1992; Smith, 1996; Kafle, et al 1992). Some 
studies have shown that a short, interactive, problem-oriented training course using 
appropriate training materials significantly improved drug prescribing practices (Laing , 
and Ruredzo, 1989; Widyatuti , Andajaningsih, and Dwiprahasto 1999). One important 
foundation for long-term improvement in drug use is improving the quality of pre-service 
training about therapeutics.(Montagne, 1995; Geest, 1987). Face to face education or 
persuasion is a common intervention strategy. It consists of interactive group discussions 
for prescribers and / or patients. The principle of this method is to talk directly to 
practicing prescribers and patients about appropriate antibiotics use. Approaches based on 
face-to-face contact are educational outreach, patient education and influencing opinion 
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leaders (Management Science for Health, 1997;
 
Soumerai, McLaughlin, and Avorn ,1989; 
Ross-Degnan et al 1992; Ross-Degnan et al 1997)
. 
In educational outreach or "academic 
detailing", which is usually used to improve prescribing practices after completion of 
training, brief, targeted, face-to-face educational visits to clinicians, principles of 
communications theory and behavioral science are combined with conventional education 
technique (Soumerai, and Avorn 1990). This method provides information to physicians 
about medicines that are often used inappropriately and to promote their replacement with 
more therapeutic alternatives (Soumerai, and Avorn 1990). It is successful but may not be 
practical or cost-effective in many countries (Thomson et al, 2000). Another educational 
approach, small group discussion, attempts to explore the underlying causes of irrational 
use of medicines. Results are then used to develop specific interventions (Santoso et al 
,1996). Also on site a small-group face-to-face educational intervention had greater effect 
in reducing the inappropriate use of medicines than a large-group formal seminar away 
from the work-site (Suryawati, 1993). Similarly Many studies have shown that education at 
an individual or small group level and peer education are effective strategies to change 
doctors’ antibiotic prescribing behaviour ( Ekedahl, et al 1995). The effectiveness of peer 
education is enhanced when the message is delivered or endorsed by local opinion leaders 
and is made relevant to the doctor’s own practice. Previous successful programmes have 
used retired doctors, (Schaffner, et al 1983) and clinical pharmacists (Avorn , and 
Soumerai, 1983).  Establishing credibility, defining clear objectives for behaviour change, 
and repetition and reinforcement are all important for peer education ( Soumerai , and 
Avorn 1990). Also engaging local opinion leaders in the process of disseminating targeted 
educational messages to their peer group has been shown to be another successful strategy 
(Finkelstein et al, 2001). Patient or consumer education has an important role in improving 
irrational use of drugs since inappropriate prescribing patterns may derive from the 
 73 
demands of patients. These demands are often exaggerated by prescribers to justify their 
prescribing habits. (Management Science for Health , 1997; WHO,1997). At health 
facilities in developing countries, the average patient contact time is often only one to three 
minutes
 
(Ross-Degnan et al, 1993). This is too short for effective communication, and 
prescribers will not consult guidelines or other information if they are forced to see one 
patient a minute  ( Holloway, 2005 ). Printed materials  including posters, scientific 
literature, pharmacy and therapeutics newsletters, journals and printed guidelines are 
examples of printed materials used as interventions. In general, using printed materials 
alone as the way to improve prescribing is based on two assumptions. The first is that the 
main reason for incorrect prescribing is a lack of information. The second is that if 
prescribers had the correct information, their prescribing would automatically improve
 
(Management Science for Health, 1997). However this is not always the case. Studies in 
Western countries have shown that distributing printed education materials alone resulted 
in brief, very small or non-existent improvements in prescribing. Many times these 
material are not even read by prescribers
 
(Soumerai, 1990). Also previous studies have 
shown that didactic sessions alone do not help. (Thomson, 2001). Providing feedback to 
clinicians regarding their own antibiotic prescribing practices has been a successful 
technique for achieving behavior change (Schoenbaum, 1993). Feedback can entail 
comparisons with peers or with a standard or indicator. As with practice guidelines, 
feedback may be most effective when the system is developed with local input, where 
clinicians accept the measures as important, fair, and relevant to their own practices. New 
communications technologies such as the internet enhance the potential to disseminate 
practice guidelines and provide feedback to clinicians. Computer assisted decision support 
has been used effectively to improve antibiotic prescribing in hospitals and could be 
extended to outpatient settings ( Evans et al, 1998). The willingness of a busy practitioner 
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to use computer support during consultations with patients, however, has not been 
assessed. A limitation of all these intervention strategies is that some providers will 
participate and others will not. Convincing local opinion leaders to change practices will 
result in eventual diffusion of the changes throughout the community, leading to a change 
in the standard of care. For this reason, identifying and educating opinion leaders as a 
priority group would be effective, particularly if resources are limited. Educating future 
healthcare providers about the importance of judicious antibiotic use will have long term 
impact and is a useful adjunct to strategies focused on current providers (Gaur , and 
English, 2006 ).  A multifaceted approach is needed to increase the public’s understanding 
of antibiotic resistance and to change expectations about use of antibiotics. The key 
elements should include a public relations campaign, clinic based education, and 
community outreach activities. Conducting a public relations campaign with paid 
advertising is an effective but expensive strategy to change health related behavior. 
Educating the public about the difference between bacterial and viral infections, and the 
potential risk of taking antibiotics, is more complex than other health education messages 
because the risk to benefit ratio is less clear. A successful public relations effort will 
require expertise in marketing and communications.  In recent years the popular media 
have been increasing their coverage of antibiotic resistance, and this can enhance the 
impact of other public education efforts ( Edward , and Benjamin, 1998). Medical 
providers should also seek opportunities for community partnerships to disseminate similar 
messages widely. For example, educational information can be disseminated through 
community organizations, schools, childcare centers, and pharmacies. In the short term, 
patients are likely to benefit from a reduction in unnecessary visits and therapy. In the long 
term, it is likely that decreased rates of resistance will improve health and cost outcomes ( 
Edward , and Benjamin, 1998). 
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2. Managerial and infrastructural factors and  policies 
 Managerial strategies attempt to improve drug decision-making by a variety of techniques 
including use of specific processes, forms, packages and monetary incentives. The 
interventions using this approach include developing and implementing Essential Drug 
Lists or Drug Formularies, Standard Treatment Guidelines, implementing drug supply kit 
system, monitoring and feedback, establishing representative Pharmacy and Therapeutics 
Committees, establishing structured drug prescribing form, providing cost information, and 
set-up financing (Management Science for Health, 1997;  Laing , Hogerzeil ,and Ross-
Degnan,1997). A recent review has suggested that locally developed guidelines are more 
likely to be accepted and followed than those developed nationally without local input or 
recognition of local needs (Grimshaw and , Russell 1993) . Essential Drug Lists or Drug 
Formularies provide prescribers with a list of the drugs felt to be most effective and 
economic in treating important health problems
 
(Ross-Degnan et al, 1997). Standardized 
diagnostic and treatment protocols are decision rules, which lead health workers to the 
most appropriate actions based on patient symptoms and clinical signs (Holloway, 2005 ). 
Certain factors are important in determining how effective such guidelines will be in 
changing behavior in different settings, for example, how the guidelines are produced, how 
the guidelines are disseminated and whether the guidelines are "user-friendly" (Quick , 
Laing , and Ross-Degnan , 1991).
 
A study from Uganda showed that implementing 
Standard Treatment Guidelines followed by training and supervision was more effective in 
reducing the average number of drug prescribed and percentage of cases given antibiotics 
compared to distributing STG alone (Kafuko , Zirabamuzaale ,and Bagenda, 1999). 
Another study from Tanzania showed that developing and implementing STGs followed 
by monitoring reduced incorrect treatment (Wiedenmayer, et al, 1999).
 
Drug supply kits 
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are an extreme example of the essential drug list concept where a limited number of drugs 
are supplied in fixed quantities at a regular interval to health facilities. Drug kits are 
usually used in peripheral areas, which are difficult to supply effectively. (Laing,1990; 
Ross-Degnan et al,1997) One study of an essential drugs kit program in Yemen showed 
that the number of drugs prescribed in the intervention district was 1.5 per patient 
compared to 2.4 in the comparison area, and that both antibiotic use (44% vs. 66%) and 
injection use (24% vs. 58%) were lower. However, kit systems are more suitable for 
emergency than regular supply situations (Hogerzeil, et al, 1989). Implementing self-
monitoring prescribing practices in health facilities is another type of managerial 
intervention. In general, there are three steps for implementing self-monitoring. The first is 
identifying suspected problems in drug use. The second is developing self-monitoring tools 
and the third is implementing self-monitoring method. A key aspect of the self-monitoring 
intervention includes the active involvement of the local staff at all stages of the study and 
use of locally meaningful indicator (Ross-Degnan et al,1997; Laing , Hogerzeil, and Ross-
Degnan 1997). Another managerial approach, the utilization audit, involves collecting and 
analyzing data on past or current prescribing by health facilities, clinical departments, or 
individual prescribers. Data on performance are usually fed back to prescribers. (Ross-
Degnan et al,1997). Drug and Therapeutics Committee (DTCs) to ensure the safe and 
effective use of medicines in the facility or area under its jurisdiction in developing 
countries  (DTCs) are less established and their success often limited due to a lack of 
experienced staff and a high staff turnover ( Holloway, 2005 ). Also there has been little 
critical evaluation of the clinical or economic impacts of this approach in developing 
countries (Management Science for Health,1997). But in developed countries the 
beneficial role of hospital therapeutic committees in the promotion of rational prescribing 
habits, monitoring of drug usage and cost containment are well established (Weekes, and 
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Brooks 1996). These committees promotes the rational use of drugs through the 
development of relevant policies and procedures for drugs selection, procurement and use 
as well as through the education of patients and staff. Additionally they define an 
antimicrobial utilization review program, with audit and feedback on a regular basis to 
providers, and promotion of active surveillance of the nature and amount of antimicrobial 
use in the hospital. The use of delayed prescribing techniques, ( Butler, 1998) a strategy of 
providing the patient with a prescription for an antibiotic but asking that the prescription 
not be filled unless symptoms do not get better within a few days has been successfully 
used in one study (Macfarlane et al, 2002). 
Infrastructure troubles as  lack of laboratory and other diagnostic facilities; high workloads 
that limit the time   spent with patients especially in the public sector; the lack of access to 
health facilities and drug  outlets, especially for rural population; the limited public 
resources for health departments to enforce regulations or provide independent information 
and education (WPCCID,1996). Finally, fiscal management strategies may also improve 
prescribing practices. Providing cost information can encourage physicians and 
paramedical staff to consider cost in their selections. This includes using cost bar graphs, 
drawing up facility drug budgets, and printing prices in drug manuals and on requisition 
forms (Management Science for Health,1997). Supervision with audit, monitoring and peer 
group review structured order forms, automatic stop orders have all been found to be 
effective in promoting improved prescribing. Also junior doctors will not prescribe 
contrary to their chiefs ( Holloway, 2005 ).  
3. Regulatory factors and policies 
Regulatory factors restrict choices and limit decisions in the use of medicines. Important 
factors in the health system include: Registration of medicines to ensure that only safe 
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efficacious non expensive medicines of good quality are available in the market and that 
unsafe non-efficacious medicines are banned ( Holloway, 2005 ). As long as there is 
enforcement of registration decisions, not allowing a drug to be registered is an effective 
strategy to control use. However, banning a product which is already in use carries the risk 
of encouraging unintended substitutions of drugs which are equally unsafe or ineffective. 
(Laing, Hogerzeil, and Ross-Degnan, 1997) For example, there is some evidence from 
Bangladesh that the banning of all antidiarrheals resulted in increased use of metronidazole 
and mebendazole as "antidiarrheal" substitutes (Chowdhury et al, 1999). Licensing of 
health professionals to ensure that all practitioners have the necessary competence with 
regard to diagnosis, prescribing and dispensing; licensing of medicine outlets to ensure that 
all supply outlets maintain the necessary stocking and dispensing standards; limiting 
prescription of medicines by level of prescriber, this includes limiting certain medicines to 
being available only with prescription; setting educational standards for health 
professionals and developing and enforcing codes of conduct; this requires the cooperation 
of the professional societies and universities;  monitoring and enforcing regulation of 
medicines promotion to ensure that it is ethical and unbiased i.e. reliable, accurate, truthful, 
informative, balanced, up-to-date, capable of substantiation and in good taste. Regulatory 
strategies are extremely important but often poorly enforced. In many developing 
countries, many prescribers and dispensers are unqualified and unlicensed, many outlets 
are not licensed, prescription drugs, including antibiotics and injections, are freely 
available over-the-counter and there is a great deal of unethical and uncontrolled 
promotion of medicines ( Holloway, 2005 ). 
A number of countries have adopted regulations to encourage the use of generic, non-
branded drugs. Generic products offer therapeutic efficacy equal to their branded 
equivalents at much lower cost. In addition, since prescribers and dispensers are often 
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unaware of the exact ingredients of a drug, regulations requiring generic prescribing or 
allowing generic substitution can cause unintended errors in therapy (Ross-Degnan et al, 
1997). A study from the Philippines showed that the implementation of a drug generic law 
without education had a lower impact on prescribing practice than regulation paired with 
education and sanctions (Ross-Degnan, et al, 1997). Administrative incentives and 
sanctions to encourage appropriate behavior include awards for appropriate prescribing,  
(WPCCID,1996). Limiting authority to prescribe certain drugs to specialized units, 
supplying reserve antibiotics only after consultation and approval from an infectious 
disease expert, automatic stop orders for prophylactic antibiotics and limiting the range of 
antibiotics for which sensitivity tests are routinely reported (WPCCID,1996). There is a 
risk with this type of arbitrary limits that patients will not receive essential drugs that they 
need. Previous study in developed country showed that prescription limits can results in 
increased use of other, more expensive types of health care (Soumerai, et al,1997). 
Regulatory interventions may have unintended impacts that could adversely affect the 
program. Great care should be taken in planning, implementing and monitoring the 
intended impacts of any regulatory action  (Management Science for Health, 1997). 
4. Economic factors and policies  
Economic factors offer incentives and disincentives in the use of medicines. Important 
factors in the health system include:  
(1) Perverse financial incentives such as: 
  
• Prescribers' salaries from drug sales so encouraging over-prescription of medicines and 
the use of more expensive medicines.  
• Flat prescription or consultation fees covering all medicines in whatever quantities so 
encouraging poly-pharmacy.  
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• Insurance policies that reimburse non-essential medicines, incorrect doses and incorrect 
treatments.  
(2) Appropriate financial incentives such as:  
• Separation of prescribing and dispensing functions. 
• Fees per medicine item preferably covering a full course.  
• Insurance policies that reimburse essential medicines and correct treatments.  
Economic policies influence very strongly the use of medicines use, yet they are often 
introduced without regard for their possible impact on use of medicines promotion of 
medicines ( Holloway, 2005 ). 
5.  Multiple Interventions 
In general combining interventions is likely to have a synergistic effect. A study from 
Indonesia showed that disseminating leaflets combined with face-to-face education 
reduced antibiotic use and increase ORS use in diarrhea at health centers (Gani , 
Tangkilisan , and Pudjilestari,1999). 
 
2. 18 Determinants of antibiotic use in developing countries 
Determinants of antibiotic use by community members 
Drug use is strongly influenced by cultural preferences and beliefs. Prescribers, dispensers, 
and consumers share similar perceptions on health, illness, and antibiotics. Antibiotics are 
often perceived as "strong", almost magical medicines, capable of curing nearly any kind 
of disease. Many cultures believe that antibiotics also have the ability to prevent disease. 
 People are willing to pay high prices for antibiotics, and if they cannot afford a full course, 
will purchase them in smaller quantities. Self-medication is often seen as an important 
determinant of improper antibiotic use. However, a patient's decisions about whether and 
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how to use antibiotics are themselves influenced by more fundamental factors, e.g. lack of 
access to appropriate health care, poverty, or the stigma associated with having certain 
illnesses. Interventions should address these underlying determinants of self-medication, 
rather than focusing exclusively on the phenomenon itself.  The decision to self-medicate 
or to seek care from other sources is determined by perceived symptoms, knowledge about 
treatment options, and their availability and accessibility. Advice may be sought from 
physicians, pharmacists, pharmacy clerks, paramedics, traditional healers, family, or 
friends at any time during an illness. Each group of advisers has its own specific 
characteristics, advantages, and disadvantages. 
Determinants of antibiotic prescribing 
It is commonly believed that physicians' practices are largely determined by what they 
know about illness and about correct prescribing, but there is little evidence to support this 
assumption. There are frequent discrepancies between biomedical knowledge and 
prescribing practices. Knowledge may be necessary for good practice, but improving 
knowledge may not improve prescribing. Peer norms and the local medical culture are 
other important influences on antibiotic prescribing. Prescribers in industrialized countries 
may fear legal action for not practicing evidence-based medicine, but their colleagues in 
non-industrialized countries may be more concerned about losing clients if they do not 
deliver a fast cure. Many doctors report that patient demand influences their prescribing 
decisions. Giving a prescription is perceived as the easiest way to end a consultation, but 
little is known about whether patients can be satisfied by less harmful drugs than 
antibiotics. Financial incentives are an important factor to prescribers, and fear of losing 
business or the higher profit margins of expensive drugs may result in inappropriate 
practices. Some physicians believe their reputations would suffer if they do not prescribe 
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desired antibiotics. This economic rationale is especially strong in private settings where 
patients pay for services (Radyowijati and Haak,2002). 
 
2.19 Methods of changing physicians' behavior 
Six general methods of changing physicians' practices have been
 
described: education, 
feedback, participation by physicians
 
in efforts to bring about change, administrative rules, 
financial
 
incentives, and financial penalties (Eisenberg ,1986). Although each method has
 
shown some success on its own, interventions that rely on more
 
than one method appear to 
be the most successful. 
Education  
Changes in practice can occur with continuing medical education,
 
however, especially 
when the curriculum is designed to change
 
specific types of behaviors (White et al,1985).
 
Clinical practice guidelines, another form of education, have
 
gained popularity as a means 
of influencing physicians' practices
 
(Audet, and Greenfield, 1990). Such guidelines are 
primarily educational, in that they attempt
 
to inform practitioners about optimal strategies 
for diagnosis
 
and management. Most studies of the effect of practice guidelines
 
have 
examined changes in physicians' practices, not changes
 
in patient outcomes. Even by this 
measure, clinical practice
 
guidelines have been remarkably unsuccessful in influencing
 
physicians (Kosecoff et al,1987; Lomas  et al,1989). 
Why are most physicians not influenced by practice guidelines?
 
Several explanations have 
been offered. First, some guidelines
 
are not written for practicing physicians, but focus 
instead
 
on the current state of scientific knowledge (Lomas, 1991). Physicians may
 
have 
difficulty applying guidelines of this type to specific
 
patients. Second, physicians may 
disagree with or distrust guidelines
 
written by so called national experts. Interviews with 
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practicing
 
physicians indicate that many rely primarily on their own experience
 
or 
colleagues' recommendations in deciding whether to adopt
 
new techniques or interventions 
(Greer,1988). Finally, physicians may choose
 
to ignore guidelines because of non clinical 
factors, such as
 
financial incentives or the fear of malpractice litigation.
 
Thus, despite the 
current enthusiasm, guidelines by themselves
 
appear to have a limited role in influencing 
physicians' practices.
 
 Although guidelines themselves may not change practice, providing
 
such guidelines to "opinion leaders" (men and women named by
 
their peers as trusted 
sources of clinical information) appears
 
to offer great promise in altering physicians' 
practices. In
 
one study, the rate of cesarean section was dramatically reduced
 
when opinion 
leaders were recruited, trained, and returned to
 
their communities to educate their 
colleagues (Lomas et al,1991). In another
 
study, dramatic changes in the perioperative use 
of antibiotics
 
were seen when department leaders were given literature-based
 
practice 
guidelines and asked to disseminate them to their colleagues (Everitt et al,1990).
 
The 
changes in practice that followed this intervention persisted
 
for at least two years.
 
Dissemination of guidelines through opinion leaders is probably
 
more efficient than 
targeting individual physicians for education
 
(a process referred to as ("academic 
detailing") (Soumerai, and Avorn.,1990).  
Feedback  
Feedback involves giving physicians information about how their
 
practices or patient 
outcomes compare with those of other physicians
 
or with an external standard (such as a 
practice guideline).
  
Participation by Physicians in the Effort to Change  
Many efforts to change physicians' behavior are imposed by outsiders
 
who may not share 
physicians' personal and professional concerns.
 
Theories of change (Klein,1976) and 
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common sense suggest that physicians
 
will oppose changes they perceive as threatening to 
their livelihood,
 
self-esteem, sense of competence, or autonomy. Thus, interventions
 
that 
decrease physicians' decision-making authority, reduce
 
their income, challenge their 
professional judgments, or appear
 
to compromise patient care are more likely to fail. 
According
 
to these notions, involving physicians in the effort to effect
 
change should make 
change less threatening. It seems especially
 
important that physicians perceive the 
proposed changes as beneficial
 
to patients (or at least not harmful).  Meeting this  goal is
 
particularly challenging at a time when the nation is seeking
 
to limit expenditures for 
health care (Klein,1976). 
 
 
Administrative Interventions  
When other efforts fail, changes in behaviour can be sought by
 
means of administrative 
interventions. At one extreme, changes
 
in behaviour can simply be encouraged either by 
creating barriers
 
to undesired practices (for example, requiring the approval
 
of a specialist 
for certain tests or medications) or by reducing
 
barriers to desired practices (for example, 
by simplifying order
 
forms). At the other extreme, changes in behaviour can be required
 
by 
laws, regulations, or institutional policies. Interventions that force physicians to alter their 
practices
 
are in widespread use. Programs in which pharmacists
 
and physicians review 
prescriptions of antibiotics for inpatients
 
have been successful in reducing expenditures on 
drugs (Coleman, et al,1991). However,
 
such programs require new personnel (or assign 
additional responsibilities
 
to existing personnel) and must be maintained indefinitely in
 
order to achieve results. Simpler administrative interventions,
 
such as altering order forms 
to reflect the preferred dosing
 
intervals for antibiotics (Avorn et al,1988) or eliminating 
certain diagnostic
 
tests from order forms, (Zaat, Van, and Bonte,1992) have been 
successful.
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Financial Incentives and Penalties 
No particular type of intervention is inherently effective,
 
particularly when it is used in 
isolation. Whether an intervention
 
succeeds depends on the circumstances in which it is 
used. In
 
general, combinations of methods are superior to single methods
 
of intervention. 
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Chapter 3 
  
 
Conceptual Framework 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3: Conceptual Framework 
 
 
3.1 Framework 
Is a logical structure of meaning that guides the development of the  study , to make 
research finding more  clarified and meaningful. Also framework ties together a bunch of 
discrete components into something more useful and provide direction for  the research 
(Artinian,1982)  
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3.2 Conceptual map  
One strategy for expressing a framework is conceptual map that diagrams the 
interrelationships of the concepts and statements (Artinian,1982; Fawcett,1999; Moody, 
1989; Newman,1979; Silva,1981) . 
A conceptual map summarizes and integrates what is  known about a phenomenon more 
succinctly and clearly than literary explanation and allows one to grasp the gestalt  of a 
phenomenon, it should be supported by references from literature ( Artinian,1982). In 
addition a conceptual map is developed to explain which concepts contribute to or partially 
cause an outcome as shown in the figure. 
 
3.3 Factors that could affect the antibiotics prescribing decision 
In our study there are many factors that could affect the antibiotics prescribing decision of 
the general practitioner and may contribute to either rational (good) prescribing pattern or 
irrational (pathological) prescribing pattern of antibiotics with the consequence of reduced 
quality of therapy , waste of resources ,risk of unwanted effects, and psycho-social impact. 
These factors are divided into three groups as shown in the Framework  : 
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Pathological 
(Irrational) 
Good 
(Rational) 
Mode of 
Prescription 
Reduced 
Quality of 
Therapy 
 Risk of Unwanted 
effects Psycho-social 
impacts 
*Morbidity 
*Mortality 
*Reduced availability 
*Increase cost 
*Adverse reaction  
*Bacterial resistance 
*Patients rely on  
un-necessary drugs 
 
 
Provider Factors 
-Knowledge 
-Physician-patient interaction. 
-Physician prestige &reputation 
-Source of information 
Consumer Factors 
-Socio -economic 
-Cultural preferences and        
  beliefs, Self-medication 
-Expressed expectations 
-Clients pressure 
-Awareness and knowledge  
 
 
      Management Factors 
        -Availability of antibiotics 
        -Over-crowding 
        -Monitoring by SMO/F.Ph.O 
        -Regulating factors 
        -Training 
        -Education 
        -Quality 
 
Framework:  Factors affecting the decision to prescribe antibiotics 
 
Clinician's Decision to 
Prescribe Antibiotics 
 
Waste of 
resources 
(Saleh, 2006) 
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1-Provider Factors  
Physicians influence antibiotic use in three ways: by writing prescriptions , by prescribing 
and directly dispensing drugs, or by giving verbal recommendations to buy antibiotics. 
Doctors' practices can legitimize popular choices of antibiotics, and their previous 
prescribing can be an important factor in determining self-medication. Despite their 
importance, there is evidence that some people prefer not to consult physicians for day-to-
day health problems, because of the high cost and time investment, lack of trust, or the 
easier availability of pharmacies. Providers influence on antibiotics prescription affected 
by the following:- 
 
Knowledge  
It is commonly believed that physicians' practices are largely determined by what they 
know about illness and about correct prescribing, but there is little evidence to support this 
assumption. There are frequent discrepancies between biomedical knowledge and 
prescribing practices. Knowledge may be necessary for good practice, but improving 
knowledge may not improve prescribing. Peer norms and the local medical culture are 
other important influences on antibiotic prescribing (Radyowijati and Haak,2002). 
Clinicians also may prescribe antibiotics as a rapid means of treating patients’ symptoms 
rather than taking the time to educate patients that antibiotics are not always necessary, 
especially if a viral infection is suspected. Moreover, clinicians may prescribe antibiotics 
as part of a defensive approach to avoid the potential sequel of not prescribing for patients 
with bacterial infection   ( Hamm , Hicks, and Bemben,1996). 
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Physician-patient interaction 
Physician-patient interactions are often inadequate. They can be short e.g., a mean of 54 
sec was recorded in a Bangladeshi study (Guyon etal,1994), and of poor quality e.g., in 
Mexico, poor patient-physician communication was partially responsible for the non-
compliance of patients with antibiotic regimens (Reyes, et al,1997). Also drug situation 
analysis by Obeidallah et al 2000 at West Bank and Gaza Strip revealed the  average 
consultation time (minutes) in Gaza Shiffa hospital was 2 minutes and in  Rimal PHC 
clinic was 1.9 and overall average was 1.96 minutes. Prescribers in industrialized countries 
may fear legal action for not practicing evidence-based medicine, but their colleagues in 
non-industrialized countries may be more concerned about losing clients if they do not 
deliver a fast cure. Many doctors report that patient demand influences their prescribing 
decisions. Giving a prescription is perceived as the easiest way to end a consultation, but 
little is known about whether patients can be satisfied by less harmful drugs than 
antibiotics (Radyowijati and Haak, 2002). 
 
Physicians’ prestige and reputations  
Some physicians believe their reputations would suffer if they do not prescribe desired 
antibiotics ( Radyowijati and Haak, 2002). 
 
Sources of information 
These include authoritative and regularly up-dated independent sources of information  
such as drug formularies, antibiotic guidelines for the management of common conditions, 
drug bulletins and/or newsletters; ethical codes of conduct concerning pharmaceutical 
promotion and health workers' interaction with the pharmaceutical industry; data (from 
audits, surveys, research)  about drug prescribing and consumption practices, attitudes, 
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beliefs, promotional techniques,  adverse drug reactions, antibiotic-resistant organisms, 
etc.; information, education and communication campaigns (IEC) involving all 
stakeholders, targeting common problems, based  on a clear understanding of prevailing 
drug prescribing and consumption habits, knowledge,  attitudes, beliefs and cultural 
practices ( WPCCID, 1996). 
 
2- Consumer Factors 
 
Socio-economic factors  
Economic considerations are also important determinants of community antibiotic use. The 
decision to buy medicines, and the amount of it, is often influenced by factors such as a 
drug's price and a consumer's ability to pay. Poverty, and lack of access to appropriate 
health care, but these factors have not been well examined in research studies (Radyowijati 
and Haak, 2002). 
Expressed expectations, clients pressure and physician- patient relationships 
Many patients who consult clinicians expect an antibiotic to be prescribed; as a result, 
clinicians may feel pressured to write antibiotic drug prescriptions to satisfy patients and to 
maintain good physician-patient relationships. Receiving an antibiotic reinforces the 
patient’s perception that antibiotics are warranted in similar situations. Thus, patients may 
continue to consult clinicians each time similar symptoms occur, expecting that antibiotics 
are again needed  ( Hamm , Hicks, and Bemben,1996). Also their demand for a "pill for 
every ill"; their expectation that every consultation ends with a prescription; and their 
perception that a "good" doctor writes "long" prescription; that more is better; their lack of 
knowledge, especially concerning the risk/benefit concept of medicine,  and that patients or 
parents who expect antibiotics receive them more frequently (Ilett, Johnson, and Greenhill, 
2000). These expectations are strongly associated with the patient’s previous experiences 
of receiving antibiotic treatment for these illnesses ( Coenen et al, 2004). 
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Cultural preferences and beliefs 
Drug use is strongly influenced by cultural preferences and beliefs. Prescribers, dispensers, 
and consumers share similar perceptions on health, illness, and antibiotics. Antibiotics are 
often perceived as "strong", almost magical medicines, capable of curing nearly any kind 
of disease. Many cultures believe that antibiotics also have the ability to prevent disease. 
Common cultural beliefs about antibiotics include the notions that there is a pill for every 
symptom; antibiotics can heal many illnesses, including dyspepsia and headaches; and 
injections are more powerful than pills. The misuse of antibiotics frequently becomes 
integrated into the local culture (Haak and Hardon, 1988) (e.g., antibiotics are used to 
prevent diarrhea after eating suspected contaminated foods or (by prostitutes) to prevent 
sexually transmitted diseases ( Lansang et al,1990) . People are willing to pay high prices 
for antibiotics, and if they cannot afford a full course, will purchase them in smaller 
quantities (Radyowijati and Haak, 2002). 
Self-medication 
Is often seen as an important determinant of improper antibiotic use. However, a patient's 
decisions about whether and how to use antibiotics are themselves influenced by more 
fundamental factors, e.g. lack of access to appropriate health care, poverty, or the stigma 
associated with having certain illnesses. Interventions should address these underlying 
determinants of self-medication, rather than focusing exclusively on the phenomenon itself 
(Radyowijati and Haak, 2002). 
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Awareness and knowledge  
The decision to self-medicate or to seek care from other sources is determined by 
perceived symptoms, knowledge about treatment options, and their availability and 
accessibility. Advice may be sought from physicians, pharmacists, pharmacy clerks, 
paramedics, traditional healers, family, or friends at any time during an illness. Each group 
of advisers has its own specific characteristics, advantages, and disadvantages 
(Radyowijati and Haak, 2002). 
 
3-Management Factors 
Availability of antibiotics  
Consistency of drug supply can also affect prescribing. Prescribers in health facilities may 
adjust prescribing practices to whatever drugs are in stock ( Radyowijati and Haak , 2002). 
 
Over-crowding   
Clinicians with greater patient workloads prescribe antibiotics for ARIs more frequently  
( Pshetizky, Naimer, and Shvartzman, 2003). 
 
Antibiotic monitoring systems   
Supervision, auditing by SMO and Field Pharmacist Officer (F.Ph.O) considered as key 
elements in management. 
 
Regulating factors 
Formularies, or antibiotic treatment protocols often reduce antibiotic prescription rates  
(Cash,1996; Turnridge,1995). Adoption of a national essential drug list (EDL) can limit the 
antibiotics available to prescribers (WHO,1992; Mabadeje, Akintonwa, and Ashorobi 
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1991).  Also clinician behavior  can be influenced  by restricting formularies ( Melander et 
al,1999). However, implementation of these strategies does not guarantee optimal 
antibiotic use by clinicians in developing countries because the irregular drug supply, 
availability of drugs from unofficial sources, and financial constraints also affect antibiotic 
choices (Munishi, 1991).        
 
Training 
The qualifications and training of community health workers, as well as the quality of care 
they provide, vary from country to country. Unskilled personnel are less aware of the 
deleterious effects of inappropriate antibiotic use. For example, pharmacy technicians in 
Thailand prescribed rifampicin for urethritis and tetracycline for young children 
(Thamlikitkul,1988). A high proportion of patients in some developing countries are 
treated by untrained practitioners simultaneously with oral and injectable antibiotics 
administered with contaminated needles and syringes (Haak ,1988) for misdiagnosed 
noninfectious diseases  (Fagbule and, Kalu 1995).  
 
Education 
Continuing medical education (CME) changes the attitude of clinicians. Studies of 
antibiotic misuse in Cuba and Pakistan (Gonzalez Ochoa et al, 1996)   recommend 
continuing medical education for health workers as the single most important tool for 
combating antibiotic misuse. A study in Zambia has demonstrated the efficacy of 
education in reducing antibiotic prescription rates (Bexell et al, 1996).  However, 
education has not been successfully implemented in many developing countries, where too 
often, governments and health workers cannot afford the time and money required for 
continuing medical education  (Robles, and Polack 1997 ). Health workers in many 
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developing countries have almost no access to objective health information ( Cash,1996). 
Pharmaceutical company representatives typically outnumber practitioners and often 
adversely influence their prescription habits ( Ronsmans, Islam, and Bennish, 1996).   
 
Quality of Antibiotics 
The quality of many antibiotics and other drugs in developing countries is often below 
standards in the formulary. In Nigeria for example, substandard ampicillin, 
ampicillin/cloxacillin, tetracycline, and oxytetracycline capsules have been detected 
(Okeke, and Lamikanra,1995). In many cases, therapeutic failure is the only indication of 
substandard drugs. Analytic laboratories to detect substandard drugs are uncommon, and 
when they exist, health workers, distributors, and consumers are often unaware of them. 
Besides the risk for therapeutic failure, degradation products or adulterants in poor quality 
antibiotics can produce sub-inhibitory concentrations in vivo, which increase the selection 
of resistant strains. Drugs that do not comply with minimum standards are illegal in all 
countries. 
 
3.4 Pathological prescribing pattern (Irrational) 
Inappropriate or irrational prescribing may be regarded as "pathological" prescribing. It 
is estimated that half or more of all medicines are used inappropriately worldwide, both by 
providers and consumers. ( Holloway, 2005 ).  A review by WHO in 2004 of 630 medicine 
use surveys done during 1990-2004  in developing and transitional countries shows that 
more than half of all patients are not treated in compliance with clinical guidelines. Such 
inappropriate use wastes resources and can cause poor patient outcomes, adverse drug 
reactions and increased antimicrobial resistance. 
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Chapter 4: Methodology 
 
The study is quantitative paradigm which is a formal, objective, systematic process were 
numerical data are used to obtain information about the world. This approach is used to 
describe variables, examine relationships among variables and determine cause and effect 
interaction between variables (Norbeck,1987). Also the quantitative researches hold the 
position that truth is absolute and that there is a single reality that one could define by 
careful measurement. To find truth, one must be completely objective, meaning that 
values, feelings and personal perception cannot enter in to the measurement of reality. Also 
quantitative researches believes that all human behavior is objective, purposeful and 
measurement (Burns and Grove,2005). This chapter describes how the study was 
conducted, it includes the study design, samples, setting, methods of measurement, process 
of data collection, pilot study, validity and reliability. To increase reliability of the study 
more than one instrument were used (instruments triangulation). 
 
4.1 Study design  
Analytic cross-sectional design which is a design used for the research that collect data on 
relevant variables one time only (data collected at the same time), it provides a snapshot of 
the variables included in the study. Two relevant instruments were chosen, WHO 
antibiotics indicators to review the prescribing practices of the GPs, and structured self 
administered questionnaire to evaluate their knowledge, attitude and practice.  (instruments 
triangulation).The prescribing encounters will be reviewed retrospectively by drawing a 
random sample from the historical pharmacies records, and through the patient records 
retained at the health facility (cases >3 years and pediatric cases 0-3 years) using WHO 
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prescribing indicators . Half the sample should be drawn from each age group, which 
represent a mix of general illness encounters and ages (WHO,1993). 
The essential elements in deciding between retrospective and prospective data for 
evaluation of antibiotics prescribing patterns are: 
- Availability of adequate sources for retrospective data collection (pharmacy 
registration). 
- Patient’s records kept at the health facility. 
- The specific data available in the patient files as date, diagnosis, name of 
antibiotics, dose and duration.  
Since all are available, so we select the retrospective method, also retrospective data are 
easier to collect than prospective data, suffer fewer potential biases, and avoid Hawthorne 
effect of prospective study, due to the fact that the providers are aware that their behavior is 
being observed. To minimize bias due to seasonal variations or interruptions of the medical 
supply cycle we select the study period from July /2006 to December /2006.  
 
4.2 Study population  
The target population is the clients prescriptions (prescribing encounters) who attend the 
general clinic of UNRWA health centers in Gaza Strip from July to December /2006, and 
all the general practitioners who are prescribing medicine at UNRWA Health Centers in 
Gaza governorates.  
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4.3 Setting of the study 
All the 15 UNRWA health centers in Gaza Strip were included in the study as in the table 
4.1 
Table (4.1) UNRWA network of primary health facilities and the response rate of the 
Questionnaire distributed to the GPs 
Governorates Health 
Centers 
Target 
population of 
GPs 
Accessible 
population 
of GPs 
Received 
questionnaire 
from GPs 
Response 
rate 
North Beit Hanoun 
Jabalia 
4 
12 
4 
11 
 
4 
10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
92.3% 
Gaza Rimal 
El-Shati 
Gaza Town 
El-Zaitone 
12 
5 
4 
4 
9 
4 
3 
4 
7 
4 
2 
4 
Middle Bureij 
Nuseirat 
Maghazi 
Deir-Balah 
6 
12 
4 
4 
6 
12 
4 
4 
5 
12 
3 
4 
Kh-Younis Kh-Younis 
Maen 
12 
5 
11 
5 
10 
5 
Rafah Rafah 
Tal Elsultan 
EL Naser 
EL Shuka 
12 
5 
2 
(New opened) 
8 
4 
2 
8 
4 
2 
Total 16 103 91 84 
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4.4 Sample size 
 Sample size were determined for the two target populations, the first was for the 
"prescribing encounters", which is estimated according to WHO recommendation, 1993. 
There should be at least 600 encounters included in cross-sectional survey and with a 
greater number if possible. So if 20 Health facilities are included we need a sample of 30 
encounters per facility. If fewer facilities are included as in our study, a larger number of 
encounters should be selected per facility, so that a minimum of 600 encounters is reached 
(WHO,1993). In order  to have a representative sample, and to draw conclusions about 
antibiotics prescribing behavior  in UNRWA  health facilities all the 15 UNRWA health 
facilities were included and 72 prescribing encounters per health facility will be chosen to 
have a sample size of 1080 encounters. The second sample size was for the general 
practitioners who are prescribing medicine at UNRWA Health Centers in Gaza 
governorates. As the target population is so small (103), so all the GPs were included in the 
study to ensure representative data. 
 
4.5 Sampling procedures  
To have a conclusions about antibiotics prescribing behavior it is important to follow the 
following procedures for drawing the samples of health facilities and 1080 prescribing 
encounters. 
1- Health facilities sampling 
The primary sampling unit is the health facility, this means that facilities are the first Units 
selected. Then we look for the client records which are sampled from the various facilities 
to measure the antibiotics prescribing indicators.  Many factors related to antibiotics supply 
and utilization patterns vary at the facility level as geographical location (villages, camp, 
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and cities), so for that reasons it would be better to include as many different facilities as 
possible (WHO,1993). In our study all the 15 facilities were included . 
2. Prescribing encounters sampling   
As the sample size was 1080 and all the 15 UNRWA  health centers were included in the 
study, so we have to draw  72 encounters per health facility, the following sections 
describe how to draw these encounters, from clients  records. 
Step 1:- confirm availability and accessibility of medical records: Possible sources of 
retrospective prescribing encounters data will be the pharmacy records which will provide 
us with the Ration Card Number for adult files and date of birth for child files.  
Step 2:- Locate encounters to be included in the sampling frame. Locate the listing of all 
clients visits reported during the selected period, 6 months retrospectively  from July/2006 
to December/2006. These will constitute the sampling frame of "target population".  
Step 3:- Select encounters at regular intervals over the study period (6 months).   
We spread the 72 cases throughout that period 36 children (0-3years) and 36 adults (>3 
years), this mean that we have to draw  6 cases every month for each group distributed two 
cases randomly  every 10
th
 day (systemic random selection). 
Regarding  the sample of general practitioners all the GPs  were selected who tend to 
exhibit consistent practices over times, so that a sample drawn at one point in time will 
provide basically the same results as a sample that covers a longer period (WHO,1993). 
 
4.6 Instrument  
To increase reliability of the study more than one instrument were used. The researcher 
developed two relevant instruments one is self administered structured  questionnaire 
(Annex 4) mainly of close ended questions, to evaluate the knowledge, attitude , practices 
and personal data of  the general practitioners of UNRWA health centers, in order to 
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achieve the objectives of the research. The scale was validated by 8 experts of different 
specialties, their comment and evaluation was taken in consideration. 
 The questionnaire is constructed of four parts: 
 Part A: General Practitioner  Knowledge was assessed by close ended questions related 
to the concept of antibiotics, generic names, and sources of information. 
 Part B: General Practitioner Attitude evaluated using the driving forces that influencing 
GPs’ intention (Favor/ Disfavor) to prescribe antibiotics. 
 Part C: General Practitioner  Practices related to examination of the cases, prescribing 
practices, availability and use of UNRWA Formulary and its effect on prescribing 
behavior. 
 Part D: General Practitioner  personal data the last part of the questionnaire due to its 
sensitivity and privacy , which is  related to age, gender, years of experience, place of 
graduation, and training courses about antibiotics. 
The second one is checklist about WHO antibiotics prescribing indicators (Annex 6) which 
is internationally approved, but in order to be more relevant, some modifications was done 
as the coding of data related to encounters age, antibiotics prescription, numbers of drugs, 
antibiotics injections, antibiotics from EDL, names of antibiotics and diagnosis mentioned.  
Data was collected  from clients records, and the data collectors recoded the information 
directly on the checklist.   
 
4.7 Pilot Study  
Prior to the process of actual data collection a pilot study was conducted to: 
- Refine data collection instrument and methodology. 
- Predict where proposed instruments are inappropriate, too complicated, or need 
modifications.    
 103 
- Examine reliability and validity of the research instruments, and to have experience 
with the subjects, setting methods of measurements. In the words ―Do not take the 
risk. Pilot test first‖ (De.Van,1993). 
A pilot study for self administered questionnaire where 8 general practitioners were 
selected conveniently from different clinics, results of analysis revealed a need for some 
modification as open ended change to close ended, coding process to facilitate data 
analysis, and change in the nature of one question about knowledge of generic name. Also 
the checklist of antibiotics indicators was examined for 33 prescription of antibiotics 
encounters, some modification in the coding of the indicators were done. The pilot subjects 
were not included in the study. 
 
4.8 Ethical consideration 
1. Permission from the UNRWA C.F.H.P. (Chief Field Health Program).(Annex 3). 
2. Ethical clearance from Helsinki committee in Gaza was obtained. 
3. Informed consent: as an attached letter to the questionnaire to protect the participants 
right by: (Annex 2) 
       -Ensuring confidentiality by using coding to hide the identity of the participants. 
       -All collected data will be kept confidential between the researcher and respondents. 
       - Ensure benefit and there is no risk. 
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4.9 Eligibility criteria 
The criteria of general practitioners and the prescribing encounters in the sample decided 
before hand.   
4.9.1 General practitioner: 
Inclusion criteria: all the general practitioners who exhibit consistent practices over times 
during the last year or more at UNRWA clinics.  
Exclusion criteria: general practitioner who are on long leave, performing administrative 
services at the clinics, or on job creation program.  
4.9.2 Prescribing encounter: 
Inclusion criteria: The sample of general illness encounters reflected in the adults (>3 
years) and pediatric cases (0-3 years) which will be drawn from separate sources, Family 
Files and Child Health Records respectively, half the sample  took from each age group , 
spread evenly over the chosen period  from July  to December 2006.  
Exclusion criteria: clients who receive care for dental, ante-natal care, and non-
communicable disease excluded from the study. 
 
4.10 Data collection  
The data  collected retrospectively from the selected samples of family files, and child 
health records by checklist of WHO antibiotics prescribing indicators and from all GPs by 
self administered questionnaire. The checklist used to create rates, averages, and other 
summary measures to describe the nature and extent of antibiotics prescriptions. The 
questionnaires used to collect data about knowledge, attitude, practices of general 
practitioners and also personal data, which were  administered  to group of  general 
practitioners to :  Save money and time, and to provide higher response rate . The sequence 
of data collections from the health centers, first the  questionnaires were given to the group 
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of G.P, and then collect the  clients files from the clerks of the health facility after having 
the sample from the pharmacy records via systematic random selection, after completing 
checklist WHO indicators, the questionnaires is collected. 
 
4.11 Response rate 
The response rate among GPs was 92.3% 
 
4.12 Validity and reliability 
Content validity : 
Prescribing encounters checklist is adopted from WHO guidelines (How to investigate 
drugs use in health facilities WHO,1993) so its valid as its internationally approved. The 
self administered scale was validated by 8 experts of different specialties, their comment 
and evaluation was taken in consideration. 
Reliability: 
To improve reliability we adopt the following : 
- Increase the numbers of measurements (two instruments). 
- The items  selected are relevant to the topic of the measurement.  
- Standardize the measurements. 
- Standardize the implementation.  
    
4.13 Period of study 
The research started in the year 2006 first with introduction, literature and conceptual 
framework in June 2006, after approval of the proposal by the School of Public Health 
Alquds University  and ethical letter was sent to the  Helsinki committee. Self administered 
constructed questionnaire and Prescribing encounters checklist were completed on 
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February 2007 after a pilot study. A permission from the Chief Field Health Program of 
UNRWA (C.F.H.P), start actual data collection on May 2007. and completed on 
October/2007. 
 
4.14 Data entry and analysis 
Statistical Package For Social Sciences (SPSS) used for entry and analysis of data, 
constructing of  the frequency tables of the study variables formulate  the following: The 
percentage of encounters with an antibiotics prescribed, the percentage of  medicine 
prescribed by generic name, and the percentage of availability of clinical guidelines and 
EDL. "Chi-square tests" is used for analyzing the relationship between two categorical 
variables and "t-students test" for continuous variables to assess whether the means of two 
groups are statistically different from each other, its appropriate whenever you want to 
compare the means of two groups . "One Way ANOVA" (analysis of variance) statistical 
analysis used to compare several groups for particular measure, its one way to deal with 
the relationship between one particular measure(Dependent  variable), its a continuous 
variable and one factor (Independent variable) its categorical variables of nominal or 
ordinal type , the factor here forms from three or more groups. The aim of One Way 
ANOVA to compare the mean of the dependent with each categories of independent. P 
Value <0.05  was considered statistically significant. 
 
4.15 Limitations  
Data from dispersed subjects ( all  UNRWA clinic) will increase the cost with each 
location,  retrospective review of medical records  during the last 6 months  /2006 needs a 
lot of effort and time and some file may be lost. Also two instruments were used which is 
time consuming.  
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Chapter 5: Results and Discussion 
 
 
A sample of 1080 prescriptions were studied 72 from each clinic, 50% from family files 
and 50% from child health records using WHO prescribing indicators in addition to 84 
structured questionnaire from the general practitioners who practiced more than one year at 
UNRWA health centers. WHO indicators enable to evaluate several aspects of the GPs 
prescribing pattern such as percentage of encounters with an antibiotics prescribed, 
percentage of antibiotics prescribed by generic name, percentage of commonest antibiotics 
prescribed, average number of drugs per encounter, percentage of encounters with an 
injectable antibiotics prescribed, in addition to diagnosis mentioned and demographic 
characteristics of the encounters. It is a cost-effective and provide a simple tool for quickly 
and reliably assessing the critical aspects of pharmaceutical use in primary health care  and 
no need to expend more resources on these features (WHO,1993). 
 
5.1 WHO antibiotics prescribing indicators 
5.1.1 Descriptive finding  
5.1.1.1 Demographic characteristics of study cases 
Distribution of the study cases according to demographic characters age and gender 
revealed the following results.  
Percentage distribution of the encounter's age 
The result of the   study showed that 51.4% are from 0-3 years and 48.6% are more than  
three years. This is in fact according to our intended plan of study  to have 50% from each 
group  for representative sample. 
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Figure 1: Percentage distribution of the study 
cases by age
49%
51%
0-3 years >3 years
 
 
 
 
 
Percentage distribution of encounter's gender: 
 
The male cases were higher than the female cases 54.5% and 45.5% respectively 
 
Figure 2: Percentage distribution of study cases by sex
54%
46%
Male Female
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With the sex ratio male : hfemale equal to 1.197 which is similar to the ratio of total 
population in Gaza Strip whic is equal to 1.04 (World Fact Book for Gaza Strip,2007 )., it 
is similar to El Khoudary study, 2002  where the male children (55.2%) and female 
children (44.8%).  
5.1.1.2 Frequency of diagnosis noted in the prescriptions 
Table (5.1)  The predominant diseases in descending rank were upper respiratory tract 
infections (URTI) (37.1%), diseases of GIT (9.1%), diseases of skin and subcutaneous 
tissues (6.7%), common colds (5.1%),conjunctivitis represented (3.4%), musculoskeletal 
diseases (3.1%), allergy (2.6%), lower respiratory tract infection (2.6%), anemia (2.4%), 
candidiasis (2.2%), acute influenza (1.8%),wheezy chest(1.5%), injuries (1.5%), others 
(1.4%), fever for investigation (1.3%), headache (0.8%),renal disease (0.7%), post 
vaccination fever (0.6%), burns (0.4%), STD (0.3%), growth retarded (0.3%), parasitic 
infestation (0.2%), congenital anomalies (0.2%), piles (0.1%), epilepsy (0.1%), and in 
(14.6%) no diagnosis were reported in the clients files, this inappropriate prescription 
needs more GP’s attention, and 46.2% of them were prescribed antibiotics, the lowest 
percentage were piles and epilepsy reached 0.1% respectively. No antibiotics were 
prescribed for some of the diagnosis as headache, parasitic infestation, fever for 
investigation, STD, anemia, growth retarded, post vaccination fever, piles, and epilepsy 
which represent 6.1% of all the diagnosis. Also the study revealed that URTI and LRTI 
were prescribed antibiotics in 82.8% and 89.3%  respectively. Similarly studies from 
various parts of the world report that over 80% of patients with viral respiratory tract 
infection receive antibiotics (WHO,2002). Elsewhere acute respiratory infections (20.14%) 
were the most common illness followed by traumatic injuries for attending the health 
facilities in Western Nepal ( Shankar et al, 2005) . 
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Table (5.1): Distribution of all the study cases according to the diagnosis  and antibiotics 
prescription  
 
 
Variables 
"All the diagnosis" 
  
Antibiotic prescription 
  
 
 
Total 
 
 
 
% 
 Yes No 
# % # % 
 1-URTI 332 82.8% 69 17.2% 401 37.1% 
 2-No diagnosis  73 46.2% 85 53.8% 158 14.6% 
 3-Diseases of GIT 41 41.8% 57 58.2% 98 9.1% 
 4-Skin disease 41 56.9% 31 43.1% 72 6.7% 
 5-Common Cold  3 5.5% 52 94.5% 55 5.1% 
 6-Conjunctivitis 34 91.9% 3 8.1% 37 3.4% 
 7-Musculoskeletal disease 2 5.9% 32 94.1% 34 3.1% 
 8-Allergy  1 3.6% 27 96.4% 28 2.6% 
 9-LRTI 25 89.3% 3 10.7% 28 2.6% 
 10-Anemia - - 26 100.0% 26 2.4% 
 11-Candidiasis 3 12.5% 21 87.5% 24 2.2% 
 12-A Influenza  3 15.8% 16 84.2% 19 1.8% 
 13-Injuries  13 81.3% 3 18.8% 16 1.5% 
 14-Wheezy chest 9 56.3% 7 43.8% 16 1.5% 
 15-Others  4 26.7% 11 73.3% 15 1.4% 
 16-Fever for investigation - - 14 100.0% 14 1.3% 
 17-Headache - - 9 100.0% 9 0.8% 
 18-Renal diseases  8 100.0% - - 8 0.7% 
 19-Post vaccination fever - - 6 100.0% 6 0.6% 
 20-Burns  4 100.0% - - 4 0.4% 
 21-Growth retarded - - 3 100.0% 3 0.3% 
 22-STD  - - 3 100.0% 3 0.3% 
 23-Congenital Anomalies  2 100.0% - - 2 0.2% 
 24-Parasitic Infestation - - 2 100.0% 2 0.2% 
 25-Epilepsy  - - 1 100.0% 1 0.1% 
 26-Piles  - - 1 100.0% 1 0.1% 
Grand total 598 55.4% 482 44.6% 1080 100% 
 
5.1.1.3 Antibiotic prescription according to diagnosis 
Table (5.2) showed that more than half of the antibiotics prescribed  was for RTIs 59.7% ( 
URTI  55.5%,and LRTI 4.2%) the second commonest antibiotics prescription were for  
GIT disease 6.9%  and skin diseases 6.9%. Similarly, data from the National Center for 
Health Statistics in the United States indicate that approximately three quarters of all 
antimicrobial drug use resulting from physician office visits is for RTIs ( McCaig, and 
 112 
Hughes,1995). Very few cases of viral infections were prescribed antibiotics (Common 
Cold and A Influenza each 0.5%), cases with no diagnosis was provided antibiotics in 
12.2%. Most ―outpatient‖ RTIs (ie, acute bronchitis, nasal pharyngitis /common cold, and 
nonspecific upper RTIs) are caused by respiratory viruses for which antibiotic use is not 
warranted. Although RTIs are caused primarily by viral pathogens and therefore show little 
or no response to antibiotic treatment ( Kaiser, Lew, and Hirschel,1996). 
Table (5.2): Percentage of antibiotic prescription according to diagnosis 
 
Variables Frequency Percentage of antibiotics 
prescribed 
URTI 332 55.5 
Eye diseases 34 5.7 
Candidiasis 3 .5 
LRTI 25 4.2 
Wheezy chest 9 1.5 
GIT diseases 41 6.9 
Musculoskeletal 2 .3 
C cold 3 .5 
Skin diseases 41 6.9 
Renal disease 8 1.3 
Congenital anomalies 2 .3 
A Influenza 3 .5 
Injuries 13 2.2 
Allergy 1 .2 
Burns 4 .7 
Others 4 .7 
No diagnosis 73 12.2 
Total 
 
598 100.0 
 
5.1.1.4 Frequency of antibiotics prescribed 
In table (5.3) and according to the general practitioner’s prescribing pattern antibiotics 
were prescribed in 55.4%, the consumption is broken down
 
into eight major antibiotic 
classes:  
Penicillin class (29.2%) were the commonest group of antibiotics prescribed to the clients , 
Cephalosporine class (6.1%), tetracyclines class (0.6%), macrolides class (6.1%),  
Sulphonamide and trimethoprim class (8.2%), Quinolone class (.4%) Anti-infective 
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dermatological drugs (1.3%) Anti-infective ophthalmological agents (3.5%), this study 
showed wide variation in preference for different antibiotics, and antibiotics other than the 
dermatological and ophthalmological medicines was 50.7% (Figure 3). 
Similarly  El Khoudary study  in Gaza 2002 has shown that Penicillin class was the 
commonly  prescribed antibiotic 72%, Sulphonamide and trimethoprim class 20%, 
macrolides class 5%  and Cephalosporine class 3% .  Elsewhere our findings are in accord 
with Iranian study in Babol, as the most prescribed antibiotics was penicillin specifically 
amoxicillin and amoxicillin /clavulanic acid, penicillin was prescribed in 33.2% of 
encounters for male GPs and 27.9% for female GPs ( Moghadamnia, Mirbolooki ,and 
Aghili,2002). Similarly in Norway, the most commonly prescribed antibiotic in general 
practice for common airways diseases was penicillin V. ( Straand, Rokstad,and Sandvik 
,1998). The same also in sharjah United Arab Emarates, antibiotics commonly prescribed 
were penicillin (most frequently amoxicillin) ( Hasan, Das, and Mourad 1997). As 
mentioned before Penicillin represented the most
 
frequently prescribed antibiotics in all 
countries, ranging
 
from 31% (Finland) to 63% (Denmark) of the total outpatient
 
antibiotic 
use. For cephalosporin, the proportional use ranged
 
from 0.2% (Denmark) to 20% 
(Greece), for macrolides from 6%
 
(Sweden) to 30% (Greece) and for quinolones from 2% 
(Denmark)
 
to 12% (Spain, Portugal and Italy) of the total outpatient antibiotic
 
use (Ferech 
et al ,2006). The high rate of penicillin prescribed could be related to the low cost, fewer 
side effects, proven effectiveness, safety and the broad availability of the medication. 
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Table (5.3): Distribution of antibiotics prescribed 
 
Variables 
 
Frequency 
 
Percentage 
 
 Percentage  of antibiotics prescribed 
 
         598 
 
        55.4% 
Antibiotics other than dermatological drugs and            
ophthalmological agents 
 
       546 
 
        50.5% 
Distribution of antibiotics prescribed according to their names 
 
  
 Penicillin class 
 
314 
 
29.1% 
 
 Cephalosporine class 
 
66 
 
6.1% 
 
 Tetracycline class 
 
7 
 
.6% 
 
 Macrolide class 
 
66 
 
6.1% 
 
 Sulphonamide and trimethoprim class 
  
 89 
 
8.2% 
 
 Quinolone class 
 
4 
 
.4% 
 
 Anti-infective dermatological drugs 
 
14 
 
1.3% 
 
 Anti-infective ophthalmological agents 
 
38 
 
3.5% 
 
Total 
 
598 
 
55.4% 
 
5.1.1.5 WHO antibiotics prescribing indicators 
In table (5.4) the percentage of encounter receiving antibiotics was 55.4%, also the 
percentage of encounter receiving antibiotics injection was 2.2%, in addition to the 
percentage of antibiotics prescribed by generic names was 4.5%, meanwhile the percentage 
of antibiotics prescribed from UNRWA Formulary was 99.7%. (Figure4) 
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Figure 4: WHO antibiotics prescribing indicators
Result Ideal
 
 
This study is not the first in UNRWA health department to quantify the GP’s prescribing 
behavior, the result revealed over-consumption of antibiotics as the rate was 55.4 %. 
Globally the antibiotics figures for unwarranted antibiotics prescription stands at roughly 
50%, exceeding the ideal of WHO 20%-26.8%, (ICIUM, 1997). 
In fact the inappropriate use of antibiotics has often been identified as problem in effective 
health care delivery and results in wastage of scarce resources and wide spread health 
hazards (WHO, 2006). The irrational antibiotic use is a very serious global public health 
problem, and much more action is needed otherwise we run the risk of returned to the pre-
antibiotic era. Reducing the extent of antibiotics prescription at UNRWA health centers 
poses multiple challenges for the clinician and the key managers, necessitating urgent 
interventions at all levels. The results of this study have important implications if 
injudicious use of antibiotics continues in this way, the emergence and the prevalence of 
antimicrobial resistance as well as the costs of health care will ever increase. 
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Frequency of antibiotics prescribed 
The over all antibiotics prescribing rate is 55.5%, for age group ( 0-3 )  50.8% and for age 
group (>3years) 60.2%  ranging at different governorate from 49% to 63%  , a finding in 
line with previous UNRWA studies, in 1999 and 2004 which were 53% and 58.2% 
respectively, but higher than the recorded rate 45% in West Bank and Gaza by Obeidalla et 
al  2000, however study of El Khoudary ,2002 about the use of antibiotics in pediatrics’ 
acute respiratory infection  in PHC in Gaza showed that 77.8% of study cases were 
prescribed antibiotics. Over-use of antibiotics is a global problem, affecting the developing 
and developed countries,  in Sudan  63% , England 60.7% (Majeed and Moser, 1999)  and 
Islamic Republic of Iran 58% (Cheraghali, et al 2004), and in Babol city in Iran 2002 the 
overall prescription rate was 61.9%. (Moghadamnia, Mirbolooki, and  Aghili, 2002). Also 
in Jordan antibiotics were prescribed in 60.9 percent of encounters  (Otoom, et al ,2002), in 
Pakistan, antibiotics were prescribed in 52 percent of encounters. ( Hafeez et al ,2004) and 
in western Nepal antibiotic was prescribed in 59.9 percent of encounters. ( Shankar et al, 
2005). However, in Indonesia (1990), Pakistan (1998) and West Bengal, India, (1999) rates 
in excess of 70% were observed.(WHO,2004b). Also in  Norway 48% (Straand, Rokstad, 
and Sandvik,1998). 
Generally the result  is higher than the ideal level of WHO (20-26%),  it is worth to 
mention that the overuse of antibiotics is still a problem in UNRWA Gaza Field  such 
prescribing behavior may be related to both the physician's and patient's attitude towards 
patient management, and use as needed prescriptions that reduce antibiotics consumption 
should be  encouraged, exploration of patient expectations and providing appropriate 
information  to patient  during the consultation may help to reduce the prescribing rate.  
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Percentage of encounter receiving injectable antibiotics 
There are great variations in attitudes towards injections across different society, although 
the majority are unnecessary. In our study the percentage of encounter receiving injectable 
antibiotics is low, (2.2%). The WHO average of injectable drugs is 13.4%-24.1% 
(ICIUM,1997). Percentage of encounters with an injection prescribed should be as low as 
possible because of the risk of communicating diseases and the increased use of healthcare 
resources. Elsewhere the prescription of injected drugs is high as in Iran, the national 
average was 41%, with considerable variation ranging from 3%-80% (Cheraghali, et al 
,2004). Previously in Babol city Iran injections were prescribed in 58 percent of encounters 
(Moghadamnia, Mirbolooki, and Aghili ,2002). Also in other areas as Western Nepal an 
injection was prescribed in 2.25 percent of encounters ( Shankar et al, 2005).  In addition 
the results of 35 country studies from 1988 to 2002 which have been evaluated using the 
WHO standard methodology revealed that on average over 23% of consultations resulted 
in an injection (WHO,2004b) and Countries with the highest percentage of injections (over 
60%) included Indonesia (1988), Pakistan, Uzbekistan and Ghana ( Pavin, et al ,2003). 
Apparently patients and or physicians consider that injections are more effective than oral 
drugs. In general the decision to administer an antibiotics by parenteral rout is influenced 
by three factors: Reduce gastrointestinal absorption in patients, lack of appropriate oral 
antibiotics, specific disease and related severity.  The cost of injection therapy is almost 
always higher than oral dosage forms, and patients requiring parenteral therapy, except in 
emergency situations, should be referred to a hospital. overall, it is estimated that up to 
90% of injections are unnecessary, because alternative, safer routes of administration are 
available ( Pavin, et al ,2003). Excessive use of injections, particularly prevalent in low-
income countries, leads to a widespread hazard to health in countries where injection safety 
cannot be guaranteed (WHO,2004a). Worldwide, it is estimated that unsafe injections 
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account for 8 million infections of hepatitis B a year, 2 million of hepatitis C, and 75 000 
cases of HIV (Simonsen et al ,1999). In a survey in Zaire, two-year-olds had received an 
average of 24 injections (Mann , et al 1986). In Moldova, where 50% of hepatitis B cases 
are associated with unsafe injection practices, 39%–57% of the population received at least 
one injection per year (Weekly Epidemiological Record, 1999). In Tanzania ( Nsimba , 
Massele ,and  Makonomalonja,2004) and Uzbekistan ( Pavin, et al ,2003) injections were 
prescribed in 38  and 57 percent of encounters respectively also  in Jordan, the percentage 
of encounters where an injection was prescribed was low, at 1.2% overall (range 0%–
8.3%) (Khoury and  Mawajdeh,2004). In some cultural settings, antimicrobials given by 
injection are considered more efficacious than oral formulations. This tends to be 
associated with the over prescribing of broad-spectrum injectable agents when a narrow 
spectrum oral agent would be more appropriate. Gumodoka et al reported that one in four 
patients in their medical districts received antimicrobials by injection and that 
approximately 70% of these injections were unnecessary (Gumodoka et al,1996). 
 
Percentage of antibiotics prescribed by generic name   
The percentage of antibiotics prescribed by generic names was very low on average 4.5%, 
the ideal value by ICIUM, 1997 was 100% so there is great need to emphasize the  
importance of using the generic names in our prescriptions as the UNRWA Formulary is 
written by generic names. To change this situation  we require information and education 
measures to encourage prescribing by generic name and ensure commitment by GPs. In 
western Nepal A total of 1395 drugs (63.5%) were prescribed by generic name ( Shankar et 
al, 2005).  The number is more than the (44 %) prescribed by generic name in a previous 
study (Kafle, Pradhan, and Shrestha, 1992). In Iran 98 percent of drugs were prescribed by 
generic name (Moghadamnia, Mirbolooki, and Aghili ,2002) which is much higher than 
the majority of developing countries. In an Ethiopian study more than 89 percent of drugs 
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in health centers and 71 percent in health stations were prescribed by generic name (Desta 
et al,1997). In sharejah 1997 all drugs where prescribed by proprietary names (Trade 
names) and no mention to generic names ( Hasan, Das, and Mourad, 1997).  In our study 
there is no statistical significance between governorates about prescription by generic 
names the highest value is in the middle  (5.8%) and lowest is in Khan Younis (1.3%) and 
on average (4.5%).  It is similar to Jordan as the overall percentage of drugs prescribed by 
generic name was (5.1%) but low when compared with that of Tanzania (82%), India 
(59%), and Nigeria (58%) (WHO,1993). Study of the  world medicines situation in 35 
countries from 1988 to 2002 revealed on average more than 60% of medications were 
prescribed by generic name for the 26 countries (WHO,2004). In Pakistan, India, 
Uzbekistan and Namibia less than 50% of medications were prescribed as generics 
(Simonsen, et al, 1999). 
 
Percentage of antibiotics from UNRWA Model Formulary   
In our study 99.7% of antibiotics were prescribed from UNRWA Model which clarify the 
high compliance of GPs with the essential drugs list available at UNRWA clinics, its 
similar to the WHO ideal value 100%. Active implementation of an Essential drug list has 
been recommended by UNRWA as an important measure to improve rationalization of  
medicine prescriptions. The percentage is higher than that reported elsewhere, in Jordan 
the percentages of prescriptions involving drugs from the essential drugs list averaged 93% 
(Otoom, et al 2002). In Nepal  75.6 percent of drugs were prescribed from the Essential 
drug list (Shankar et al, 2005). Study of the  world medicines situation in 35 countries from 
1988 to 2002 revealed on average, that over 60% of the drugs were prescribed from an 
essential medicines list, but in Namibia (2001), only 12% of medicines prescribed were 
from the essential medicines list (WHO,2004a). The majority of low- and middle-income 
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countries use essential medicines lists in selecting their medicines and are more likely to 
use these to limit procurement choices than are high-income countries. 
 
Table (5.4):  WHO antibiotics prescribing indicators used in the study 
 
 
Ideal values* 
 
Results 
 
 
Indicators 
 
 
<25% 
 
55.4% 
Percentage of encounters 
receiving  antibiotics 
 
 
13.4-24.5%** 
 
 
2.2% 
Percentage of encounters 
receiving  antibiotics injection 
 
100% 
 
4.5% 
Percentage of antibiotics 
prescribed by generic names 
 
 
100% 
 
99.7% 
Percentage of antibiotics from 
UNRWA Formulary 
 
 
(* WHO).  (**For all injected drugs). 
 
5.1.1.6 Average number of drugs per encounter  
As shown in table (5.5) the average number of drugs prescribed per encounter was 2, the 
minimum value was 1, the maximum value was 5, and SD = 0.805. This is also similar to 
the result of Fatouh study in Gaza, 2005 rate of 1.92  and better than the result of Obeidalla 
et al  average 2.55 in West Bank and Gaza in 2000 but more than the ideal value of WHO 
1.6-1.8 (WHO,1993) , our result is also better than the regional Arabic country, as in 
Jordan the mean number of drugs was 2.3 (Otoom et al,2002) while in Sharjah, United 
Arab Emirates the average number of drugs prescribed per encounter was 2.7 ( Hasan, Das, 
and Mourad 1997). Elsewhere in non Arabic country as in Western Nepal the average 
number of drugs per prescription was 1.5 ( Shankar et al, 2005) which was higher than the 
previous study in 2003 were  average of drugs prescribed 1.26 ( Shankar et al, 2003). A 
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study in Pakistani public sector health facilities had reported a mean of 2.7 drugs per 
prescription (Hafeez et al, 2004). Also a study in Iran had reported a high average of 4.4 
drugs per encounter (Moghadamnia, Mirbolooki, and Aghili ,2002). This finding reflects 
the fact that UNRWA in comparison with other developing countries, has reasonable 
prescribing practices towards polypharmacy. Increased number of drugs can lead to 
increased risk of drug interactions, errors of prescribing, toxicity and non-compliance.  
 
Table (5.5): Drugs prescribing indicators used in the study 
 
 
Ideal 
 
Results 
 
Indicators 
 
 
1.6-1.8 
 
2 
 
 
Average number of drugs 
 
- 
 
1 
 
 
Minimum 
 
 
- 
5 
 
 
 
Maximum 
 
 
- 
 
0.805 
 
 
S.D 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 122 
5.1.2 Inferential statistics 
 
5.1.2.1 Specific diagnosis that affect on antibiotics prescription 
 
Table (5.6) shows that the percentage of RTIs who were prescribed antibiotics (83.2%), 
more than Wheezy chest (56.3%), and  Flu like syndromes  (8.1%). The difference 
between the groups reached a statistical significant level ( X
2
= 177.3, P= 0.000). Numerous 
studies have shown widespread unnecessary use of antimicrobials in patients with viral 
upper respiratory tract infections (Gaur et al,2005). In a study by Macfarlane et al the 
authors assessed patients' views and expectations when they consult their general 
practitioners in the UK with acute lower respiratory symptoms and the influence these 
have on management. They found that most patients think their symptoms are caused by 
infection, think an antibiotic will help, and want antibiotics. Three quarters of previously 
well adults in this study consulting with the symptoms of an acute lower respiratory tract 
illness received antibiotics even though their general practitioners assessed that antibiotics 
were definitely indicated in only a fifth of such cases, (Macfarlane et al, 1997). Also in the 
United States more than a fifth of all antibiotic prescriptions for children and adults are 
written for upper respiratory tract infections or bronchitis, conditions that are almost 
always viral (Nyquist, et al ,1998;Gonzales, Steiner, and Sande,1997). 
 
Table (5.6): Chi-Square test for specific diagnosis that affect on antibiotics prescription. 
 
 
P-Value 
 
X
2 
Antibiotics prescription  
Variables 
Specific diagnosis 
No Yes 
% # % # 
 
0.000 
 
 
177.31 
 
 
16.8% 
 
43.8% 
 
91.9% 
 
 
 
72 
 
7 
 
68 
 
 
 
83.2% 
 
56.3% 
 
8.1% 
 
 
 
357 
 
9 
 
6 
 
 
 
RTIs 
 
Wheezy chest 
 
Flu like syndromes  
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5.1.2.2 Encounter’s demography ( age and gender) that affect on drugs prescriptions  
Table (5.7).  t-Student test is used to explore the relation  between the numbers of drugs 
prescribed  and the age of the encounters, the test is used to assess whether the means of  
two groups are statistically different from each other. In relation to the number of drugs 
prescribed, and the age groups, no statistical significant differences between the two mean 
groups (P-Value 0.071).  Regarding gender the means for both male and female are closely 
similar in the number of drugs prescribed , no statistical significant difference between 
groups  was found (P = >0.333).  
Table (5.7): t-Student test for encounter’s demography that affect on drugs 
prescriptions. 
Depen. variables: 
“Drugs prescription” 
Indepen.variables: 
Demography  
N Mean S.D t P-value 
 
# of drugs prescribed 
 
Up to 3 years 555 1.97 0.836 -1.249 0.071 
> 3 years 525 2.03 0.77 
Male 589 2.03 0.818 1.326 0.333 
Female 491 1.97 0.788 
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5.1.2.3 Clinic governorate that affect on number of drugs prescription 
 
One way ANOVA for the relation between number of drugs prescribed and governorates, 
used to measure the statistical significance differences between different group means. The  
number of drugs prescription (the dependent variables) which is a continuous variables that 
will be examined for similarity of the means for every governorate.  
In the table (5.8)  there were   mild differences between the means of governorates ,with 
the highest mean was for Gaza (Town) (2.07) and the lowest mean was for Khan-Younis 
(1.93), but there was no statistical significant differences between the different 
governorates in relation to the mean of drugs  prescribed (P value=0.409). 
Table (5.8): One way ANOVA test for clinic governorate that affect on drugs  
prescription.  
Dep. Var. 
"Drugs 
Prescription" 
Indep. Var. 
"Clinic 
Governorate 
" 
Mean Sum of Squares DF Mean 
square 
    F P-
Value 
 
 
# of drugs 
prescribed 
 
Middle  
 
Khan-Younis 
 
Rafah 
 
North 
 
Gaza 
 
1.99 
 
1.93 
 
1.97 
 
2.01 
 
2.07 
 
 
Bet. 
Groups 
 
2.582 
 
4 
 
0.645 
0.996 0.409 
 
Within 
groups 
 
696.41 
 
1075 
 
0.648 
 
Total 
 
698.99 
 
1079 
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5.1.2.4 Encounter’s demography, and clinic governorate that affect on antibiotics 
prescription 
Chi-square test for the relation between the independent variables as encounters age, 
gender, and clinic governorate. For the encounter age the percentage of antibiotics 
prescribed for the age (> 3 years) was 60.2% and for age (0-3 years) 50.8%, the difference 
between groups reached statistical significance ( P Value= 0.002), regarding the genders 
didn’t reach  statistical significance (P=0.55), in relation to governorates  the highest 
antibiotics prescription was for the Gaza governorate (62.5%) and the lowest was for the 
middle governorate (48.8%) which reach the statistical significance (P=0.007), mostly 
explained by different factors as socioeconomic level, clients expectations, and attitude of 
the GPs, further studies could be needed to investigate the reasons. 
 
Table (5.9): Chi-Square test for encounter’s demography (age, gender) and clinic 
governorate that affect on antibiotics prescription. 
 
P-
Value 
 
X
2 
Antibiotics prescription  
Variables 
 
No Yes 
% # % # 
 
0.002 
 
9.605 
 
49.2% 
39.8% 
 
273 
209 
 
50.8% 
60.2% 
 
282 
316 
Age groups: 
0-3 years 
>3 years 
 
0.550 
 
0.358 
 
43.8% 
45.6% 
 
258 
224 
 
56.2% 
54.4% 
 
331 
267 
Gender: 
 Male 
Female 
 
 
0.007 
 
 
 
 
 
 
14.161 
 
39.3% 
37.5% 
51.2% 
49.7% 
45.7% 
 
57 
108 
144 
73 
100 
 
60.7% 
62.5% 
48.8% 
50.3% 
54.3% 
 
88 
180 
137 
74 
119 
Governorates: 
North 
Gaza 
Middle  
Khan-Younis 
Rafah 
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5.1.2.5 Encounter’s age, gender, and clinic governorate that affect on antibiotics 
injections. 
In the table (5.10) there was no statistical significance for antibiotics injection in relation to 
encounter age group (P=0.946) and the same for encounter gender (P=0.654). 
In some cultural settings, antimicrobials given by injection are considered more efficacious 
than oral formulations. Gumodoka et al reported that one in four patients in their medical 
districts received antimicrobials by injection and that approximately 70% of these 
injections were unnecessary ( Gumodoka et al,1996). 
  
Table (5.10): Chi-Square test for encounter’s demography (age, gender) that affect on 
antibiotics injections 
 
P-
Value 
 
X
2 
Antibiotics injection  
Variables 
 
No Yes 
% # % # 
 
0.946 
 
0.005 
 
97.9% 
97.8% 
 
276 
310 
 
2.1% 
2.2% 
 
6 
7 
Age groups: 
0-3 years 
>3 years 
 
0.654 
 
0.201 
 
97.6% 
98.1% 
 
324 
262 
 
2.4% 
1.9% 
 
8 
5 
Gender: 
 Male 
Female 
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5.2 Questionnaire  
5.2.1 Descriptive analysis 
5.2.1.1 General practitioners personal data: 
A sample of 84 general practitioners were included in the study from all UNRWA health 
centers with different education, skills, and experience with response rate about 92.3%. 
Table (5.11) clarifies the important personal data of the general practitioners which include 
gender, age, years of experience, place of graduation and if they had received training 
courses about antibiotics or not.  
As shown in the table (5.11) the majority were male general practitioners  represented 
about (79.7%), the remaining were female. In relation to age of GP varied from 26 to 60 
years, the mean was 42.29, the median 45.5, and SD equal to 10.1867,  more than half 
(53.6%)  aged more than 45 years (>45 years), few (15.5%) from (36-45 years) and the 
remaining (31%)  from (26-35). The majority 64.3% have experience more than 10 years, 
experience from 0-5 years were 22.6% and from 6-10 years were 13.1%. Regarding place 
of graduation of the general practitioners the majority were graduated from Arabic 
countries (69.3%), while the remaining (30.7%) from non Arabic countries. 
Most of the respondent (51.3%) have received training courses about antibiotics and the 
remaining (48.7%) have not. Arabic study of the  percentage of women in the labor force 
in 2003  showed that the highest was in Somalia 43% the lowest in United Arab Emirates 
13% other countries as Jordan 24% and Egypt, Lebanon, and Sudan 30%, Oman 17% (Ifad 
and Firdos,2005). 
The percentage of GPs aged (26 -35) is 31% which indicates a high hiring rate of young 
staff who had low experience about technical instructions including the UNRWA 
Formulary Model and STG. The high rate of recruitments were in response to the  
expansion of health services and to improve quality of care by decreasing clients/GPs load. 
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The percentage is similar to other local study at government sector were the physicians age 
group (25-34) was 33.8% (Fatouh, 2005).The mean age of the GPs was 42.29, similarly  
the mean age of the physicians were 43.6 and 40 years in (Hutchinson and Foley ,1999) 
and (Fatouh study,2005) respectively. 
In relation to place of graduation 69.3% graduated from Arabic countries and only 51.3% 
have received training about antibiotics indicating the need for in-service training to ensure 
update knowledge of GPs and information about new medicines. In the study there were 
statistical significance between training courses received by GPs and antibiotics prescribed 
in sure bacterial diagnosis (P=0.003).  Elsewhere in the Netherlands after nine months 
training intervention which consisted of group education meetings, with a consensus 
procedure on indication for and type of antibiotics and with training in communication 
skills; monitoring and feedback on prescribing behavior, group education for assistants of 
general practitioners, the prescription rates in the intervention group fell from 27% to 23%, 
whereas the control group's rose 27% to 37% (Welschen, et al, 2004). In a study reported 
by Steinke et al, non-training practices in Tayside, UK were in general found to prescribe 
significantly more antibiotics as well as a higher proportion of broad spectrum penicillin, a 
higher proportion of newer antibiotics and a greater number of different antibiotics per 
doctor compared to training practices (Steinke et al,2000). 
The same concept advocated by the 1985 Nairobi conference , that initial efforts to 
improve drug use were based on a simple rational actor model which assumed that 
problems in drug use stemmed from knowledge deficits, among prescribers and consumers 
and that education and training were appropriate strategy to improve medicines use. Also 
study by Ross-Degnan et al ,1997 in improving pharmaceutical use in primary health care 
in developing countries have tested the impact of  fourteen interventions of educational 
strategies such as training seminars and workshops, three (21.4%) of these intervention 
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achieved large improvement in primary care pharmaceutical use ,seven (50%)  showed 
moderate effects and four (28.6%) had little impact. Two of three interventions were 
carried out training in large groups using multiple problem oriented sessions (De Vries et 
al ,1995) at communicating  skills.(Lopez linares,1991). The third intervention in Pakistan 
teaching Hospital (Qazi, Rehman, and Khan,1996) achieved 31% reduction in out patients 
antibiotics use for ARI , using small group training in case management followed by 
refresher seminars and ongoing supervision. The  most effective training approaches were 
problem focused , role playing and practical skills development. 
Also Gonzalez et al, 1996 found that reduction in community antibiotics use were twice as 
large (18.9% vs. 8.9%) when multi-method training and supervision for local physicians on 
ARI management was combined with intensive community education. Study by Ross-
Degnan et al ,1997 showed that well-designed training interventions, whether conducted in 
large or small groups, can successfully improve targeted prescribing outcomes by an 
average of 15% or more.  The impact of training seems to be increased by: employing 
multiple training modalities (lectures, group problem-solving, role playing, opportunity to 
practice skills); repeated sessions; focus on one clinical problem at a time; training at the 
work site; and using opinion leaders or district-level staff as trainers. Also in the present  
study there were Statistical Significance between of experience years and antibiotics  
prescribed in sure bacterial diagnosis ( P values 0.013 ).  
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Table (5.11): Distribution of study General Practitioners by personal data 
 
Variables Frequency Percentage 
Gender: 
Male 
Female 
Total 
 
63 
16 
79 
 
79.7% 
20.3% 
100% 
Age group: 
26-35 
36-45 
>45 
Total 
 
26 
13 
45 
84 
 
31% 
15.5% 
53.6% 
100% 
Years of experience 
0-5 
6-10 
>10 
Total 
 
19 
11 
54 
84 
 
22.6% 
13.1% 
64.3% 
100% 
Place of graduations 
Arabic countries 
Non Arabic countries 
Total 
 
52 
23 
75 
 
69.3% 
30.7% 
100% 
Governorate: 
North 
Gaza 
Middle  
Khan-Younis 
Rafah 
Total 
 
14 
17 
24 
15 
14 
84 
 
16.7% 
20.2% 
28.6% 
17.9% 
16.7% 
100% 
Receiving training courses: 
about antibiotics: 
Yes 
No 
Total 
 
 
40 
38 
78 
 
 
51.3% 
48.7% 
100% 
 
 
5.2.1.2 General Practitioners knowledge  
Table (5.12) illustrated the variables related the respondents knowledge, regarding  the 
definition of an antibiotics it was moderate as (67.9%) provide correct answer, while 
(32.1%) provide incorrect answer. The vast majority of GP (89.3%) were aware about the 
danger to the clients associated with taking antibiotics, and (98.8) of the respondent were 
agreed with the statement of "rational antibiotic use". 
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 About half of the respondent (48.2%) mentioned the seven correct generic names of 
antibiotics, while (26.5%) mentioned six correct names out of seven, (22.9%) mentioned 
five or less, and (2.4%) incorrect. Regarding the importance to know the generic names 
(71.4%) of the respondent mentioned the values to know the generic names of antibiotics. 
 
Sources of information 
Knowledge which rely  on guidelines as UNRWA Formulary and STG and researches  aim 
to reduce inappropriate variations in practice and to promote the delivery of evidence-
based health care, but there are other sources of knowledge  as experience, training courses  
and pharmaceutical representative. (59%) of the respondent mentioned "UNRWA Model 
Formulary" as a sources of information, also (59%) mentioned the STG, experience 
(51.2%), training (44%), pharmaceutical representative (36.9%). Medical pharmacopeias 
(14.3%), medical books (10.7%), and internet (1.2%) (Figure 5). 
 
1.20%
10.7%
14.3%
36.9%
44%
51.2%
59% 59%
0%
10%
20%
30%
40%
50%
60%
1
Figure 5: General practitioner's sources of information
UNRWA Model Formulary: STG Experience Training
Pharmacy representative: Medic Pharmacopeias Medical books Internet
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In many developing countries health workers have almost no access to objective health 
information  (Cash R, 1996). Pharmaceutical company representatives typically outnumber 
practitioners and often adversely influence their prescription habits (Ronsmans Islam , and 
Bennish 1996) as reflected by sales of nonessential drugs and drug combinations (Hartog 
,1993). 
Table (5.12): Distribution of the study General Practitioners by their knowledge 
Variables 
 
Frequency Percentage 
What is the definition of an antibiotic: 
Antibacterial, antifungal, antiviral ,and anti-parasitic 
Drug kill or prevent growth of bacteria and fungi 
Drug kill or prevent growth of bacteria 
Drug prevent growth of bacteria and parasite 
Non of the above 
 
12 
9 
57 
1 
5 
 
14.3% 
10.7% 
67.9% 
1.2% 
6% 
Awareness of GP of any danger: 
Emerging of antibiotics resistance 
Allergy 
Kill friendly  microbes 
Misuse 
all of the above 
 
1 
5 
1 
2 
75 
 
1.2% 
6% 
1.2% 
2.4% 
89.3% 
Rational antibiotic use involves "The correct antibiotic, 
administered by the best route in the right amount, at optimum 
intervals for the appropriate period and after an accurate 
diagnosis" 
Yes 
No 
 
 
 
 
83 
1 
 
 
 
 
98.8% 
1.2% 
Mention the generic names 
All  of them are correct 
Most of them are correct 
Some of them are correct 
Non are correct 
 
 
40 
22 
19 
2 
 
 
48.2% 
26.5% 
22.9% 
2.4% 
 
What is the importance of generic name of antibiotics: ―Generic 
names facilitate good communication, avoid manipulation, 
monopolies &generate knowledge‖ 
Yes 
No 
 
 
 
 
60 
24 
 
 
 
71.4% 
28.6% 
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5.2.1.3 General Practitioners attitude  
 
The driving forces that influence (favor) the GP to prescribe antibiotics 
As represented in the table (5.13), the majority (95.2%) mentioned that purulent discharge 
favor them to prescribe antibiotics, in addition to antibiotics resistance concern (48.2%) 
fever  (65.1%)., patient satisfaction 8.3% and time pressure (72.6%).  
Elsewhere in a study from five districts of Tamilnadu state, in India,: 285 general 
practitioners and specialists believed that antibiotics are over-prescribed, especially broad-
spectrum antibiotic, and purulent discharge (65%), antibiotic-resistance concerns (48%), 
fever (40%), and patient satisfaction (29%) were proposed as the strong reasons to 
prescribe an antibiotic (Sivagnanam et al 2004).  Factors like patient and time pressures, 
diagnostic and treatment uncertainties, poor patient compliance due to high cost and fear of 
antibiotic resistance are the key forces behind irrational prescription of antimicrobial 
combinations (Stohr, 2000).  
  
The driving forces that decrease (disfavor) the GP to prescribe antibiotics 
Patients request expectation (96.4%), potential return visit costs (94%), patients 
satisfaction (91,7%), treatment uncertainty (66.7%) and antibiotics resistance concern 
(51.8%). Similarly  in Massachusetts Physician survey, 1998 in which the physicians 
indicated the factors which influenced them to increase antibiotic prescribing as  purulent 
discharge 64%, diagnostic uncertainty 62%, Patient request 59%, and factors which 
decreased their overall prescription of antibiotics are concern over emerging antibiotic 
resistance, 66% , and medication cost, 33%. In Bharathiraja, et al ,2005, it was found that 
the presence of fever increased the likelihood of antibiotic being prescribed. This is largely 
due to the fact that the practicing physicians tend to consider fever as a sign of bacterial 
infection, which is not the case always . Also in over-crowding, clinicians with greater 
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patient workloads prescribe antibiotics for ARIs more frequently (Pshetizky, Naimer , and 
Shvartzman , 2003). Also a variety of factors contribute to the inappropriate use of 
antibiotics, such as patient expectations, time constraints imposed on the clinician, and the 
practice of defensive medicine (Audit Commission London, England: HMSO; 1994).  
Physician time constraint is a factor that is frequently mentioned as a hypothesis for 
antibiotic overuse (Butler et al 1998). Also prescribing just to be safe increases when there 
is diagnostic uncertainty, lack of prescriber knowledge regarding optimal diagnostic 
approaches, lack of opportunity for patient follow-up, and/or fear of possible litigation 
(Paredes, et al 1996). When a parent or child has received an antibiotic prescription for an 
illness in the past, that experience engenders expectations that the same therapy is required 
should such symptoms recur (Mainous et al, 1997). Parental expectation is often cited as a 
reason for antibiotic prescriptions (Vinson, and Lutz ,1993). Patients' expectations and 
views and doctors' concern that the patient may otherwise re-consult had a powerful effect 
on doctors' decision to prescribe. Patients who did not receive an antibiotic that they 
wanted were more likely to be dissatisfied and re-consulted twice as frequently 
(Macfarlane, et al ,1997). 
Attitude of clinicians could be changed by Continuous medical education (CME). Studies 
of antibiotic misuse in Cuba and Pakistan (McEachern, et al, 1991) recommend continuing 
medical education for health workers as the single most important tool for combating 
antibiotic misuse. A study in Zambia has demonstrated the efficacy of education in 
reducing antibiotic prescription rates (Berwick, Godfrey, and Roessner,1990). In 
industrialized countries, patients often pressure physicians to prescribe antibiotics  
(Paredes, et al, 1996). 
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Table (5.13): Distribution of study General Practitioners by their attitude 
 
 
Variable: GP intention to prescribe antibiotics 
 
Frequency Percentage 
Fever: 
Favor 
Disfavor 
 
54 
29 
 
65.1% 
34.9% 
Purulent discharge: 
Favor 
Disfavor 
 
80 
4 
 
95.2% 
4.8% 
Patient request expectation: 
Favor 
Disfavor 
 
3 
81 
 
3.6% 
96.4% 
Potential return visits costs 
Favor 
Disfavor 
 
5 
78 
 
6% 
94% 
Patient satisfaction 
Favor 
Disfavor 
 
7 
77 
 
8.3% 
91.7% 
Time pressure 
Favor 
Disfavor 
 
61 
23 
 
72.6% 
27.4% 
Treatment uncertainty 
Favor 
Disfavor 
 
24 
56 
 
28.6% 
66.7% 
Antibiotics resistance concern 
Favor 
Disfavor 
 
40 
43 
 
48.2% 
51.8% 
 
 
5.2.1.4 General practitioners practices 
 
Table (5.14) illustrated the general practitioners  practices  (83.1%) prescribed antibiotics 
in sure bacterial diagnosis. Also (64.3%) have received UNRWA Model Formulary, 
(9.5%) mentioned that its in front of him (on the table), facing problems in using it 
(28.6%), and lead to improvement in prescribing pattern in (74.5%).  
Clinical practice guidelines aim to reduce inappropriate variations in practice and to 
promote the delivery of evidence-based health care. In our study GPs  response about using 
UNRWA Formulary in their prescription of antibiotics was as follow : currently  using 
(71%), used in the past (9%), and not used (20%)  the same mentioned improvement in 
74.5% in prescribing pattern after using UNRWA Formulary. Also there were no statistical 
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significance relation ship between the use of UNRWA Formulary and antibiotics 
prescribed in sure bacterial diagnosis, (P=0.754). Although physicians interest in clinical 
guidelines has never been greater, uncertainty persists about whether they are effective, 
and doubts whether it can perform the behavior there was a  good evidence  that clinical 
guidelines and lists of essential
 
medicines, when properly developed, introduced, and 
supported,
 
improve prescribing quality and lead to better health outcomes (Grimshaw,  and 
Russell ,1993).  
Also it is important to mention that the dissemination of printed clinical guidelines or 
unbiased drug information alone is not sufficient to cause measurable improvements in 
behaviour, and consistently failed.   
However, active dissemination of guidelines through staff training, peer group re-invention 
of guidelines, or audit and feedback has resulted in improved compliance with the 
guidelines ( Ross-Degnan, et al,1997). Similarly in 1998 Massachusetts Physician survey, 
formularies were said to exert little influence on prescribing behavior  only in 28%. 
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Table (5.14): Distribution of study General Practitioners by their practices 
 
 
Variable 
 
Frequency Percentage 
Antibiotics prescribed in: 
Suspected bacterial  
Yes 
No 
Viral 
Yes 
No 
Sure bacterial diagnosis 
Yes 
No 
Fear of serious condition 
Yes 
No 
 
 
59 
24 
 
1 
82 
 
69 
14 
 
22 
61 
 
 
71.1% 
28.9% 
 
1.2% 
98.8% 
 
83.1% 
16.9% 
 
73.5% 
26.5% 
Have you received UNRWA Formulary: 
Yes 
No 
 
54 
30 
 
64.3% 
35.7% 
Availability of UNRWA Formulary: 
In front of the GP 
In the drawer 
In the keyboard 
At home 
 
 
8 
17 
6 
23 
 
14.8% 
31.4% 
11.1% 
42.5% 
Did you use UNRWA Formulary in your prescription of 
antibiotics: 
Currently in using 
Used in the past 
Not used 
 
 
39 
5 
11 
 
 
71% 
9% 
20% 
Problem in using UN Formulary: 
Yes 
No 
 
 
23 
24 
 
 
48.9% 
51.1% 
 
Improvement in prescribing pattern after using UNRWA 
Formulary 
Yes 
No 
 
 
35 
12 
 
 
74.5% 
25.5% 
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5.2.1.5 Reported problems in using UNRWA Model Formulary 
 
Table (5.15) illustrated problems related to UNRWA Formulary in which lack of time due 
to overcrowding was the most prominent factor (58.3%), followed by not all the antibiotics 
present in the Formulary (50%). Also insufficient knowledge (29%), difficult to be handled 
in front of the clients (25%), lack of motivation (25%), the rarest was the lack of  
continuous training in using it (12.5%).  
Table (5.15): Distribution of study General Practitioners by reported problems in using 
UNRWA Model Formulary 
Variable 
 
Frequency Percentage 
Insufficient knowledge 
Yes 
No 
 
7 
17 
 
29% 
71% 
Lack of training 
Yes 
No 
 
 
3 
21 
 
 
12.5% 
87.5% 
 
Lack of time due to overcrowding 
Yes 
No 
 
 
14 
10 
 
 
58.3% 
41.7% 
 
Difficult to be handled 
Yes 
No 
 
 
4 
20 
 
 
16.6% 
83.4% 
 
Not all the antibiotics present in the Formulary 
Yes 
No 
 
 
12 
12 
 
 
50% 
50% 
 
Difficult to be used in front of the clients(barrier) 
Yes 
No 
 
 
6 
18 
 
 
25% 
75% 
 
Lack of motivation to change previous practices 
Yes 
No 
 
 
6 
18 
 
 
25% 
75% 
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5.2.1.6 Practices related to Standard Treatment Guidelines (STG) 
 
Table(5.16) shows the respondent practices related to STG which is (72.3%) received the 
materials, (85.2%) using it (30.1%) facing obstacles in using it ,the majority (92.5%) 
reported improvement in using it, some of the respondents reported obstacles in using it, as 
doubts whether it can perform the behavior (31.2%), (37.5%) mentioned lack of familiarity 
with STG ,lack of agreement to the concept of guidelines about (31.2%) and patient related 
barriers (43.7%).  
 
Table (5.16): Distribution of the study General Practitioners about practices related to 
Standard Treatment Guidelines (STG) 
Variable 
 
Frequency Percentage 
Receiving  STG 
 
60 72.3% 
Using  STG 
 
52 85.2% 
Obstacles in using STG 
 
16 30.1% 
Did you see improvement in using STG 
 
50 92.5% 
Reported obstacles in using STG 
 
Doubts whether it can perform the behavior 
 
5 31.2% 
Lack of familiarity with STG 
 
6 37.5% 
Lack of agreement to the concept of guidelines 
 
5 31.2% 
Patient related barriers 
 
7 43.7% 
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5.2.1.7 Use of antibiotics as prophylaxis 
 Regarding uses of antibiotics as prophylaxis in the table (5.17) the respondents reported 
correct answers in (64.3%) which is the SBE & Rheumatic fever. 
 
Table (5.17): Distribution of study General Practitioners about the use of antibiotics as 
prophylaxis 
Variables 
 
Frequency Percentage 
Uncertain condition 
Yes 
No 
 
10 
74 
 
11.9% 
88.1% 
Fear induced 
Yes 
No 
 
3 
81 
 
3.6% 
96.4% 
SBE&Rh-fever 
Yes 
No 
 
54 
30 
 
64.3% 
35.7% 
All of the above 
Yes 
No 
 
20 
64 
 
23.8% 
76.2% 
Non of the above 
Yes 
No 
 
9 
75 
 
10.7% 
89.3% 
 
 
5.2.1.8 General Practitioners  believe about antibiotics over-prescription 
In Figure (6) 96.4% of the respondents reported yes to the general question: Do you 
believe that antibiotics are over prescribed?  Yes  :  81 (96.4%),  No : 3 (3.6%). 
The same finding in Massachusetts Physician survey, 1998:in which 93% of respondents 
answered yes to the general question: Do you think physicians over-prescribe antibiotics? 
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Figure 6: General Practitioners' believe about 
antibiotics over-prescription
96%
4%
Yes No
 
 
 
5.2.1.9 The most important factors that lead to over-prescriptions of antibiotics 
 
Table (5.18) illustrate the analysis of the open ended question about important factors 
leading to over-prescriptions of antibiotics the most important were over-crowding (65%). 
Similarly clinicians with greater patient workloads prescribe antibiotics for ARIs more 
frequently (Pshetizky , Naimer , and Shvartzman, 2003). Other factors clients pressure 
(55.7%), antibiotics prescription without diagnosis (36.3%), outside prescription (31.2%), 
lack of knowledge of some GP (31.3%).The less important was that no evaluation and 
monitoring of antibiotics (2.5%), the role of job creation's GP (6%) and free of charge 
(6.17%) (Figure7). 
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Table (5.18): Distribution of the study General Practitioners by the most important 
factors that lead to over-prescriptions of antibiotics 
 
Percentage Frequency Factor 
 
 
65% 
35% 
 
52 
28 
1-Overcrowding: 
Yes 
No 
 
55.7% 
54.3% 
 
44 
35 
2-Clients pressure: 
Yes 
No 
 
36.25% 
63.75% 
 
29 
51 
3-Antibiotics prescription without diagnosis: 
Yes 
No 
 
31.25% 
68.75% 
 
25 
55 
4-Lack of knowledge of some GP: 
Yes 
No 
 
31.2% 
68.8% 
 
25 
55 
5-Outside prescriptions: 
Yes 
No 
 
21.12% 
78.75% 
 
17 
63 
6-Poor practices and commercial factor of private sector: 
Yes 
No 
 
15.18% 
84.8% 
 
12 
67 
7-To get red of some clients and avoidance of problems: 
Yes 
No 
 
13.75% 
86.25% 
 
11 
69 
8-Easy way adopted by the GP to satisfy the clients: 
Yes 
No 
 
11.25% 
88.75% 
 
9 
71 
9-Lack of laboratory investigations: 
Yes 
No 
 
11.2% 
88.8% 
 
9 
72 
10-No trust of the clients due to  prescription without examin: 
Yes 
No  
 
10% 
90% 
 
8 
72 
11-Client-general practitioner relation: 
Yes 
No 
 
9.8% 
90.2% 
 
8 
73 
12-Economic constrains: 
Yes 
No 
 
8.7% 
91.25% 
 
7 
73 
13-No training courses about antibiotics: 
Yes 
No 
 
8.6% 
91.4% 
 
7 
74 
14-Belief that some clients will not cure without antibiotic: 
Yes 
No 
 
7.4% 
92.6% 
 
6 
75 
15-Low awareness of the clients about hazard of antibiotics: 
Yes 
No  
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6.17% 
93.8% 
 
5 
76 
16-Free of charge: 
  Yes 
No 
 
6% 
94% 
 
5 
78 
17-Job creation Medical officer: 
Yes 
No 
 
2.5% 
97.5% 
 
2 
79 
18-No evaluations & monitoring  of antibiotics: 
Yes 
No 
 
5.2.1.10 General Practitioners’ opinion to promote more prudent use of antibiotics: 
Table (5.19) illustrated the general practitioners opinion after analysis of the open ended 
question on how to promote more prudent usage of antibiotics, the results were about half 
the respondent mentioned that health education  of the clients (48.7%), and workshop 
(47.4%). Other mentioned "to increase community awareness" by using media (28.6%), 
improving knowledge of GP (29.4%) and implementation of appointment system (25.6%) 
(Figure 8).  
 
Table (5.19): Distribution of the study General Practitioners by opinion to promote more 
prudent use of antibiotics 
Percentage Frequency Variable  
 
 
48.7% 
51.3% 
 
38 
40 
1-Health Education of the clients  
Yes 
No 
 
47.4% 
52.6% 
 
37 
41 
2-Workshop(training seminar) 
Yes 
No 
 
33.3% 
66.7% 
 
26 
52 
3-Decreasing overcrowding 
Yes 
No 
 
29.4% 
70.6% 
 
23 
55 
4-Improving knowledge of general practitioner 
Yes 
No 
 
 
28.6% 
71.4% 
 
 
22 
55 
5-Increase community awareness by TV, Radio , and 
school health education programs 
Yes 
No 
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25.6% 
74.4% 
 
20 
58 
6-Appointment system 
Yes 
No 
 
24.4% 
75.6% 
 
19 
59 
7-More follow up and supervision 
Yes 
No 
 
21.8% 
78.2% 
 
17 
61 
8-Proper diagnosis, C&S 
Yes 
No 
 
16.6% 
83.45 
 
13 
65 
9-Strict regulation and dispensing of antibiotics 
Yes 
No 
 
15.4% 
84.6% 
 
12 
66 
10-Increase number of general practitioner 
Yes 
No 
 
12.8% 
87.2% 
 
10 
68 
11-Provision of updated material UNRWA Formulary 
Yes 
No 
 
8.7% 
91.3% 
 
7 
73 
12-Enough protection and support for the staff: 
Yes 
No 
 
5% 
95% 
 
4 
76 
13-Continuous daily pharmacy prescription studies 
  Yes 
No 
 
3.8% 
96.2% 
 
3 
75 
14-Improving quality by adopting  MHIS 
Yes 
No 
 
3.8% 
96.2% 
 
3 
75 
15-More cooperation between staff 
Yes 
No 
 
 
 
3.7% 
96.3% 
 
 
 
3 
77 
16-Cooperation between all sectors of health :UNRWA 
,government, private sectors about importance of rational 
use of antibiotics 
Yes 
No 
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5.2.2 Inferential analysis 
5.2.2.1 Relation between GPs personal data and antibiotics prescribed in fear of 
serious conditions 
In table (5.20) Chi-Square test used to examine GPs personal data that affect on antibiotics  
prescribed in fear of serious conditions, the result were as follow: 
Antibiotics prescribed in fear of serious conditions and age groups of GPs. 
The age groups showed statistical significant differences regarding antibiotics prescribed in 
fear of serious condition (P=0.037). The age 26-35 showed the highest percentage (38.5%), 
mostly due to low experience and insufficient training. 
Antibiotics prescribed in fear of serious conditions and gender. 
The percentage for male GPs who prescribed antibiotics in fear of serious conditions was 
(25.8%) which is slightly higher than female GPs (25%), but the difference between 
groups did not reach statistical significant level (X
2
=0.004, P= 0.947). 
Antibiotics prescribed in fear of serious conditions and graduation countries. 
 The percentage of graduation from Arabic countries were antibiotics prescribed in fear of 
serious condition was (23.5%) which is lesser than those from non-Arabic countries 
(30.4%), but the difference between groups did not reach statistical significant level 
(X
2
=0.396, P= 0. 529), the different GPs’ educational backgrounds especially from schools 
in more affluent regions of the world (from more than twenty different countries) did not 
greatly influence their prescribing behavior. 
Antibiotics prescribed in fear of serious conditions and training courses received 
about antibiotics. 
The percentage for those who received training courses were antibiotics prescribed in fear 
of serious condition was (23.1%) which is lesser than those who did not received training 
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courses (28.9%). The difference between groups didn’t reach statistical significant level 
(X
2
= 0.345, P= 0.557). 
Antibiotics prescribed in fear of serious conditions and years of experience. 
The percentage for years of experience more than 10 years were antibiotics prescribed in 
fear of serious condition was (22.6%) which is lesser than 0-10 years (33.3%). The 
difference between groups didn’t reach statistical significant level (X2= 1.124, P= 0.289). 
 
Table (5.20): Chi-Square test for Personal  data that  affect on  Antibiotics prescribed in 
fear of serious conditions. 
 
P-
Value 
 
X
2 
Antibiotics prescribed in fear of serious  
conditions 
 
Variables 
Personal data No Yes 
% # % # 
 
0.037 
 
6.61 
 
61.5% 
79% 
 
16 
45 
 
38.5% 
21% 
 
10 
12 
Age group of GP: 
26-35 years 
>=36 
 
 
0.947 
 
0.004 
 
74.2% 
75% 
 
46 
12 
 
25.8% 
25% 
 
16 
4 
Gender: 
Male 
Female 
 
 
0.529 
 
0.396 
 
76.5% 
69.6% 
 
39 
16 
 
23.5% 
30.4% 
 
12 
7 
Graduation countries 
Arabic 
Non-Arabic 
 
0.557 
 
0.345 
 
 
79.9% 
71.1% 
 
 
30 
27 
 
 
23.1% 
28.9% 
 
 
9 
11 
Have you received training 
courses about A.B 
Yes 
No 
 
0.289 
 
1.124 
 
66.7% 
77.4% 
 
20 
41 
 
33.3% 
22.6% 
 
10 
12 
 
Years of experience 
0-10 
>10 
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5.2.2.2 Relation between ( personal data and Governorates ) and antibiotics 
prescribed in suspected bacterial diagnosis 
Antibiotics prescribed in suspected bacterial diagnosis and age groups of GPs. 
The age groups showed no statistical significant differences regarding antibiotics 
prescribed  in suspected bacterial diagnosis (P=0.687). The age ( >36) showed the lowest 
percentage (68.6%), while age (26-35) was 73.1%. 
 Antibiotics prescribed in suspected bacterial diagnosis and gender. 
The percentage for female GPs who prescribed antibiotics in suspected bacterial diagnosis 
was (75%) which is slightly higher than male GPs (69.4%), but the difference between 
groups did not reached statistical significant level (X
2
=0.195, P= 0.659). 
Antibiotics prescribed in suspected bacterial diagnosis and graduation countries. 
 The percentage of graduation from Arabic countries were antibiotics prescribed in 
suspected bacterial diagnosis was (70.6%) which was higher than those from non  Arabic 
countries (65.2%), but the difference between groups did not reached statistical significant 
level (X
2
=0.213, P= 0.644).  
Antibiotics prescribed in suspected bacterial diagnosis and training courses received 
about antibiotics. 
The percentage for those who received training courses were antibiotics prescribed in 
suspected bacterial diagnosis was (66.7%) which is lesser than those who did not received 
training courses (73.7%). The difference between groups didn’t reach statistical significant 
level (X
2
= 0.452, P= 0.501). 
Antibiotics prescribed in suspected bacterial diagnosis and years of experience. 
The percentage for years of experience more than 10 years were antibiotics prescribed in 
suspected bacterial diagnosis was (67.9%) which is lesser than 0-10 years (76.7%). The 
difference between groups didn’t reach statistical significant level (X2= 0.712, P= 0.399). 
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Antibiotics prescribed in suspected bacterial diagnosis and clinic governorate.  
The governorates revealed statistical significant differences regarding antibiotics 
prescribed in suspected bacterial diagnosis (P=0.004), the Middle  governorate  showed the 
highest percentage (83.3%), Gaza (82.4%), Rafah (78.6%) Khan-Younis (71.4%) and the 
lowest North (28.6%) 
 
Table (5.21): Chi-Square test for Personal data and Governorates that affect on  
antibiotics prescribed in suspected bacterial diagnosis. 
 
P-
Value 
 
X
2 
Antibiotics prescribed in suspected 
bacterial diagnosis. 
 
Variables 
Personal data No Yes 
% # % # 
 
0.687 
 
0.163 
 
26.9% 
31.4% 
 
7 
16 
 
73.1% 
68.6% 
 
19 
35 
Age group of GP: 
26-35 years 
>=36 
 
0.659 
 
0.195 
 
30.6% 
25% 
 
19 
4 
 
69.4% 
75% 
 
43 
12 
Gender: 
Male 
Female 
 
 
0.644 
 
0.213 
 
29.4% 
34.8% 
 
15 
8 
 
70.6% 
65.2% 
 
36 
15 
Graduation countries 
Arabic 
Non-Arabic 
 
0.501 
 
0.452 
 
 
33.3% 
26.3% 
 
 
13 
10 
 
 
66.7% 
73.7% 
 
 
26 
28 
Have you received training 
courses about A.B 
Yes 
No 
 
0.399 
 
0.712 
 
23.3% 
32.1% 
 
7 
17 
 
76.7% 
67.9% 
 
23 
36 
 
Years of experience 
0-10 
>10 
 
0.004 
 
15.495 
 
71.4% 
17.6% 
16.7% 
28.6% 
21.4% 
 
10 
3 
4 
4 
3 
 
28.6% 
82.2% 
83.3% 
71.4% 
78.6% 
 
4 
14 
20 
10 
11 
Governorates: 
North 
Gaza 
Middle  
Khan-Younis 
Rafah 
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5.2.2.3 Relation between (personal data and Governorates) and antibiotics prescribed 
as prophylaxis in SBE and Rh. Fever 
Antibiotics prescribed as prophylaxis in SBE and Rh. Fever and age groups of GPs. 
The age groups showed no statistical significant differences regarding antibiotics 
prescribed as prophylaxis in S.B.E and Rh. Fever (P=1.00). The age (>36) showed the 
same percentage (65.4%), as the age (26-35).  
Antibiotics prescribed as prophylaxis in SBE and Rh. Fever and gender. 
The percentage for female GPs who prescribed antibiotics as prophylaxis in SBE and Rh. 
Fever was (75%) which is slightly higher than male GPs (61.9%), but the difference 
between groups did not reach statistical significant level ( P= 0.328). 
Antibiotics prescribed as prophylaxis in SBE and Rh. Fever and graduation 
countries. 
 The percentage of GPs graduation from Arabic countries were antibiotics prescribed as 
prophylaxis in SBE and Rh. Fever was (71.2%) which was higher than those from non  
Arabic countries (60.9%), but the difference between groups did not reach statistical 
significant level ( P= 0.379).  
Antibiotics prescribed as prophylaxis in SBE and Rh. Fever and training courses 
received about antibiotics. 
The percentage for those who received training courses were antibiotics prescribed as 
prophylaxis in SBE and Rh. Fever was (75%) which is higher than those who did not 
received training courses (55.3%). The difference between groups didn’t reach statistical 
significant level (P= 0.067). 
Antibiotics prescribed as prophylaxis in SBE and Rh. Fever and years of experience 
The percentage for years of experience more than 10 years were Antibiotics used as 
prophylaxis in SBE and Rh. Fever was (64.8%) which is slightly higher than 0-10 years 
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(63.3%). The difference between groups didn’t reach statistical significant level (P= 
0.892). 
Antibiotics prescribed as prophylaxis in SBE and Rh. Fever and clinic governorate  
No statistical significant differences regarding Antibiotics prescribed as prophylaxis in 
SBE and Rh. Fever in relation to the governorates, (P=0.779). 
5.22. Chi-Square test Relation between (personal data and Governorates) and antibiotics 
 
 prescribed as prophylaxis in SBE and Rh. Fever. 
 
 
P-
Value 
 
X
2 
Used as prophylaxis in SBE and Rh. 
Fever 
 
Variables 
Personal data No Yes 
% # % # 
 
1.00 
 
0.00 
 
34.6% 
34.6% 
 
9 
18 
 
65.4% 
65.4% 
 
17 
34 
Age group of GP: 
26-35 years 
>=36 
 
0.328 
 
0. 956 
 
38.1% 
25% 
 
24 
4 
 
61.9% 
75% 
 
39 
12 
Gender: 
Male 
Female 
 
 
0.379 
 
0.775 
 
28.8% 
39.1% 
 
15 
9 
 
71.2% 
60.9% 
 
37 
14 
Graduation countries 
Arabic 
Non-Arabic 
 
0.067 
 
3.354 
 
 
25% 
44.7% 
 
 
10 
17 
 
 
 
75 % 
55.3% 
 
 
30 
21 
Have you received training 
courses about A.B 
Yes 
No 
 
0.092 
 
0.010 
 
36.7% 
35.2% 
 
11 
19 
 
63.3% 
64.8% 
 
19 
35 
 
Years of experience 
0-10 
>10 
 
0.779 
 
1.764 
 
35.7% 
41.2% 
29.2% 
46.7% 
28.6% 
 
5 
7 
7 
7 
4 
 
64.3% 
58.8% 
70.8% 
53.3% 
71.4% 
 
9 
10 
17 
8 
10 
Governorates: 
North 
Gaza 
Middle  
Khan-Younis 
Rafah 
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5.2.2.4 Use of UNRWA Formulary 
  
Relation between use of UNRWA Formulary and antibiotics prescribing patterns: 
In table (5.23) Chi-Square test used to examine the use of UNRWA Formulary that affect 
on antibiotics prescribing patterns, there were no statistical significant differences between 
the different groups (P value > 0.05). 
Table (5.23): Chi-Square test for Use of UNRWA Formulary that  affect  on antibiotics  
 
 prescribing patterns. 
 
 
P-
Value 
 
X
2 
Currently using UNRWA Formulary  
Variables 
antibiotics  prescribing 
patterns 
Not Used Used 
% # % # 
 
0.544 
 
0.309 
 
 
 
31.6% 
23.5% 
 
 
 
12 
4 
 
 
 
68.4% 
76.5% 
 
 
 
26 
13 
Antibiotics prescribed in 
suspected bacterial 
diagnosis. 
Yes 
No 
 
0.724 
 
0.125 
 
 
25% 
30.2% 
 
 
3 
12 
 
 
75% 
69.8% 
 
 
9 
30 
Antibiotics prescribed in 
fear of serious condition 
Yes 
No 
 
0.396 
 
0.720 
 
33.3% 
22.7% 
 
11 
5 
 
66.7% 
77.3% 
 
22 
17 
Antibiotics used as 
prophylaxis in S.B.E and 
Rh. Fever 
Yes 
No 
 
 
 
5.2.2.5 Relation between personal data and antibiotics prescribed in sure bacterial 
diagnosis 
Antibiotics prescribed in sure bacterial diagnosis and years of experience 
Table (5.24) showed that the percentage for years of experience more than 10 years were 
antibiotics prescribed in sure bacterial diagnosis was (90.6%) which is higher than 0-5 
years (78.9%), and 6-10 years (54.5%). The difference between groups reached statistical 
significant level (X
2
= 8.757, P= 0.013). Study by  Bharathiraja, et al, 2005 showed that  
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physicians with more than 20 years of experience are less likely to prescribe antibiotics, 
(Bharathiraja, et al ,2005). 
Antibiotics prescribed in sure bacterial diagnosis and training courses received about 
antibiotics 
The percentage for those who received training courses were antibiotics prescribed in sure 
bacterial diagnosis was (97.4%) which is higher than those who did not received training 
courses (73.7%). The difference between groups reached statistical significant level (X
2
= 
8.867, P= 0.003). In a study reported by Steinke et al, non-training practices in Tayside, 
UK were in general found to prescribe significantly more antibiotics as well as a higher 
proportion of broad spectrum penicillin, a higher proportion of newer antibiotics and a 
greater number of different antibiotics per doctor compared to training practices ( Steinke 
et al,2000). 
Antibiotics prescribed in sure bacterial diagnosis and graduation countries 
 The percentage of graduation from Arabic countries were antibiotics prescribed in sure 
bacterial diagnosis was (86.3%) which is higher than those from non  Arabic countries 
(82.6%), but the difference between groups did not reached statistical significant level 
(X
2
=0.168, P= 0. 682), the different GPs’ educational backgrounds especially from schools 
in more affluent regions of the world (from more than twenty different countries) did not 
greatly influence their prescribing behavior. 
Antibiotics prescribed in sure bacterial diagnosis and gender 
The percentage for female GPs who prescribed antibiotics in sure bacterial diagnosis was 
(87.5%) which is higher than male GPs (83.9%), but the difference between groups did not 
reached statistical significant level, (X
2
=0.129, P= 0.720). 
Antibiotics prescribed in sure bacterial diagnosis and age groups of GPs 
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The percentage for age group  more than 45 years who were antibiotics prescribed in sure 
bacterial diagnosis was (90.9%) followed by (76.9%) for age group 36-45 years, the lowest 
was for age group 26-35 (73.1%). The difference between groups did not reached 
statistical significant level (X
2
=4.130, P= 0.127). 
Table (5.24): Chi-Square test for Personal  data that  affect on  Antibiotics prescribed in 
sure bacterial diagnosis. 
 
P-
Value 
 
X
2 
Antibiotics prescribed in sure bacterial 
diagnosis 
 
Variables 
Personal data No Yes 
% # % # 
 
0.013 
 
8.757 
 
21.1% 
45.5% 
9.4% 
 
4 
5 
5 
 
78.9% 
54.5% 
90.6% 
 
15 
6 
48 
Years of experience 
0-5 
6-10 
>10 
 
0.003 
 
8.867 
 
 
2.6% 
26.3% 
 
 
1 
10 
 
 
97.4% 
73.7% 
 
 
38 
28 
Have you received training 
courses about A.B 
Yes 
No 
 
0.682 
 
0.168 
 
 
13.7% 
17.4% 
 
 
7 
4 
 
 
86.3% 
82.6% 
 
 
44 
19 
Graduation countries 
Arabic 
Non-Arabic 
 
0.720 
 
0.129 
 
16.1% 
12.5% 
 
10 
2 
 
83.9% 
87.5% 
 
52 
14 
Gender: 
              Male 
           Female 
 
 
0.127 
 
4.130 
 
26.9% 
23.1% 
9.1% 
 
7 
3 
4 
 
73.1% 
76.9% 
90.9% 
 
19 
10 
40 
 
Age group of GP: 
26-35 years 
36-45 years 
>45 years 
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5.2.2.6 Knowledge 
 
 
In table (5.25): illustrate the sources of information (UNRWA Formulary, STG experience, 
training courses, and pharmaceutical representative) that affect on antibiotics prescribed in 
sure bacterial diagnosis. 
Antibiotics prescribed in sure bacterial diagnosis and source of information 
(UNRWA Formulary) 
The percentage for source of information (UNRWA Formulary) were antibiotics 
prescribed in sure bacterial diagnosis was (89.8%) which is higher than source of 
information not (UNRWA Formulary) (73.5%) The difference between groups did not 
reached statistical significant level (X
2
=3.788, P= 0.052). 
Antibiotics prescribed in sure bacterial diagnosis and source of information (STG) 
 
The percentage for source of information (STG) were antibiotics prescribed in sure 
bacterial diagnosis was (85.7%) which is higher than source of information not (STG) 
(79.4%). The difference between groups did not reached statistical significant level 
(X
2
=0.569, P= 0.451). Clinical practice guidelines, another form of education, have
 
gained 
popularity as a means of influencing physicians' practices
 
(Audet and Greenfield, 1990). 
Such guidelines are primarily educational, in that they attempt
 
to inform practitioners about 
optimal strategies for diagnosis
 
and management. Even by this measure, clinical practice
 
guidelines have been remarkably unsuccessful in influencing
 
physicians. (Lomas, et al, 
1989). A study from Uganda showed that implementing Standard Treatment Guidelines 
followed by training and supervision was more effective in reducing the average number of 
drug prescribed and percentage of cases given antibiotics compared to distributing STG 
alone ( Kafuko , Zirabamuzaale ,and Bagenda 1999). Another study from Tanzania showed 
that developing and implementing STGs followed by monitoring reduced incorrect 
treatment  (Wiedenmayer et al 1999).  
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Antibiotics prescribed in sure bacterial diagnosis and source of information 
(Experience). 
The percentage for source of information (experience) were antibiotics prescribed in sure 
bacterial diagnosis was (95.3%) which is higher than source of information not 
(experience) (70.0%). The difference between groups reached statistical significant level 
(X
2
=9.496, P= 0.002). 
Antibiotics prescribed in sure bacterial diagnosis and source of information  
(Training courses) 
The percentage for source of information (training courses) were antibiotics prescribed in 
sure bacterial diagnosis was (94.6%) which is higher than source of information not 
(training courses) (73.9%). The difference between groups reached statistical significant 
level (X
2
=6.255, P= 0.012), In many countries overall or region specific (for e.g. in rural 
areas) lack of trained health care providers combined with poverty, low literacy rate and 
out of pocket expenses for medical care have allowed untrained prescribers of antibiotics 
to flourish (Gaur and English ,2006). 
Antibiotics prescribed in sure bacterial diagnosis and source of information 
(Pharmaceutical representative) 
The percentage for source of information (Pharmaceutical representative) were antibiotics 
prescribed in sure bacterial diagnosis was (93.5%) which is higher than source of 
information not (Pharmaceutical representative) (76.9%). The difference between groups 
did not reach statistical significant level (X
2
=3.828, P= 0.050). 
In our study analysis of the relation between knowledge and practices of General 
practitioner , there was no statistical  relation ship  between UNRWA formulary as a 
source of information and  antibiotics prescribed in sure bacterial diagnosis ,(P = 0.052)  
also the same there was no statistical  relation ship  between STG information source and 
antibiotics prescribed in sure bacterial diagnosis ,(P = 0.451). But there was statistical 
significance relation ship between experience as a source of information and antibiotics 
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prescribed in sure bacterial diagnosis, (P = 0.002 ), the same there was statistical 
significance between training and antibiotics prescribed in sure bacterial diagnosis, (P= 
0.012) . But there was no statistical relation between pharmaceutical representative and 
antibiotics prescribed in sure bacterial diagnosis, (P = 0.05 ) which clarify appropriate 
prescribing behavior. Contrary elsewhere pharmaceutical representatives are often the 
major source, and sometimes the only source, of medicines information for prescribers and 
continuing medical education is also often heavily dependent on the pharmaceutical 
industry. A review by WHO in 2005 of 2700 articles on drug promotion showed that: 
prescribers who see sales representatives often prescribe more medicines and more new 
medicines than their colleagues who see sales representatives less often; and that direct to 
consumer advertising is associated with increased patient requests and prescriptions ( 
Holloway,2005). Similarly  Bharathiraja, et al study in  2005 showed the fact that the 
prescription was largely based on the beliefs, knowledge and experience of the physician 
rather than on the workload in the practice setting. The same result of  Ross-Degnan, et 
al,1997 study were dissemination of printed clinical guidelines or unbiased drug 
information alone is not sufficient to cause measurable improvements in behavior.  
However, active dissemination of guidelines through staff training, peer group re-invention 
of guidelines, or audit and feedback has resulted in improved compliance with the 
guidelines.  Also Physicians who updated their knowledge through academic methods   
like  seminars, journals etc,  were less likely to prescribe antibiotics when compared to 
those depending on the information provided by the pharmaceuticals. This is primarily due 
to the bias caused by the pharmaceuticals promoting their products (Bharathiraja, et al 
,2005). Several explanations have been offered Why are most physicians not influenced by 
practice guidelines?. First, some guidelines
 
are not written for practicing physicians, but 
focus instead
 
on the current state of scientific knowledge (Lomas , 1991). Physicians may
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have difficulty applying guidelines of this type to specific
 
patients. Second, physicians may 
disagree with or distrust guidelines
 
written by so called national experts. Interviews with 
practicing
 
physicians indicate that many rely primarily on their own experience
 
or 
colleagues' recommendations in deciding whether to adopt
 
new techniques or interventions 
(Greer,1988). Finally, physicians may choose
 
to ignore guidelines because of non clinical 
factors, such as
 
financial incentives or the fear of malpractice litigation.
 
Thus, despite the 
current enthusiasm, guidelines by themselves
 
appear to have a limited role in influencing 
physicians' practices. 
Table (5.25): Chi-Square test for sources of information (UNRWA Formulary, STG, 
experience, training courses, and pharmaceutical representative) that affect on 
Antibiotics prescribed in sure bacterial diagnosis. 
 
 
P-
Value 
 
X
2 
Antibiotics prescribed in sure bacterial 
diagnosis 
 
Variables 
Sources of information No Yes 
% # % # 
 
0.052 
 
3.78 
 
10.2% 
26.5% 
 
 
5 
9 
 
 
89.8% 
73.5% 
 
 
44 
25 
UNRWA Formulary 
Yes 
No 
 
0.451 
 
0.569 
 
14.3% 
20.6% 
 
7 
7 
 
85.7% 
79.4% 
 
42 
27 
STG 
Yes 
No 
 
0.002 
 
9.496 
 
4.7% 
30% 
 
2 
12 
 
95.3% 
70.0% 
 
41 
28 
Experience 
Yes 
No 
 
 
0.012 
 
6.255 
 
5.4% 
26.1% 
 
2 
12 
 
94.6% 
73.9% 
 
35 
34 
Training courses 
Yes 
No 
 
0.050 
 
3.828 
 
 
6.5% 
23.1% 
 
 
2 
12 
 
 
93.5% 
76.9% 
 
 
29 
40 
Pharmaceutical 
representative 
Yes 
No 
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Chapter 6: Conclusion and Recommendation 
 
 
Conclusion: 
  
The aim of the study is to evaluate the antibiotics prescribing patterns and review the 
potential factors of inappropriate use. 
The study revealed over-use of antibiotics, as the percentage per encounter was 55.4%, and 
for antibiotics other than dermatological and opthalmological was 50.8%. The over-
consumption of antibiotics has great implications on the scarce health care resources, as the 
medication constitute the 2
nd
 budget after salary, and antibiotics represented 14% of total 
expenditure (UNRWA,2006). Also it leads to reduction in quality of health care and 
increase antimicrobial resistance. 
Great focus was given to cover the two dimensions of antibiotics prescriptions which were 
the consumers and health providers. The encounters antibiotics prescription was assessed 
by WHO prescribing indicators and the health providers prescribing behavior was 
evaluated by structured questionnaire related to knowledge, attitude and practice. 
The WHO antibiotics indicators clarify the following areas: 
High percentage of encounters with antibiotics prescribed, low percentage of antibiotics 
prescribed by generic names, 14.6% of prescription with no diagnosis, mainly (74%) in the 
Family Files. No mention for age in (49.5%) of the family files, the commonest diagnosis 
reported was URTI (37.1%) and (82.8%) of URTI were prescribed antibiotics, studies from 
various parts of the world report that over 80% of patients with viral respiratory tract 
infection receive antibiotics (WHO,2002), so years of prescribing antibiotics for viral 
respiratory infection have created a cycle of supply and demand, and misconceptions for 
the clients that every respiratory ill needs antibiotics pill. Breaking this cycle require public 
information, GPs education, and clients communication rather than prescribing to end the 
consultation. Most of antibiotics prescribed from UNRWA Formulary (99.7%) it is less 
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than 100% due to occasional availability of some donation medicines. There were 
statistical significance relationship between the antibiotic prescription and  the following 
demographical factors:  For governorate, the highest antibiotics prescription percentage 
was at Gaza governorate, and for age groups: The highest antibiotics prescription 
percentage was for adults, and the highest antibiotics injection mean was for 0-3 years. 
Questionnair: 
In relation to practice and personal data, 31% of GPs age from 26 to 35 years due to new 
recruitment, indicating their need for more training as there were statistical significance 
between age group 26-35 and  antibiotics prescription in fear of serious conditions. 
Regarding training and experience, there were statistical significance relationship between 
GPs who received training and antibiotics prescribed in sure bacterial diagnosis and the 
same for GPs who had more than 10 years experience confirming the importance of both 
training and experience. It is important to mention that there was  no statistical significance 
relationship between the place of graduation of GPs and antibiotics prescribed in sure 
bacterial diagnosis, indicating that the   prescribers have graduated from different countries 
with similar prescribing behaviour.  
Related to GPs knowledge, the present study emphasized the relation between the source 
of information as experience and training courses and antibiotics prescription in sure 
bacterial diagnosis, and no relation with UNRWA Formulary, STG and pharmaceutical 
representative. 
It is important to mention that dissemination of clinical guidelines as UNRWA Formulary, 
STG alone is not sufficient to cause measurable achievement in prescribing behavior, but 
active dissemination of clinical guidelines, through staff training, support and follow up 
will greatly improve the prescribing behavior and better health quality. Also physicians 
interest in clinical guidelines has never been great, only 9.5% of     UNRWA Formularies 
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available in front of GPs and 27.4% were at home, 71% currently using it and 48.9% 
facing problems in using it. Lack of  knowledge  represented  by: 67.9% of GPs stated the 
correct definition of antibiotics, 48.2% mention the correct generic names of some of 
antibiotics, 71.4% mention the importance to know the generic names, 64.3% antibiotics 
used in sub-acute bacterial endocarditis and rheumatic fever as prophylaxis, 71.1% 
antibiotics prescribed in suspected bacterial diagnosis, and 11.9% antibiotics prescribed in 
uncertain condition as prophylaxis. So the best intervention is education approach and 
increase awareness about antibiotics use among the practicing GPs to dispel inappropriate 
information and initiate necessary steps to deliver the latest advances of knowledge. GPs 
attitude toward antibiotics prescription is generally good, but GPs favor to prescribe 
antibiotics in case of fever was 65.1%, time pressure 72.6%, treatment uncertainty 28.6% 
and antibiotics resistance concern disfavor 51.8%  so the practicing GPs need to know that 
fever is not always a sign of bacterial infection and appropriate use of antibiotics is vital to 
reduce the development of further antibiotics resistance and not to prescribe antibiotics in 
uncertain condition. 
There were statistical significance relationship between the antibiotic prescription and  the 
following variables: 
-GPs having >10 years experience and antibiotics prescribed in sure bacterial diagnosis 
(P=0.013). 
-GPs age 26-35 years and antibiotics prescribed in fear of serious conditions (P=0.037). 
 -GPs at middle governorate and antibiotics prescribed in suspected bacterial diagnosis 
(P=0.004). 
-GPs having received training courses and antibiotics prescribed in sure bacterial diagnosis 
(P=0.003). 
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-Sources of information (experience) and antibiotics prescribed in sure bacterial diagnosis 
(P=0.002). 
-Sources of information (training courses) and antibiotics prescribed in sure bacterial 
diagnosis (P=0.012). 
GPs opinion about over prescription of antibiotics 
96.4% of respondents agree that antibiotics are over prescribed (Figure 6). The most 
important factors for over-prescriptions were: (Figure 7) Over-crowding 65%, clients 
pressure 55.7%, antibiotics prescribed without diagnosis 36.25%, lack of knowledge 
31.25%, outside prescriptions 31.25%, poor practice of private 21%, to get red of clients 
15.18%, and to satisfy clients 13.75%. 
The most important ideas for promotion of more prudent use of antibiotics: (Figure 8) 
Health educations of consumers 48.7%, training 47.4%, decrease over-crowding 33.3%, 
improve knowledge 29.4%, increase community awareness by media and school health 
program 28.6%, appointment system 25.6%, follow up and supervision 24.4%, and proper 
diagnosis, C&S 21.8%.  
 
 
 
 
 
 
 
 
 
 163 
Recommendation: 
1-  Active dissemination of independent un-biased information as therapeutic 
protocols and additional copies of UNRWA formulary and STG through staff 
training support and follow up to improve prescribing behavior and quality of 
care. 
2- There is a need to provide training on implementation of self- monitoring tools 
(WHO antibiotics indicators) to all the SMO and auditing the prescriptions as 
well as giving feedback to the health centers. 
3- Improving knowledge and change attitudes of prescribers by continuous in-
service medical education, seminars and workshops, especially for newly 
recruited staff to dispel inappropriate information and initiate necessary steps to 
deliver the latest advances of knowledge, as lack of knowledge was important 
underlying factors. 
4- Decrease over-crowding by recruitment of sufficient staff to decrease heavy 
patient load and time pressure. 
5- Efficient enforcing regulations: as limiting authority to prescribe certain 
antibiotics to  SMO and specialist , automatic stop orders for prophylactic 
antibiotics, fever is not always a sign of bacterial infection and so not an 
indication for providing antibiotics, in uncertain condition, in suspected bacterial 
diagnosis and fear of serious condition as appropriate use of antibiotics is vital to 
reduce the development of further antibiotics resistance, also instruct the GPs to 
report the diagnosis of the prescription as 14.6% of the encounters without 
diagnosis mainly (74%) in the family files, and encouraging the use of generic 
names of antibiotics. 
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6- Establishment of ―UNRWA Therapeutic Committee‖ to ensure the safe, efficient 
and effective use of antibiotics. 
7- Administrative incentives and sanctions to encourage appropriate behavior 
include awards for appropriate prescribing by incentives, promotion, and rewards.  
8- Cooperation between all sectors of health: UNRWA, government, private sectors 
and NGOs about importance of rational use of antibiotics. 
9- Caution during prescribing antibiotics for ―outpatient‖ ARI’s as it consumed 
more than half of antibiotics (59.7%) although mostly (>80%) due to viral 
infections. 
 
Recommendation for further studies:  
- The study needs to be repeated over time at the national  level to maintain good 
quality health care. 
- Further more it is essential to extend the study to private, and NGOs. 
- It is important to deal with other aspect of WHO drugs  indicators as patient care 
indicators and facility indicators. 
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Annex 1 
ُ١ؽشٌا ّٓؽشٌا الله ُغث 
 
 
ذ١غٌا  /د                                 /                خ١ؾزٌا ذؼث 
 
 
 تٌبطٌا بٔأ /ؼٌبط ٝغ١ػ ذّؾِ ٝغ١ػ .
 
 
ٌنذداٍع ٍِ ىخسأ  صىظخت ٌنريتاقٍ وأ ٌنذاظحلاٍ غػوو ٌٍنحذ(Questionnaire )
صاخىا  ثحثىات: 
“Antibiotics prescribing  patterns  by UNRWA general practitioners 
primary health care Gaza 2006 ’’. 
ةيطرٍ هّأ ثٍح حؼٍادىلىرو حٍاؼىا ححظىا حٍيم طذقىا  حىاعس ًيػ هىظحيى 
فذهذ ًهو شٍرغخاَىاىىإ : 
To evaluate the current prescribing patterns by the physicians and to 
identify the potential factors of irrational use of antibiotics  in UNRWA 
health center/ Gaza Strip. 
خظؽلاِ  :
خعاسذٌا خٍئعأ ،فاذ٘لأا ،حادلأا ٗ١طث ُىٌ كفشِ. 
ُىٔٚبؼر ُىٌ ٓ٠شوبش. 
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                        2 xennAتغٌ الله اىشحَِ اىشحٌٍ
 
 )َّىرج ٍىافقح لإخشاء تحث طحً  (
 
 tnesnoc demrofnI
 
 
اىَحرشٍح  / اىَشاسمح                                                اىَحرشً / حؼشج اىَشاسك 
تؼذ اىرحٍح 
: ٍىػىع اىذساعح 
لطبع غضح ٚوزٌه ِؼشفخ - رم١١ُ أّٔبؽ ٚطف اٌّؼبداد اٌؾ١ٛ٠خ ِٓ لجً الأؽجبء  فٟ ػ١بداد اٌٛوبٌخ 
ٚ لذ رغبػذ اٌذساعخ فٟ رؾغ١ٓ اعزخذاَ اٌّؼبداد , اٌؼٛاًِ اٌّؾزٍّخ ٌلاعزخذاَ اٌغ١ش سش١ذ ٌٙب 
. اٌؾ١ٛ٠خ فٟ ػ١بداد اٌٛوبٌخ
ئٕٟٔ ألَٛ ثؼًّ ثؾش ػٍّٟ ٚ٘ٛ عضء ِٓ دساعزٟ فٟ ثشٔبِظ ِبعغز١ش اٌظؾخ اٌؼبِخ فٟ عبِؼخ 
. فٍغط١ٓ- اٌمذط 
ع١زُ عّغ اٌج١بٔبد اٌّطٍٛثخ ِٓ ع١بدرىُ ِٓ خلاي الاعزج١بْ اٌزٞ  ٠ؾزٛٞ ػٍٝ خ١بساد ٌلإعبثخ ػٍٝ 
.   دل١مخ51 - 01وً عإاي ، اٌشعبء اخز١بس الإعبثخ الألشة ٌٍّّبسعخ اٌٛالؼ١خ ٌٚٓ رغزغشق أوضش ِٓ 
اٌّشبسوخ فٟ ٘زا اٌجؾش ؽٛػ١خ ٌٚه اٌؾك فٟ الأغؾبة فٟ أٞ ٚلذ رشبء ٚفٟ ؽبٌخ اٌّٛافمخ ع١زُ 
.  اؽزشاَ اٌغش٠خ ؽ١ش لا ؽبعخ ئٌٝ وزبثخ أعّبء ػٍٝ الاعزج١بْ لاْ الا٘زّبَ ثؾضٟ ٌٚ١ظ شخظٟ 
 شىشا ًٌزؼبٚٔىُ
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 3 xennA
 
       اىذمرىس أٌىب اىؼاىٌ       اىَىقش/ ٍذٌش تشاٍح اىظحح / اىغٍذ
 
ذحٍح ؽٍثح وتؼذ  
 
: اىَىػىع 
 ؽٍت اٌّٛافمخ ػٍٝ اٌم١بَ ثذساعخ رم١١ُ أّٔبؽ ٚطف اٌّؼبداد اٌؾ١ٛ٠خ ِٓ لجً الأؽجبء فٟ ػ١بداد 
. لطبع غضح ٚوزٌه ِؼشفخ اٌؼٛاًِ اٌّؾزٍّخ ٌلاعزخذاَ اٌغ١ش سش١ذ ٌٙب- اٌٛوبٌخ 
أؽ١ؾ ع١بدرىُ ػٍّب ثإٟٔٔ أسغت ثؼذ ِٛافمزىُ ػًّ اٌجؾش اٌّزوٛس أػلاٖ ؽ١ش أٔٗ ِزطٍت أعبعٟ ِٓ 
عبِؼخ اٌمذط ٚأٚد أْ أػٍُ ع١بدرىُ ثأْ - ِزطٍجبد اٌزخشط فٟ ثشٔبِظ اٌّبعغز١ش ٌىٍ١خ اٌظؾخ اٌؼبِخ 
:  اٌذساعخ عزىْٛ فٟ ػ١بدح اٌٛوبٌخ ٚعزشًّ اٌفئبد اٌزبٌ١خ
.  الأؽجبء اٌّؼبٌغ١ٓ فٟ ػ١بداد اٌٛوبٌخ. 1
: ٍِفبد اٌّشػٝ ِٓ اٌفئز١ٓ . 2
.  ٍِفبد الأؽفبي : ألً ِٓ صلاس عٕٛاد - 
.  ٍِفبد اٌؼبئٍخ : أوضش ِٓ صلاس عٕٛاد -  
٘زا ٠زطٍت اٌّمبثٍخ اٌشخظ١خ ِغ الأؽجبء اٌّؼبٌغ١ٓ ٚرٌه ٌزؼجئخ الاعزج١بٔبد اٌخبطخ ثبٌجؾش ٚوزٌه 
.  أخز ػ١ٕبد ػشٛائ١خ ِٓ ٍِفبد اٌّشػٝ 
 
.  ٚػٍ١ٗ ٔشعٛ ِٓ ع١بدرىُ اٌزىشَ ثبٌّٛافمخ ٚرٛع١ٗ اٌزٛط١بد اٌلاصِخ 
 
 
 ٚشىشاً 
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Annex 4 
1- Questionnaire:   Serial No:_________  
Part A:General Practitioner  Knowledge  
1-Please what do antibiotic mean for you?  
 
1- It is an antimicrobial that have antibacterial , anti- fungal , anti-viral, and 
anti-parasitic.    
2- It is a drug that kill or prevent growth of  bacteria and fungi.   
3- It is a drug that kill or prevent growth of the bacteria only.   
4- It is a drug that prevent growth of the bacteria and parasites.  
5- Non of the above. 
 
2-Are you aware of any danger to the clients associated with taking 
antibiotics?  
1- Emerging antibiotic resistance.                                                  
2- Allergic reactions.                                                                      
3- Antibiotics may kill ―friendly‖ ―good‖ microbes.                     
4- Misuse.                                                                                           
5- All of the above.                                                                         
6- Don't know.                  
3-Rational antibiotic use involves:   
The correct antibiotic, administered by the best route in the right amount, at 
optimum intervals, for the appropriate period  and after an accurate diagnosis. 
            0- No                1             1- Yes 
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4- Sources of information about antibiotics: 
 
1- UNRWA Model Formulary "off Essential Medicine" 
2- Standard Treatment Guidlines (STG)  
3- Experience  
4- Training courses  
5- Pharmaceutical representative  
6- Others  specify__________________________________ 
 
5-Who should provide information for the clients about antibiotics? 
1-  General Practitioner 
2-  Pharmacists 
3-  Nurses 
4-  1 & 2 
5-  All of the above 
6-Please mention the generic names of the following  antibiotics : 
a. Azimex:______________________ b Ogmine:. _____________________ 
c. Ciprocare:____________________ d. Ultracept:_____________________ 
e. Keflex:_______________________ f. LAP:________________________ 
g. Ospen:__________________________ 
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7-What is the importance to know the generic names of antibiotics? 
(0=No,1=yes) 
1- Facilitate good communication between health providers &citizens as we 
use the same terminology for certain antibiotics  
2- Avoidance of manipulation  
3- Prevent monopolies of the antibiotics by avoiding use the trade name.            
4- Knowledge generation. 
5- All of the above 
6- Non of the above 
Part B:-General Practitioner  Attitude 
Factors influencing G.P intention ( Favor / Disfavor) to prescribe 
antibiotics in UNRWA Health facilities (Pressure to) 
 
 Factors Favor(1) Disfavor(0) 
8- Fever   
9- Purulent discharge   
10- Patient request expectation   
11- Potential return visits cost   
12- Patient satisfaction   
13- Time pressure   
14- Treatment uncertainty   
15- Antibiotics resistance concern   
 
Part C: General Practitioner Practices 
 
16- Do you examine every case before prescribing antibiotics?  
1- Every case                           2- Sometimes          
 3- Rarely                                4- Not at all (over-crowding)                       
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17- Antibiotics are prescribed in : (0=No,1=Yes) 
 
1-Suspected  bacterial  diagnosis                    2-Viral infection              
 
3-Sure bacterial diagnosis                              4-Fear of serious Condition  
           
 
18-Have you received UNRWA Model Formulary? 
                
 1-   Yes                            0-  No                              If No go to Q : 26 
 
19- Availability of UNRWA Model Formulary "off essential medicine"? 
 (The data collector must observe the site of them) (0=Skip Q) 
1- In front of the G.P. at the desk  
2- In the drawer  
3- In the key board  
4- Other places please specify__________________________ 
 
 20- Did you use UNRWA Formulary in your prescription of antibiotics?  
           
1- Currently using it                2-Used in the past                3-Not used  
 
If not used go to Q: 26   (0=Skip Q) 
 
21-If currently using it or used in the past have you  noticed any problem  
 
in using UNRWA formulary?  
 
 1-Yes                            0-No                      (2=Skip Q)    If No go to Q: 23    
 
   
22- What problems do you face in using the UNRWA Formulary? 
(0=No,1=Yes,2=Skip Q)  
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1- Insufficient knowledge about antibiotics. 
2- Lack of continuous training on using it. 
3- Lack of time due to overcrowding. 
4- Difficult to be handled. 
5- Not all the antibiotics present in the EDL 
 
6- It is difficult to be used in front of the clients (barrier) 
 
7- Lack of motivation to change previous practices 
 
 
23- Did you see any improvement in prescribing pattern of antibiotics  
 
after using UNRWA Formulary?     1-Yes              0-No     (2=Skip) 
 
24 -Did you prescribe antibiotics outside UNRWA Formulary EDL? 
 
1-Frequently                  2-Sometimes                    3-Never                 4-Skip  
If never proceed to Q: 26 
 
25 – If frequently or sometimes  please mention the most common  
 
antibiotics were prescribed during  the last year and for what reasons.  
                                       
Antibiotics 
(0=No,1=Yes,2=Skip) 
Reasons 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
26- Have you received Standard Treatment Guidlines (STG) about the  
 
use of antibiotics in the management of infectious diseases 
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1-Yes                         0-No                                    If no proceed to Q:  31 
 
27-Have you used them during antibiotics prescriptions? 
 
1-Yes                        0-No                     ( 2=Skip)  
 
If no  proceed to Q: 31 
 
28-Have you seen any obstacles in using STG? 
 
1-Yes                       0-No                     (2=Skip)      If no go to Q : 30 
 
29-What are the obstacles in using Standard Treatment Guidlines? 
(0=No,1=Yes,2=Skip) 
 
1- Doubts whether it can perform the behavior 
 
2- Lack of familiarity with STG 
 
3- Lack of agreement to the concept of guidelines in general 
           
4- Patient-related barriers (difficult to be used in front of the clients) 
 
 
30-Did you notice improvement in antibiotics prescriptions by using 
STG?   
 
1- Yes                              0- No                           (2=Skip) 
 
31- Did you use antibiotics as a prophylaxis: (1=Yes,0=No) 
 
1- In uncertain conditions 
2- Fear induced  
3- In sub-acute bacterial endocarditis & Rh-fever  
4- All of the above  
5- Non of the above  
32- Do you believe that antibiotics are over prescribed?  
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           1- Yes                    0- No 
            If no go to Q: 35 (0=No,1=Yes,2=Skip) 
33-What are the most important factors that lead to over prescription of 
antibiotics  in UNRWA\H.C 
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________ 
 
34 - Regarding your opinion expressed what would help to promote more  
 
Prudent(rational) usage of antibiotics : (0=No,1=Yes,2=Skip) 
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________ 
 
35-Any comment not covered in the questionnaire: (0=No,1=Yes). 
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
_____________________________________________________________ 
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Part E: Personal data 
36- Age: ................ 
37 -Gender:    1-Male               2-Female  
38-Years of experience:  _______________________________________ 
39-Place of graduation:  _______________________________________       
 
40-Qualification: ______________________________________________ 
 
41-Have you received training courses about antibiotics?  
 
  1-  Yes                             0-No 
    
If no don't proceed to Q: 42,43, 44,45.              
 
42-How many times: (0=Skip) 
 
1- One time                          2-Two times           
 
3- Three times                      4-Four times                                                
 
 
43-last time:  (0=Skip) 
 
1-One year ago           2- Two years ago          3-Three years ago 
 
4-Four years ago        5- Five years ago   
 
 
44- Is it sufficient :               1- Yes                     0- No            (2=Skip) 
 
45-If no what do you suggest: (0=Skip,1=yes)________________________ 
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________ 
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Annex 5 
 
Diagnosis Codes 
Code Diagnosis Code Diagnosis 
1 Ear, Nose and Throught (ENT) 16 Male genital 
2 Eye disorders 17 Sexual Transmitted Diseases 
3 Headache 18 Blood diseases 
4 Migraine 19 Neoplasms 
5 URTI 20 Congenital Anomalies 
6 Candidiasis 21 A Influenza 
7 Lower respiratory tract infection 22 Typhoid 
8 Wheezy chest 23 Injuries 
9 Diseases Of The Digestive System 24 Growth Retarded 
10 Parasitic Diseases 25 Allergy 
11 Musculoskeletal diseases 26 Post vaccination fever 
12 Fever for investigation 27 Piles 
13 C-Cold 28  
14 Diseases Of The Skin And 
Subcutaneous Tissue 
29  
15 Renal diseases 30  
 
Classes of antibiotics (WHO)(Generic names) 
Penicillin: Code (1) 
Benzathine 
benzylpenicillin 
Procaine 
benzylpenicillin Phenoxymethylpenicillin 
(penicillin V) 
Benzylpenicillin 
(penicillin G) 
Amoxicillin Co-amoxiclav 
Cephalosporins: Code (2) 
Cephalexin 
Tetracycline: Code (3) 
Tetracycline capsules Doxycycline capsules  
Aminoglycosides: Code (4) 
Gentamycine 80 mg 
Macrolides: Code (5) 
Erythromycine Syrup 125mg,Tab 250mg Azithromycine Syrup 200mg ,Cap 250 mg 
Sulphonamide&Trimethoprim: Code (6) 
Co-Trimoxazole Syrup ,Tablet 
Quinolones : Code (7) 
Ciprofloxacine Tablet 250 mg Norfloxacine Tablet 400 mg 
Anti-Infective dermatological drugs : Code (8) 
Neomycin Sulphate and Bacitracin Ointment Silver Sulphdadiazine1% cream 
Anti-Infective Ophthalmological agents : Code (9) 
Chloramphenicol eye 
ointment 
Tetracycline eye ointment Sulphacetamide 
eye drops 
Gentamcine eye drops 
Code (0)for drugs other than antibiotics 
        
 
 196 
Annex 6                                               WHO Antibiotics prescribing indicator form 
Location:__________________________________ Date:______________      * 0 = No 1 = Yes 2= Not applicable 
 
Diagnosis Name 
Antibiotic 
Antibiotic on 
EDL 
(0/1/2)* 
Antib.Inj 
(0/1/2)* 
Generic 
(0/1/2)* 
Antib 
(0/1)* 
# drugs Gend 
M=1 
F=2 
Age Date ser
ial 
          1 
          2 
          3 
          4 
          5 
          6 
          7 
          8 
          9 
          10 
          11 
          12 
          13 
          14 
          15 
          16 
          17 
          18 
          19 
          20 
         Total 
         Average 
  % 
Of  total 
Antibiot. 
 %
Of  total 
Antibiot. 
 %
Of  total 
Antibiot. 
% 
Of  total  
cases 
   Percetage 
 791 
 7 :xennA
 )noisreV cibarA( eriannoitseuQ
ٍؼيىٍاخ اىطثٍة اىؼاً : اىدضء الأوه
: ِٓ فؼٍه ِبرا ٠ؼٕٟ اٌّؼبد اٌؾ١ٛٞ  . 1
 .ئٔٗ ِؼبد ٌٍّ١ىشٚثبد ٌزٌه فٍٗ فؼبٌ١خ ػذ اٌجىز١ش٠ب، اٌفطش٠بد،اٌف١شٚعبد، ٚوزٌه اٌطف١ٍ١بد . أ
 
 . ئٔٗ اٌذٚاء اٌزٞ ٠مزً أٚ ٠ّٕغ ّٔٛ اٌجىز١ش٠ب ٚ اٌفطش٠بد . ة
 
 .ئٔٗ اٌذٚاء اٌزٞ ٠مزً أٚ ٠ّٕغ ّٔٛ اٌجىز١ش٠ب فمؾ . د
 
 .ئٔٗ اٌذٚاء اٌزٞ ٠ّٕغ ّٔٛ اٌجىز١ش٠ب ٚاٌطف١ٍ١بد . س
 
. ٌ١ظ ِّب عجك . ط
 
 ً٘ أٔذ ٚاػٟ ٌٍّخبؽش  اٌّظبؽجخ لاعزخذاَ اٌّؼبد اٌؾ١ٛٞ ػٍٝ اٌّش٠غ؟. 2
 .أجؼبس ثىز١ش٠ب غ١ش ِغزغ١جخ ٌٍّؼبداد اٌؾ١ٛ٠خ . أ
 
 .ؽغبع١خ . ة
 
 .اٌّؼبد ِّىٓ أْ ٠مزً اٌّ١ىشٚثبد اٌظذ٠مخ ٚاٌغ١ذح . د
 
 .عإ اعزخذاَ . س
 
 .وً ِب عجك . ط
 
. لا أػشف . ػ
 
: الاعزخذاَ اٌؼملأٟ ٌٍّؼبد اٌؾ١ٛٞ ٠شًّ. 3
اخز١بس اٌّؼبد اٌؾ١ٛٞ الأِضً، ٚئػطبؤٖ ػٓ اٌطش٠ك إٌّبعجخ ثبٌىّ١خ اٌظؾ١ؾخ خلاي فزشح ِٕبعجخ ثؼذ اٌزشخ١ض 
. اٌذل١ك
لا . ٔؼُ                                                                                ة. أ
 
: ِظبدس اٌّؼٍِٛبد ثخظٛص اٌّؼبد اٌؾ١ٛٞ. 4
 .دٌ١ً اٌٛوبٌخ اٌذٚائٟ . أ
 
 .دٌ١ً اٌّؼبٌغخ اٌم١بعٟ . ة
 
 .اٌخجشح . د
 
 .اٌذٚساد اٌزذس٠ج١خ . س
 
 ِّضٍ١ٓ ششوبد الأدٚ٠خ . ط
  
 .أخشٜ، ؽذد . ػ
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ِٓ اٌزٞ ٠ؼطٟ ِؼٍِٛبد ٌٍّش٠غ ػٓ اٌّؼبد اٌؾ١ٛٞ؟ . 5
 .اٌطج١ت . أ
 
 .ِغبػذ ط١ذٌٟ . ة
  
 .اٌّّشع . د
 
 .ة+  أ . س
 
.  وً ِب عجك . ط
 
: ٍِ فؼيل أرمش الاعٌ اىؼيًَ ىنو ٍِ اىَؼاداخ اىراىٍح. 6
__________________   ع١جشٚوغ١ٓ. د _____________  ألّٕز١ٓ. ة_____________  أصِىظ. أ
 
_____________ ثٕغٍ١ٓ ؽٛ٠ً اٌّذٜ . ػ_______________ وفٍىظ. ط___________ اٌزشاعجذ. س
 
. ______________ أعجٓ. ؿ
 
 
: ٍا هً أهٍَح ٍؼشفح الأعَاء اىؼيٍَح ىيَؼاداخ اىحٍىٌح. 7
٠غبػذ فٟ ػٍّ١خ اٌزٛاطً اٌغ١ذ ث١ٓ ِضٚد اٌخذِخ ٚاٌّٛاؽٕ١ٓ ِٓ خلاي اعزخذاَ ٔفظ اٌّظطٍؾبد  . أ
 .ٌٍّؼبداد اٌؾ١ٛ٠خ
 
 .٠ّٕغ ػٍّ١خ اٌزلاػت . ة
 
 .٠ّٕغ ػٍّ١خ الاؽزىبس ٌٍّؼبداد اٌؾ١ٛ٠خ ػٓ ؽش٠ك ِٕغ اعزخذاَ الاعُ اٌزغبسٞ . د
 
 .رٌٛ١ذ اٌّؼشفخ . س
 
 .وً ِب عجك . ط
 
. ٌ١ظ ِّب عجك . ػ
 
 
اىرىخه ىيطثٍة  : اىدضء اىثاًّ
: ىىطف اىَؼاداخ اىحٍىٌح فً ػٍاداخ اىىماىح )ذحثز أو لا ذحثز(اىؼىاٍو اىرً ذؤثش فً ذىخه اىطثٍة 
 
ٍغيغو 
 
لا ٌحثز ٌحثز اىؼاٍو 
  اسذفاع  دسخح اىحشاسج . 8
  إفشاصاخ طذٌذٌح . 9
  سغثاخ وذىقؼاخ اىَشٌغ . 01
  ذىقغ ذنيفح صٌاسج ثاٍّح  . 11
  إسػاء اىَشٌغ . 21
  ػغؾ اىىقد . 31
  شنىك حىه اىؼلاج اىَىطىف . 41
  اهرَاً تظهىس تنرٍشٌا غٍش ٍغردٍثح ىيَؼاداخ . 51
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ٍَاسعاخ اىطثٍة اىؼاً : اىدضء اىثاىث 
 
هو ذفحض مو حاىح قثو وطف اىَؼاد  . 61
 
أثذا . ٔبدسا                         د. أؽ١بٔب                       ط. وً ؽبٌخ                      ة. أ
 
: اىَؼاد اىحٍىي ٌىطف فً . 71
 .اشزجبٖ رشخ١ض ثىز١شٞ . أ
 
 . اٌزٙبة ف١شٚعٟ . ة
 
 .اٌزٙبة ثىز١شٞ ِإوذ . د
 
اٌخٛف ِٓ ؽبٌخ خط١شح  . س
 
 
: هو اعريَد دىٍو اىىماىح اىذوائً. 81
 
 62لا                                       ئرا لا ار٘ت ٌٍغإاي . ٔؼُ                               ة. أ
 
. ٍناُ وخىد اىذىٍو اىذوائً. 91
 
 .ػٍٝ اٌّىزت . أ
 
 .فٟ اٌذسط . ة
 
 .)اٌخضأخ(فٟ اٌذٚلاة  . د
 
. ____________________ ِٕبؽك أخشٜ  ؽذد  . س
 
: هو اعرخذٍد اىذىٍو اىذوائً أثْاء اىىطفاخ ىيَؼاداخ اىحٍىٌح. 02
 
لا رغزخذَ  . اعزخذِزٙب فٟ اٌّبػٟ                        ط. ؽبٌ١ب أعزخذِٙب                    ة. أ
 
  62ئرا لا رغزخذَ ار٘ت ٌٍغإاي 
 
إرا ذغرخذً حاىٍا أو اعرخذٍد فً اىَاػً هو لاحظد أي ٍشامو  . 12
 
   32لا                                                  ئرا لا ار٘ت ٌٍغإاي . ٔؼُ                                      ة. أ
                                                                                                                                                  
 
: ٍا هً اىَشامو اىرً ذىاخهل ػْذ اعرخذاً اىذىٍو اىذوائً. 22
 
. ِؼٍِٛبد غ١ش وبف١خ ػٓ اٌّؼبد اٌؾ١ٛٞ. أ
 
ٔمض فٟ اٌزذس٠ت اٌّغزّش . ة
  
. لٍخ اٌٛلذ ثغجت الاصدؽبَ . د
 
. طؼت اٌزؼبًِ ِؼٗ. س
 002 
. ٌ١ظ وً اٌّؼبداد ِغٛدح فٟ اٌذٌ١ً. ط
 
. طؼت اعزخذاِٗ أِبَ اٌّش٠غ. ػ
 
. ٔمض فٟ اٌؾٛافض ٌزغ١١ش اٌّّبسعبد اٌمذ٠ّخ. ؿ
 
: هو وخذخ أي ذحغِ فً ػَيٍح وطف اىَؼاد اىحٍىي تؼذ اعرخذاً دىٍو اىىماىح اىذوائً. 32
 
لا    . ٔؼُ                                                                       ة. أ
 
: هو ذىطف ٍؼاداخ حٍىٌح  خاسج  اىذىٍو. 42
 
أثذا  . أؽ١بٔب                                       ط. ػذح ِشاد                                ة. أ
                         
 62ئرا أثذا ار٘ت ٌٍغإاي 
 
إرا ماُ ػذج ٍشاخ أو أحٍاّا ٍِ فؼيل أرمش أهٌ اىَؼاداخ اىرً وطفد خلاه اىؼاً اىَاػً وىَارا . 52
 
اىغثة اىَؼاد 
 
  
  
  
  
 
 
: هو اعريَد دىٍو اىَؼاىح اىقٍاعً حىه اعرخذاً اىَؼاداخ فً ٍؼاىدح الأٍشاع اىَؼذٌح. 62
 
لا  . ٔؼُ                                                                           ة. أ
      
 13ئرا لا ار٘ت ٌٍغإاي 
 
: هو اعرخذٍد اىذىٍو اىَؼاىح اىقٍاعً فً وطفاخ اىَؼاداخ اىحٍىٌح . 72
 
لا . ٔؼُ                                                                            ة. أ
       
 13ئرا لا ار٘ت ٌٍغإاي 
 
: هو لاحظد أي ٍؼىقاخ ٍِ اعرخذاً  اىذىٍو اىَؼاىح اىقٍاعً. 82
 
لا  . ٔؼُ                                                                             ة. أ
 
 03ئرا لا ار٘ت ٌٍغإاي 
 
: ٍا هً اىَؼىقاخ اىرً لاحظرها ٍِ اعرخذاً اىذىٍو اىَؼاىح اىقٍاعً. 92
 
الفض   =  2ٔؼُ           =   1لا         =  0             
 
 .شىٛن فٟ ئِىبٔ١خ رؼذ٠ً اٌغٍٛن . أ
 
 102 
 
 .غ١ش ِأٌٛف . ة
 
 .ػذَ ٚعٛد ئعّبع ػٍٝ ِفَٙٛ اعزخذاَ اٌذٌ١ً  . د
 
 .طؼٛثخ اعزخذاِٗ أِبَ اٌّشػٝ . س
 
 
: هو لاحظد ذحغِ فً وطفاخ اىَؼاداخ اىحٍىٌح ٍغ اعرخذاً اىذىٍو اىَؼاىح اىقٍاعً. 03
 
لا  . ة.                                                                       ٔؼُ. أ
 
: هو ذغرخذً اىَؼاداخ ىيىقاٌح ٍِ الأٍشاع. 13
 .فٟ اٌؾبلاد اٌغ١ش ِإوذٖ . أ
 
 .دافغ اٌخٛف . ة
 
 .اٌزٙبة ثطبٔخ اٌمٍت اٌجىز١شٞ اٌغ١ش ؽبد ٚاٌؾّٝ اٌشِٚبرضِ١خ . د
 
 .وً ِب عجك . س
 
 . ٌ١ظ ِب عجك . ط
 
. هو ذؼرقذ أُ اىَؼاداخ اىحٍىٌح ذىطف أمثش ٍِ اىلاصً. 23
 
لا  . ٔؼُ                                                                            ة. أ
 
. ٍا هً أهٌ اىؼىاٍو اىرً ذؤدي إىى الاعرخذاً اىَفشؽ فً اىَؼاداخ اىحٍىٌح فً ػٍاداخ اىىماىح. 33
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________ 
 
 )الاعرخذاً اىششٍذ(تخظىص سأٌل ٍا هً الأفناس اىرً ٌَنِ أُ ذحغِ اعرخذاً اىَؼاداخ اىحٍىٌح . 43
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________ 
 202 
. أي ٍلاحظاخ ٍهَح ىٌ ذغطى فً الاعرثٍاُ. 53
_________________________________________________________________________
_________________________________________________________________________
_____________________________________________________________ 
 
ٍؼيىٍاخ شخظٍح : اىدضء اىشاتغ
 :___________________ اىؼَش. 63
 
 أّثى- 2رمش                                                             -1:  اىدْظ. 73
 
:______________ عْىاخ اىخثشج. 83
 
:_______________ ٍناُ اىرخشج. 93
 
:_______________ ٍؤهلاذل اىداٍؼٍح. 04
 
هو أخزخ دوساخ ذذسٌثٍح تخظىص اىَؼاداخ اىحٍىٌح . 14
 
لا  . 2ّؼٌ                                                                               . 1
  
 54,44,34,24ئرا لا  الفض ػٓ الأعئٍخ 
 
: مٌ ٍشج. 24
 .ِشح ٚاؽذح .1
 
 .ِشربْ .2
 
 .صلاس ِشاد .3
 
. أسثغ ِشاد .4
 
: آخش ٍشج . 34
 لجً عٕخ .1
 
 .لجً عٕزبْ .2
 
 .لجً صلاس عٕٛاد .3
 
 .لجً أسثغ عٕٛاد .4
 
 .لجً خّغخ عٕٛاد .5
 
: هو اىرذسٌة مافً . 44
 
لا   . ٔؼُ                    ة. أ
. إرا لا ٍارا ذقرشذ. 54
_____________________________________________________________________ 
_________________________________________________________________________
_________________________________________________________________________
_____________________________________________________________ 
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Annex 8  
WHO Drug Use Indicators for primary health care facilities  
Core Drug Use Indicators 
Prescribing indicators 
1- Average number of medicines prescribed per patient encounter 
2- Percentage of medicines prescribed by generic name 
3- Percentage of encounters with an antibiotic prescribed 
4- Percentage of encounters with an injection prescribed 
5- Percentage of medicines prescribed from an EML or formulary. 
Patient care indicators 
1- Average consultation time 
2- Average dispensing time 
3- Percentage of medicines actually dispensed 
4- Percentage of medicines adequately labelled 
5- Percentage of patients with knowledge of correct dose. 
Health Facility indicators 
1- Availability of essential medicines list or formulary to practitioners 
2- Availability of clinical guidelines 
3- Percentage of key medicines available. 
Complementary drug use indicators 
1- Average medicine cost per encounter 
2- Percentage of prescriptions in accordance with clinical guidelines. 
3- Percentage of patients treated without drugs 
4- Percentage of drug costs spent on antibiotics 
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5- Percentage of drug costs spent on injections 
7- Percentage of patients satisfied with care they received 
8- Percentage of health facilities with access to impartial drug information 
 
Reference : (Management Science for Health, 1997) , (WHO,1993) 
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Annex 10 
Principles of academic detailing "Educational Outreach" 
 Conducting interviews to investigate baseline knowledge and motivations for 
current prescribing patterns  
 Focusing programs on specific categories of physicians as well as on their opinion 
leaders  
 Defining clear educational and behavioral objectives  
 Establishing credibility through a respected organizational identity, referencing 
authoritative and unbiased sources of information, and presenting both sides of 
controversial issues  
 Stimulating active physician participation in educational interactions  
 Using concise graphic educational materials  
 Highlighting and repeating the essential messages  
 Providing positive reinforcement of improved practices in follow up visits 
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Annex 11 
 
Materials available to support an intervention program on antibiotic use 
Principles of judicious antibiotic use for pediatric infections. 
Academic sheets providing one page summaries of the principles of antibiotic use. 
Posters for educating patients. 
Pamphlets for educating patients.  
Question and answer sheets for viral respiratory diagnoses. 
A ―prescription pad‖ including recommendations for symptomatic treatment for patients 
with viral respiratory infections.  
A letter to childcare providers stating that the child can return to day care without an 
antibiotic.  
These materials are available from the Centre for Disease Control and Prevention.(CDC)     
( Edward A Belongia, and Benjamin Schwartz, 1998) 
 
 
 
 
 
 
 
 
 
 
 
 
 
